Doctor of Philosophy by Haliski, Melissa Leigh
REGULATION OF SUBCELLULAR MRNA LOCALIZATION IN STRIATAL 
EFFERENT NEURON SUBPOPULATIONS AND DISRUPTION BY 
METHAMPHETAMINE 
by 
Melissa Leigh Haliski 
A dissertation submitted to the faculty of  
The University of Utah  
in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy 
Department of Pharmacology and Toxicology 
University of Utah 
May 2013 
Copyright © Melissa Leigh Haliski 2013 
All Rights Reserved 
T h e  U n i v e r s i t y  o f  U t a h  G r a d u a t e  S c h o o l
STATEMENT OF DISSERTATION APPROVAL 
The dissertation of Melissa Leigh Haliski 
has been approved by the following supervisory committee members: 
Kristen Keefe , Chair 3/14/2013 
Date Approved 
Andrea Bild , Member 3/14/2013 
Date Approved 
Julie Hollien , Member 3/14/2013 
Date Approved 
Carol Lim , Member 3/14/2013 
Date Approved 
Karen Wilcox , Member 3/14/2013 
Date Approved 
and by William Crowley , Chair of 
the Department of Pharmacology and Toxicology 







The striatum is the key input nucleus of the basal ganglia, which critically mediate 
normal action selection. Coordinated neuroplasticity within striatonigral and striatopallidal 
efferent neuron subpopulations of striatum facilitates the maintenance of learned behaviors. 
In this regard, abnormal striatal plasticity is implicated in compulsive and addictive 
behaviors. The immediate-early gene, Arc (activity-regulated, cytoskeleton-associated), 
critically mediates such normal neuroplasticity. In normal animals, more striatonigral than 
striatopallidal neurons contain cytoplasmic Arc mRNA, despite equivalent transcriptional 
activation of the Arc gene. Thus, these neuronal populations may differentially regulate Arc 
mRNA posttranscriptional processing and/or cytoplasmic localization and, consequently, 
utilize different mechanisms of synaptic plasticity. Therefore, these studies determined the 
subcellular basis for such differential cytoplasmic localization of Arc in striatal efferent 
neuron subpopulations. First, we characterized the striatal expression of eIF4A3, which 
regulates cytoplasmic Arc stability in vitro through the process of translation-dependent 
mRNA decay. Then, to assess whether phenotypic expression differences are unique to Arc, 
we investigated a similarly regulated immediate-early gene, zif268/egr-1, which is not subject 
to cytoplasmic translation-dependent mRNA decay, as well as dendritically localized, but 
constitutively expressed, Map2. Like Arc, normal animals had more striatonigral than 
striatopallidal neurons with zif268 mRNA in the peri-nuclear cytoplasm, whereas Map2 
expression showed no phenotypic differences. Importantly, striatopallidal neurons had 
predominately nuclear zif268 retention whereas striatonigral neurons had predominately 
cytoplasmic zif268 localization. Finally, examining transcriptional activation and cytoplasmic 
expression of Arc in striatopallidal and striatonigral neurons subsequent to partial dopamine 
denervation induced by methamphetamine (METH) revealed increased basal Arc expression, 
but impaired activity-induced transcription of Arc in METH- vs saline-pretreated rats. 
Furthermore, METH-pretreated rats showed blunted cytoplasmic Arc localization. 
Interestingly, cytoplasmic localization of zif268 was also disrupted by partial dopamine loss, 
suggesting that dopamine may contribute to cytoplasmic mRNA localization in striatal 
efferent neurons. The present findings suggest that striatonigral and striatopallidal neurons 
differentially regulate posttranscriptional processing and/or nuclear export of activity-
regulated mRNAs, highlighting a novel, unexplored subcellular difference in striatal efferent 
neuron subpopulations. These data further suggest that striatal efferent neuron 
subpopulations may normally utilize different mechanisms of synaptic plasticity to 
coordinate basal ganglia signaling.  
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CHAPTER 1 
INTRODUCTION 
Introduction to the Basal Ganglia 
The basal ganglia critically mediate normal behavioral functions by linking cortical 
activation to the output systems necessary to execute such intended behavior [1]. These 
output pathways project onto four different brain areas: thalamic nuclei that project to 
frontal cortical areas mediating action selection and execution of movement; midbrain 
regions, including the superior colliculus, contributing to eye movements; the 
pedunculopontine nucleus mediating orientating movements; and finally, hypothalamic 
structures that regulate autonomic function [2,3]. The major anatomical components of the 
basal ganglia include the frontal cortex, striatum (caudate and putamen in primates), nucleus 
accumbens (ventral striatum), external and internal segments of the globus pallidus, 
subthalamic nucleus, and substantia nigra pars reticulata. Altogether, these nuclei of the basal 
ganglia coordinate parallel circuits between striatum, thalamus, and cortex to facilitate 
normal behavioral selection. 
The striatum is the key input nucleus of the basal ganglia (Figure 1.1). There are 
regional divisions within rodent and primate cortex with respect to input onto striatum, with 
the medial striatum (caudate in primates) primarily receiving excitatory input from prefrontal 
cortical circuits and the lateral (putamen in primates) receiving excitatory input from the 
somatosensory and motor cortices. In addition to the gross neuroanatomical division 
between medial and lateral striatum, there also exists within the striatum distinct subclasses 
of GABAergic spiny efferent neurons that can be phenotypically differentiated at the level of 
their output pathways. Approximately ninety-five percent of neurons in striatum are spiny 
efferent neurons, and these efferent neurons can be divided into two subpopulations: 
striatonigral "direct" pathway neurons and striatopallidal "indirect" pathway neurons (Figure 
1.1) [4-7]. The striatonigral neurons primarily project to the internal segment of the globus 
pallidus and substantia nigra pars reticulata, whereas striatopallidal neurons primarily send 
their axonal projections to the external segment of the globus pallidus [1]. The “direct” 
pathway neurons selectively provide direct input to the internal segment of the globus 
pallidus and substantia nigra, and thus reinforce planned movements [5,8,9]. Conversely, the 
“indirect” pathway neurons selectively project to the external segment of the globus pallidus, 
which in turn projects to the subthalamic nucleus to modulate cortical activity and terminate 
movements previously directed by activation of the direct pathway [5,8,9]. This differential 
and antagonistic output circuitry of striatal spiny efferent neurons contributes to the 
coordinated regulation of basal ganglia function and thus behavioral selection. 
Importantly, striatal efferent neurons also can be phenotypically differentiated at the 
cell body level by their selective expression of neuropeptides and neurotransmitter receptors. 
Striatonigral neurons contain preprotachykinin (ppt) / substance P, and preprodynorphin / 
dynorphin [10]. Striatopallidal neurons express preproenkephalin (ppe) / met-enkephalin [11]. 
We will herein utilize the phenotypic neuropeptide expression to differentiate striatal efferent 
neuron subpopulations. Additionally, these striatal efferent neuron subpopulations also 
selectively express different receptors, resulting in differential regulation of intracellular 
signaling cascades and responses to afferents (Figure 1.1). For example, striatonigral neurons 
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express stimulatory Gαs/olf protein-linked D1-type dopamine receptors, which are positively 
coupled to adenylyl cyclase (AC) [12,13]. Conversely, striatopallidal neurons selectively 
express inhibitory Gαi/o protein-coupled D2-type dopamine receptors [14,15], which inhibit 
AC activity [16]. Such distinct dopamine receptor expression within specific striatal output 
neurons leads to differential regulation by dopamine of the activity of AC and thus protein 
kinase A (PKA) [17], a key second messenger, within these neurons. Additionally, 
striatopallidal neurons selectively express the Gαs-coupled adenosine 2a receptor (A2A) [18]. 
A2A receptors antagonize D2-dopamine receptor function by reducing the affinity and 
transduction potential of D2 receptors in response to dopamine [19]. Furthermore, Gs/olf-
coupled A2A receptors activate AC-PKA, and thus oppose the inhibitory effect on AC 
produced by Gi-coupled D2 receptors [20]. By differentially regulating key cellular receptors 
and second messengers involved in synaptic plasticity processes, such integrated 
neurochemical signaling in striatal projection neurons allows for normal, coordinated 
regulation of their target nuclei (D1-SNpr; D2-GPe; Figure 1.1) and, thus, action selection 
and behavior [14,21]. 
Neuronal Synaptic Plasticity 
The majority of fast neuronal synaptic transmission within the adult mammalian 
brain proceeds either through the presynaptic regulation of neurotransmission or through 
the postsynaptic strengthening or weakening of the efficacy of neuronal connections at 
synapses via changes in the expression of AMPA-type glutamate receptors (AMPARs). The 
cycling of AMPARs at the cell surface in synapses contributes to the development of long-
term potentiation (LTP) and long-term depression (LTD), forms of synaptic plasticity 
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implicated in learning and memory [22-24]. Additionally, neuronal homeostatic plasticity 
regulates longer-duration plastic responses to these subcellular modifications in synaptic 
transmission and receptor cycling without large-scale modifications of regional synaptic 
connectivity within neuronal networks [25,26]. Neuronal circuit activity and the history of 
activity at individual synapses tightly regulate the number, synaptic localization (externalized 
or internalized), and subunit composition of AMPARs. Thus, neurons can strengthen or 
weaken their response to excitatory input for durations of minutes to months, and such 
changes in relative synaptic strength contribute to long-term learning and memory processes 
within the brain. 
One process by which synaptic strength is altered is through LTP, in which there is 
increased efficiency of synaptic connectivity due to cytoskeletal remodeling, enhanced 
AMPAR exocytosis, and AMPAR recycling. Much work has identified significant alterations 
in cytoskeletal architecture during LTP, including the formation of new dendritic spines and 
the enlargement of existing ones [27-29]. Importantly, fluctuations in F-actin polymerization, 
shifting between filamentous F- and globular G-actin, result in structural modifications 
necessary to remodel dendritic spines [30-34], and it is currently believed that a shift in the 
F-actin/G-actin ratio results in the modifications to dendritic spine structure contributing to 
LTP [35-37,29]. In dendritic spines, two pools of F-actin exist that directly coordinate 
synaptic response: one dynamic pool located directly below the spine surface to coordinate 
AMPAR, NMDAR, and scaffolding protein expression; and a second, less dynamic pool that 
supports overall spine structure [35,36]. There are increased numbers of new thin, “learning” 
spines in LTP [38], and late LTP (>3 hours post activity) requires new spine formation [39]. 
One of the most important and highly enriched postsynaptic molecules contributing to LTP 
is CaMKII [40,41], which directly contributes to F-actin polymerization through the F-actin 
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binding domain of the CaMKIIβ subunit [42]. CaMKII activity is essential to structural 
plasticity, as the targeted blockade of kinase activity disrupts long-term spine enlargement 
underlying LTP [42,43,29].  
Modifications in AMPA receptor surface expression at synapses may contribute to 
the changes in spine morphology. Furthermore, the surface expression of AMPARs is highly 
correlated to spine size, with thin, "learning" spines possessing few AMPARs, and large, 
stable spines having many AMPARs [44]. Localized insertion of recycling endosomes plays 
an essential role in LTP [45]. Synaptic potentiation drives the Ca2+ sensitive motor proteins 
myosinVa and Vb to deliver cargo vesicles containing AMPARs to the synaptic surface, thus 
increasing AMPAR surface expression [46,47]. Once inserted at the synaptic surface, there is 
also lateral diffusion of AMPARs from nonsynaptic dendritic surfaces into the synapse [48-
52]. Importantly, GluA1 subunit insertion is essential to the stable enlargement of spines 
with LTP [53,54]: under basal conditions, GluA1 is not present at synapses, but in response 
to LTP, GluA1 is driven to the synaptic membrane [52,54]. It is thus clear that AMPA 
receptor externalization and cytoskeletal remodeling results in increased efficacy of synaptic 
transmission in LTP, leading to improved ability to depolarize the postsynaptic neuron and 
thus synaptic strengthening. 
In contrast to LTP, cytoskeletal remodeling and receptor trafficking in LTD results 
in dampening of neuronal responses to excitatory afferents. First, there is both shrinkage and 
elimination of existing dendritic spines in LTD [55,56]. Additionally, whereas LTP increases 
the F-/G-actin ratio, LTD shifts the actin equilibrium towards increased G-actin [42]. Third, 
endocytosis and lysosomal degradation of AMPARs can decrease spine transmission 
efficiency [24], and AMPARs are known to be subject to such regulation depending on the 
cellular stimulus [51,57]. For example, glutamate stimulation [58] results in endocytosis of 
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AMPARs through a clathrin- and dynamin-dependent pathway [59-61] within endocytic 
zones located lateral to the postsynaptic density (PSD) of dendritic spines [62,51]. Thus, 
AMPA receptor internalization plays a critical role in LTD. 
AMPA receptor internalization is a highly regulated process. For example, in 
response to glutamate NMDA receptor activation, endocytosed AMPARs are sorted into 
recycling endosomes in a PKA-dependent manner. Conversely, in response to AMPAR 
activation, internalized AMPARs are degraded [63,51]. Interestingly, Lee and colleagues 
further observed that the fate of the internalized receptors is even more highly regulated, 
with different AMPAR subunits selectively sorted along the endosomal pathway [63]. In 
response to NMDA receptor stimulation, homomeric GluA2-containing receptors enter the 
late endosomal pathway and undergo degradation, whereas in response to AMPA receptor 
activation, the receptors are recycled. GluA1 subunit-containing AMPA receptors, on the 
other hand, remain in the recycling pathway following NMDA receptor stimulation [63]. 
These findings suggest that incorporation of the GluA2 subunit defines the endosomal 
pathway into which AMPARs [63,51,64] will cycle and, thus, AMPAR intracellular fate. Such 
regulation of AMPA receptors clearly is of high significance, as the coordinated regulation of 
AMPAR localization on dendritic spines is a critical mediator of synaptic transmission and 
increased AMPAR internalization is a hallmark feature of LTD. 
These immediate modifications of Hebbian forms of synaptic plasticity (LTP and 
LTD), wherein correlations between pre- and postsynaptic neuronal firing drives 
postsynaptic changes in the efficacy of synaptic transmission, occur relatively rapidly, and 
result in localized, ultrastructural modifications to specific synapses in neurons. Such forms 
of plasticity are dependent on neuronal firing patterns and progressively modify neuronal 
connectivity to make associative changes in response to such stimuli, ultimately resulting in 
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neuronal destabilization due to the increased or decreased ease with which a postsynaptic 
neuron can subsequently be depolarized by the presynaptic input [65]. To counterbalance 
these rapid, destabilizing changes, neurons also undergo homeostatic plasticity, which 
stabilizes their own activity, as well as circuit-level activity [24]. Homeostatic plasticity is thus 
a more global mechanism that neurons and neuronal circuits utilize to maintain a specific 
level of activity or parameter “set point” [26]. Should signals or activity deviate from this set 
point, the neurons/system respond to return activity in the necessary direction. Thus, these 
more universal compensatory mechanisms in a neuron can be activated to maintain normal 
activity while leaving synapse-specific changes in strength relatively maintained.  
Homeostatic plasticity allows neurons to dynamically respond to stimulation 
specifically through the scaling up or scaling down of synaptic transmission to calibrate 
neuronal excitability. One the one hand, increased activity, over time, leads to a global 
decrease in excitability and thus, normalization of firing. For example, hippocampal and 
cortical neuron cultures induced to fire repeatedly over many hours eventually return firing 
rates to basal levels [66,67]. Mechanistically, extraneous synaptic activity results in enhanced 
intracellular calcium, gene transcription, CaMKIV activation, and polo-like kinase 2 
(Plk2)/Cdk-5 activation [68,69]. Plk2 activation phosphorylates factors which regulate the 
calcium-impermeable, slowly deactivating GluA2 subunits [68,70], resulting in a reduction in 
activity-induced AMPAR accumulation in synapses [69], and thus, a scaling down of synaptic 
transmission. An additional scaling down pathway has recently been demonstrated to depend 
on activation of the immediate-early gene Homer1a, resulting in reduced tyrosine 
phosphorylation of GluA2 [71,26]. On the other hand, decreases in neuronal activity are 
associated with an overall increase in neuronal excitability, termed "scaling up," which also is 
secondary to alterations in AMPA receptor expression and cell-surface insertion. For 
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example, blocking postsynaptic neuron firing leads to decreases in somatic calcium, 
CaMKIV activation, and gene transcription [72]. Also, the AMPAR binding protein, PICK1, 
specifically regulates the intracellular pool of receptors, selectively binds to GluA2 receptors 
[73], and is essential to scaling up, but not scaling down [26]. These intracellular scaling 
responses then result in enhanced AMPAR externalization and increased amplitude of 
miniature excitatory postsynaptic currents (mEPSCs). Such cell-autonomous changes in 
synaptic scaling are exquisitely different from LTP and LTD and operate over a longer 
duration within a wider spatial range in a neuronal network, employing distinct cellular 
trafficking and molecular events to regulate AMPARs within a neuron [26], thus making 
homeostatic plasticity an additional means by which neurons and neuronal circuits respond 
to stimuli. 
Striatal Synaptic Plasticity 
The dorsal striatum is involved in reward processing, goal-directed behaviors, and 
habit formation [74,75,1,9]. Synaptic plasticity within this brain region is thus critical to the 
acquisition and maintenance of such learned behaviors [76,77]. Abnormal signaling and 
plasticity in the basal ganglia is implicated in compulsive and addictive behaviors, as well as 
behavioral sequelae of neurodegenerative disorders, such as Parkinson’s and Huntington’s 
disease [78-82], including L-DOPA-induced dyskinesias [83-85]. Thus, understanding the 
mechanisms underlying LTP, LTD, and homeostatic plasticity in striatal efferent neurons 
will be critical for advancing our ability to prevent or manage neurological and 
neuropsychiatric consequences of basal ganglia dysfunction. 
Much of our understanding of synaptic plasticity processes in general has been 
developed based on studies of hippocampal and cortical systems (see for example [86]), as 
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reviewed above. Unfortunately, the neuroanatomical heterogeneity of striatal projection 
neurons has slowed our understanding of plasticity-related cellular processes in the striatum 
in vivo. Importantly in this regard, recent work by Baucum and colleagues highlighted 
selective, but significant, differences between the hippocampus and striatum at the level of 
the assembly of synaptic and extrasynaptic signaling complexes essential to neuroplasticity 
processes [87]. Thus, it is essential to further examine the specific cellular and molecular 
processes mediating striatal neuroplasticity in identified striatal efferent neuron populations 
so as to better understand both normal, as well as aberrant, functions within this key nucleus 
of the basal ganglia. By fully understanding normal mechanisms underlying neuronal synaptic 
plasticity processes within the striatum, novel methodologies and therapeutic targets can be 
identified to improve treatment strategies for disorders of the basal ganglia, including drug 
abuse and addiction, and movement and compulsive disorders. 
Striatal neuron plasticity is regulated by glutamate derived from cortical and thalamic 
afferents, dopamine derived from nigral afferents, and calcium. Glutamate input alone seems 
to result in the development of LTP of synaptic transmission [88,89], whereas glutamate 
input coincident with dopamine input onto striatal spiny efferent neurons can induce LTD 
of synaptic transmission [88,89]. Additionally, removing the magnesium block from the 
NMDA receptor results in calcium influx that can induce LTP in the absence of dopamine 
[90]. Furthermore, in response to presynaptic stimulation following postsynaptic spikes (10 
ms), spiny efferent neurons show specific differences in response to stimulation; cultured D2 
receptor-containing spiny efferent neurons (presumed striatopallidal) show LTD, whereas 
D1 receptor-containing spiny efferent neurons (presumed striatonigral) show no change in 
excitatory postsynaptic potential (EPSP) amplitude, indicating no induction of LTD or LTP 
[91]. Furthermore, Shen and colleagues demonstrated that selectively blocking D1 receptors 
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during this paradigm of pairing postsynaptic spiking followed by presynaptic activity resulted 
in robust LTD in D1 receptor-containing spiny efferent neurons, thereby demonstrating that 
DA is required for LTP induction in D1 receptor-containing neurons (presumed 
striatonigral) [91]. These studies demonstrate that spiny efferent neurons show a differential 
response to pre- and postsynaptic stimulation pairings, indicating that DA is required to 
induce bidirectional, timing-dependent plasticity at glutamatergic synapses in medium spiny 
neuron cultures and that such plasticity is DA receptor content-dependent [91]. As normal, 
tonic firing of DA neurons results in sufficient levels of DA to stimulate D2-, but not D1-, 
containing DA receptors in medium spiny neurons [92,93], the absence of behaviorally-
relevant stimuli (i.e., low extracellular DA concentration) would normally result in LTP in 
striatopallidal neurons, but should only induce LTD in striatonigral neurons [91]. On the 
other hand, phasic DA release in response to behaviorally-relevant stimulation will 
sufficiently activate D1-containing DA receptors to induce LTP in striatonigral neurons 
[93,92,91]. Thus, under periods of fluctuations in behavioral activation, DA can differentially 
modulate the plasticity response within striatonigral and striatopallidal neurons. Such data 
highlight the myriad ways in which synaptic efficacy in striatal medium spiny neurons can be 
modified through both glutamate and dopamine signaling, as well as providing an intriguing 
explanation for divergent roles that medium spiny neurons play in regulating behavior. 
Striatal neurons rapidly respond to excitatory input due to their expression of 
AMPA-type glutamate receptors on the cell surface [23,94]. Heteromeric AMPA-type 
glutamate receptors are composed of subunits GluA1-4, with GluA1 and GluA2 subunits 
predominating within striatum [95-98]. Importantly, subunit composition critically 
determines the biophysical properties of AMPA receptors [99-102]. GluA2 subunit-
containing AMPA receptors are Ca2+ impermeable, show smaller conductance, and 
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desensitize and deactivate more slowly than do GluA1 subunit-containing receptors [103-
106]. Furthermore, the presence or absence of GluA2 subunits contributes to changes in 
synaptic strength [107,108], as detailed above. AMPA receptor functional properties also are 
acutely responsive to phosphorylation of the GluA1 subunit at two separate sites [102]. 
Phosphorylation by PKA at Ser845 increases the open probability of the channel and drives 
synaptic membrane insertion [109-111]. For example, within striatal spiny efferent neurons, 
PKA-dependent phosphorylation of GluA1 at Ser845 results in enhanced AMPA receptor 
surface expression [112,113]. Phosphorylation of GluA1 at Ser831 [114,115] by protein 
kinase C and calcium/calmodulin-dependent protein kinase II results in increased AMPA 
channel conductance [116]. As previously detailed, increases in AMPAR surface expression 
and function result in LTP, whereas removal of synaptic AMPARs results in LTD [24]. 
Thus, the subunit composition and subunit phosphorylation state of AMPA receptors can 
critically regulate striatal synaptic plasticity.  
Within the striatum, AMPAR subunit distribution likely contributes to factors 
underlying differences in synaptic plasticity in striatal efferent neuron populations. Although 
AMPARs can be comprised of multiple subunits, immunohistochemical staining and 
coimmunoprecipitation for GluA1, GluA2/3, and GluA4 subunits within dorsal striatum 
demonstrate that GluA1 and GluA2/3 subunits predominately colocalize with striatal 
projection neurons [117-119,98]. However, ultrastructural imaging of the spines of striatal 
efferent neuron subtypes suggests that there are distinct differences in subunit expression, 
with striatonigral dendritic spines more commonly containing GluA2 and/or GluA3 
subunits, whereas striatopallidal dendritic spines more commonly contain GluA1 subunits 
[120]. As described previously, subunit composition determines routes of AMPAR 
trafficking, with GluA1 determining AMPAR fate during exocytosis, and GluA2 regulating 
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endocytosis and postendocytotic endosomal sorting [24]. In the absence of GluA2 surface 
expression, maintenance of LTP is abolished, and there is Ca2+-dependent intracellular 
retention of GluA2 in endosomal compartments during LTD [24]. As GluA2 subunits 
predominately control AMPAR recycling and endocytotic sorting in response to changes in 
synaptic transmission efficiency, such divergent distribution of GluA2 expression on the 
spines of striatal efferent neurons provides another basis for neuroplasticity processes within 
striatal efferent neurons to be differentially regulated.  
Neuromodulators critical to striatal neuron function may differentially contribute to 
regulation of AMPA receptor trafficking and surface expression in the subtypes of striatal 
projection neurons. Specifically, AMPA GluA1 subunits are phosphorylated at Ser845 by 
PKA downstream of D1-type dopamine receptor activation [113,121]. Furthermore, using 
the D1-receptor agonist SKF 81297, Mangiavacchi and Wolf demonstrated that GluA1 
subunit surface expression is enhanced, in a PKA-dependent manner, in ventral striatum 
following D1 receptor activation [112]. Given that D1-type dopamine receptors are 
selectively expressed in striatonigral neurons [14,122], it is likely that such D1 receptor 
activation contributes to enhanced surface expression of AMPA receptors in striatonigral 
efferent neurons [113]. Conversely, activation of D2-type dopamine receptors, 
predominately expressed in striatopallidal neurons [14], inhibits GluA1 subunit 
phosphorylation at Ser845, resulting in AMPA receptor endocytosis [123]. Thus, differences 
in AMPA receptor subunit composition in specific striatal efferent neuron populations, as 
well as differential regulation of AMPA receptor subunit surface expression by dopamine 
signaling within those neuronal populations may contribute to differential forms of synaptic 
plasticity processes, including LTP [94,23], LTD [23], and homeostatic synaptic scaling 
[124,125] within striatal efferent neuron subpopulations. Further understanding the 
12
processes and molecules that thus regulate AMPA receptor surface expression within striatal 
efferent neurons will afford improved direction in developing therapeutic interventions for 
basal ganglia-mediated pathologies. 
Arc and Neuroplasticity 
The immediate-early gene Arc (activity regulated, cytoskeleton-associated protein) is 
an important molecule that contributes to normal AMPA receptor surface expression and, 
thus, neuroplasticity. Arc mRNA expression and subcellular distribution is activity regulated 
[126,127], and the mRNA is localized to dendritic spines in response to neuronal activation 
where it undergoes localized protein translation [128]. Importantly, knockdown of Arc 
impairs both hippocampal- [129,130] and basal ganglia-mediated learning and memory 
processes [131,132], thereby highlighting the critical role Arc plays in mediating normal 
synaptic plasticity processes, including those in the striatum.  
As a synaptic protein, Arc likely makes several contributions to processes involved in 
synaptic remodeling [133]. First, Arc appears to play a role in LTD. For example, Arc 
protein localizes to the PSD of excitatory synapses [126,134], where it interacts with 
endophilin 2/3 and dynamin to form a trafficking endosome to regulate endocytosis of 
AMPA receptors [135-137]. Consistent with this role mediating endocytosis, overexpression 
of Arc protein reduces the amplitude of synaptic currents mediated by AMPA receptors 
[136]. Furthermore, Arc regulation of AMPA-receptor endocytosis appears to be different 
for AMPA receptors comprised of different subunits, although the specifics of such 
regulation are currently less clear. On the one hand, Arc protein has been reported to result 
in the global removal of GluA2/3 subunit-containing AMPA receptors in neurons in 
hippocampal slice preparations [136,137]. Conversely, Peebles and colleagues recently 
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demonstrated that Arc protein specifically plays a role in internalizing GluA1 subunit-, but 
not GluA2/3 subunit-, containing AMPA receptors in thin "learning" spines [44] in cultured 
hippocampal neurons, suggesting that Arc protein may directly facilitate modifications in 
spine morphology through the selective regulation of GluA1 internalization. Furthermore, 
Waung and colleagues recently demonstrated that Arc critically regulates GluA1 endocytosis, 
as induction of mGluR-LTD led to rapid dendritic Arc protein synthesis, and knockdown of 
Arc protein specifically disrupted the activity-dependent decreases in GluA1 surface 
expression and disrupted the onset of LTD [138]. Finally, Okuno and colleagues have 
recently demonstrated that Arc specifically interacts with CaMKIIβ to create an inverse 
synaptic tag that senses inactive synapses, thereby specifically increasing GluA1-containing 
AMPAR endocytosis [139]. Thus, Arc appears to play a crucial role in regulating the 
development of LTD. 
Arc also appears to play a critical role in the regulation of plasticity processes in 
dendritic spines contributing to LTP. For example, Arc regulates F-actin stabilization 
essential to LTP [129,30,31]. Second, in studies using neuronal cultures in which the 
endocytic functions of Arc are disrupted, the normal activity-induced increase in thin 
"learning" spine formation is disrupted [44]. Additionally, Arc expression in vitro increases 
spine density and knockdown of Arc mRNA decreases spine density, thereby impairing LTP 
[44]. Arc mRNA expression is also correlated to dendritic spine density in the amygdala in a 
rodent model of alcoholism [140], providing further translational relevance to the role of Arc 
mRNA in mediating neuroplasticity processes. In light of these findings, it is clear that Arc 
critically regulates both normal and aberrant plasticity processes, particularly via regulation of 
AMPA receptor surface expression.   
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Recent in vivo studies using site-specific Arc antisense oligonucleotide infusions (Arc 
AS) or RNA-interference (i.e., shRNA/RNAi) to disrupt Arc expression in specific brain 
regions have demonstrated the essential role that Arc plays in mediating normal long-term 
memory processes [130,141]. One of the first studies to disrupt Arc signaling within the basal 
ganglia was performed by Ploski and colleagues [142] who were examining memory 
consolidation in the lateral amygdala following Pavlovian fear conditioning. Infusions of Arc 
AS into the lateral amygdala disrupted long-term (24 hr), but not short-term (3 hr), fear 
memory [142]. Likewise, place aversion induced by conditioned morphine withdrawal 
(CMW) is blocked following lentiviral vector-mediated delivery of Arc shRNA to the 
basolateral amygdala. Interestingly, in relation to the discussion of AMPA regulation detailed 
above, such disruption of Arc signaling results in significant elevations in surface AMPA 
GluA1 and GluA2 surface expression relative to control animals following CMW [31]. Thus, 
knockdown of Arc within the amygdala impairs retention of learned behaviors (i.e., fear 
conditioning and conditioned place aversion) and this impairment is associated with 
disrupted AMPAR endocytosis.  
In the basal ganglia, disruption of Arc also impairs long-term consolidation of basal 
ganglia-mediated learning. For example, infusion of Arc AS into the nucleus accumbens 
(NAc) core and shell of rats significantly impaired morphine-induced conditioned place 
preference (CPP) [143]. Additionally, Hearing and colleagues have shown that Arc AS 
infused into the dorsal striata of rats impairs extinction of context-induced cocaine-seeking 
and also significantly reduced GluA1 subunit- and increased GluA2 subunit-surface 
expression in striatum [132]. Finally, Pastuzyn and colleagues have also recently 
demonstrated an essential role for Arc in contributing to dorsal striatum-mediated motor 
response reversal learning, as rats receiving Arc AS infusions failed to retain previously 
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acquired behavioral performance on a response reversal T-maze task relative to rats infused 
with PBS or a scrambled oligonucleotide [131]. Thus, overwhelming evidence illustrates a 
crucial role for Arc in facilitating synaptic plasticity necessary for learning and memory 
processes in the brain in general, and in the basal ganglia in particular. As such, Arc 
represents a pivotal tool through which to understand both normal and aberrant synaptic 
plasticity in striatal efferent neuron subpopulations of the basal ganglia. 
In addition to the phenotypic expression of neuropeptides and receptors within 
striatonigral and striatopallidal neurons delineated previously, we have repeatedly 
demonstrated that more striatonigral neurons contain Arc mRNA in the cytoplasm than 
striatopallidal neurons, despite similar numbers of these neurons showing transcriptional 
activation of the Arc gene [144,145]. Thus, striatal efferent neuron subpopulations somehow 
differentially regulate Arc mRNA nuclear posttranscriptional processing and/or cytoplasmic 
stability and protein translation. Given the critical role of Arc in regulating AMPAR 
endocytosis and synaptic plasticity processes, this difference in cytoplasmic Arc mRNA 
availability may lead to differences in AMPAR surface expression and thus synaptic plasticity 
processes within striatonigral and striatopallidal neurons.  In theory, such differences may 
contribute to striatal neuron subpopulation-specific induction of LTP in response to DA 
input [91], as detailed above. As normal behavior selection depends on appropriate, 
coordinated activity between striatonigral and striatopallidal efferent neurons [146], the 
difference in cytoplasmic Arc mRNA availability is intriguing and provides a means to 
further expand our understanding of both normal and aberrant synaptic plasticity processes 
within the basal ganglia.  
While it is now well established that more striatonigral than striatopallidal neurons 
have Arc mRNA in the cytoplasm [145,144,147], what is less clear is whether this difference 
16
reflects a feature unique to Arc mRNA vs. global differences in striatal neuron 
posttranscriptional processing of mRNAs. Although much work into factors and processes 
contributing to general neuronal mRNA regulation has been conducted both in vivo and in 
vitro, how these factors specifically alter mRNA subcellular distribution within striatal 
efferent neuron subtypes in vivo, and thus basal ganglia signaling in general, remains 
undefined. The remaining section of this introduction will thus be dedicated to exploring the 
vast, dynamic regulatory mechanisms contributing to both constitutive and activity-regulated 
neuronal mRNA signaling. Discussions of the potential impact of such subcellular regulation 
on the previously observed differences in Arc mRNA expression will be discussed where 
relevant, with other exemplary synaptic plasticity-associated genes included in pertinent 
sections, as well.  
Neuronal RNA Regulation and Implications for Striatal Signaling 
The polarized nature of neuronal cells requires tight regulation of cellular responses 
being transmitted from the nucleus to activated synapses. Neurons achieve diverse responses 
to myriad synaptic inputs by tightly controlling gene expression on multiple levels, including: 
transcriptional activation, posttranscriptional processing, cytoplasmic mRNA stabilization, 
micro-RNA regulation of mRNAs, localized mRNA transport, and localized protein 
translation in dendrites. In the following sections, we will explore these myriad regulatory 
pathways and how such regulation may contribute to factors regulating synaptic plasticity, 
and thus learning and memory processes, within the striatum and basal ganglia. Because of 
the extensive research on the posttranscriptional processing and trafficking of Arc, as well as 
our own work into its expression and regulation within the basal ganglia, we will focus on 
this gene. However, where relevant, discussion of other candidate genes that contribute to 
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synaptic plasticity processing and that demonstrate prototypical characteristics pertinent to a 
particular section will be included. 
Transcriptional Control and Nuclear Packaging 
Neurons rapidly respond to synaptic stimuli through a class of rapidly transcribed 
immediate-early genes (IEGs) that encode transcription factors and effector proteins 
involved in cellular response and remodeling processes. Such IEGs are unique in that they 
require no de novo protein synthesis to induce their transcription but can, in turn, activate the 
expression of downstream cellular targets [148]. It has been estimated that some 30-40 
neuronal genes are IEGs, with approximately 10-15 encoding neuronal transcription factors 
and the remaining genes encoding effector IEGs [149,150]. This diversity of IEGs differs 
from the constitutively expressed transcription factors, such as Elk-1 and cAMP-response 
element binding protein (CREB), in that they are activated on the order of minutes after 
stimulation. Prototypical inducible transcription factor IEGs include zif268/egr-1 and c-Fos, 
whereas effector IEGs directly involved in synaptic scaling and plasticity processes include 
Arc (as described in detail above) and Homer1a [149]. Importantly, while synaptic activation 
induces IEG transcription, the early phases of LTP are dependent on second messengers 
and kinase activity. It is only the later phases of LTP that depend on transcription and 
translation, with IEGs playing a major role in mediating such long-term synaptic 
modifications [148,151]. Thus, rapid activation of cellular signaling pathways inducing IEG 
mRNA transcription gives neurons the ability to quickly respond to changes in synaptic 
stimulation.  
The rapid cellular response to changes in intracellular Ca2+ concentration following 
synaptic stimulation can activate or suppress transcriptional activity of IEGs essential to 
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LTP and LTD. Synaptic activity rapidly induces both zif268 and Arc mRNA transcription via 
activation of NMDA-type glutamate receptors and the extracellular signal-regulated kinase 
(ERK) signaling pathway [133,128,126,127,152]. Both zif268 and Arc contain serum response 
elements (SREs) within their promoters [153-157], tightly coordinating the rapid induction 
of these genes in response to cellular stimuli. In the case of zif268, SREs are the main 
activation site necessary for mRNA induction [157], while other regulatory factors acting at 
individual binding sites, such as CREB [156,158] or Activator Protein 1 (AP-1) [158,157], 
play more modulatory roles in the regulation of zif268 transcription [155,148]. Furthermore, 
neurons can rapidly induce transcription of some IEGs, in particular zif268 and Arc, through 
the poised stalling of RNA Polymerase II (Pol II) just downstream of the transcription start 
site [159]. Under basal conditions and prior to any second messenger activation, Pol II 
transcribes approximately 20-25 nucleotides of these rapid IEGs, then stalls on the IEG 
promoter and sits primed until an action potential triggers changes in intracellular calcium 
concentration[160], leading to the dissociation of Negative Elongation Factor (NELF) from 
Pol II, thereby allowing Pol II transcription to continue. In the absence of such Pol II 
stalling, rapid induction of zif268 and Arc mRNA is abolished [159]. Thus, neurons tightly 
control the transcriptional activation of IEGs through the coordinated response to 
excitatory input and the poised stalling of Pol II on the IEG promoter, allowing for rapid 
neuronal response to synaptic stimulation. 
Stimulation-dependent regulation of transcriptional activation is, however, just the 
first stage within the nucleus by which neurons tightly sculpt responses to synaptic 
activation. Following this rapid transcription, pre-mRNAs can undergo complex 
posttranscriptional splicing via the spliceosome to regulate the information being conveyed 
from DNA to synapses, with spliced mRNAs ultimately possessing higher translational 
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capacity than nonspliced mRNAs [161]. The Homer family of scaffolding proteins, for 
example, signals through different Homer transcripts depending on the posttranscriptional 
splicing [162]. Arc is also subject to pre-mRNA splicing, whereby introns within the 3’ 
untranslated region (UTR) are removed and exon-exon junction protein complexes (EJC) 
loaded upstream of the ligation site (Figure 1.2) [163-166]. The EJC is anchored to Arc by 
the DEAD-Box RNA helicase, eIF4A3 [167,168,164]. Importantly, the EJC is involved in 
splicing events for multiple neuronal mRNAs [169,170,166], mediates normal mRNA quality 
control through nonsense-mediated mRNA decay (NMD) [171-173], and travels with spliced 
mRNAs until they are degraded or translated by the ribosome [174-176]. However, although 
other neuronal mRNAs, such as Map2 and CaMKIIα, precipitate with eIF4A3, they do so to 
a much lesser extent than does Arc [166], suggesting a role of the EJC in selectively 
regulating certain neuronal mRNAs. Thus, addition of the EJC is a critical 
posttranscriptional regulatory step for mature mRNAs that proceeds within the nucleus 
[177]. Furthermore, such posttranscriptional addition of the EJC has recently been 
demonstrated to mediate synaptic plasticity processes within cultured hippocampal neurons 
[166], thereby further implicating posttranscriptional splicing and processing as a critical step 
underlying neuronal signaling and plasticity.  
Following nuclear splicing of the pre-mRNA, the mature mRNA is packaged and 
prepared to exit the nucleus. In addition to the core EJC proteins added within the nucleus, 
the nuclear protein UAP56, a core component of the TREX protein complex essential to 
mRNA export [178], transiently associates with EJC proteins to couple spliceosome 
assembly to nuclear export of mRNA-protein complexes (mRNPs) [179-182]. UAP56 is 
essential to mRNA packaging and export due to its key role in recruitment of the export 
factor, Aly/REF, onto spliced mRNAs (Figure 1.2) [183,163,184]. Aly/REF then serves as 
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the adaptor protein necessary to recruit the principal mRNA Nuclear eXport Factor (NXF) 
TAP/NXF1 onto mRNAs [185-188], creating an export-competent mRNP. This export-
competent mRNP, containing the EJC [189,190,173], Aly/REF, and TAP/NXF1, then 
travels via Brownian motion to the nuclear pore complex (NPC) for nuclear export 
[191,192]. Thus, in addition to tight transcriptional control, multiple levels of splicing and 
packaging occur within the nucleus prior to export of the mRNP. Such discrete intranuclear 
regulation contributes to the added complexity of gene expression within activated neurons. 
A comprehensive understanding of the expression of these nuclear packaging and 
export factors within the adult mammalian brain is only just beginning to be achieved now 
that these components and pathways have undergone more and more scrutiny in model 
organisms such as Saccharomyces cerevisiae and Drosophila melanogaster. Interestingly, in mice, the 
NXF family of proteins, of which Tap/NXF1 is the principal export factor, is encoded by at 
least four genes (Tap/NXF1, NXF2, NXF3, and NXF7). In mouse hippocampal neurons, 
NXF2 also acts as an mRNP exporter and specifically interacts with kinesin KIF17 [193]. 
This is of intriguing relevance to striatal synaptic plasticity, as KIF17 transports NR2B 
subunit-containing NMDA receptors within dendrites [194], and overexpression of KIF17 
enhances spatial and working memory in transgenic mice [195]. Moreover, NR2A and NR2B 
subunits predominate within medium spiny projection neurons striatum [196,197]. As 
described above, NMDA receptors are critical to postsynaptic signaling necessary to induce 
Arc and zif268 mRNA transcription [155,135], thus NXF2 could potentially contribute to 
striatal neuroplasticity. Moreover, NXF2, but not NXF1, specifically interacts with Fragile X 
mental retardation protein (FMRP) [198], and NXF2 and FMRP together destabilize the 
NXF1 mRNA in vivo [199], thereby serving as a posttranscriptional regulation complex of 
the principal mRNA export factor, NXF1. With FMRP playing a known role in Arc-
21
dependent neuroplasticity processes [200,201] and dysfunction of this protein contributing 
to neurological disorders [202-205], understanding the expression of the export factors 
NXF1 and NXF2 in vivo is of critical importance to advancing our understanding of striatal 
neuroplasticity processes. How these factors and protein families are expressed in neurons of 
the mammalian brain in general, and within striatal efferent neurons in particular, will likely 
afford a more comprehensive understanding of the means by which neurons communicate 
in response to synaptic activation. 
Nuclear Export of mRNPs 
Distribution of mRNPs from the nucleus to the cytoplasm via export through the 
NPC is another “speed-bump” on the road to nuclear communication with synapses. As 
delineated above, export competent mRNPs, with TAP/NXF1 bound, exit the nucleus 
through the NPC (Figure 1.2). TAP/NXF1 interaction with FG(phenylalanine-glycine)-
containing nucleoporins facilitates export of the mRNP through the NPC [206-209]. Most 
evidence suggests that export through the NPC is a relatively fast process in metazoans 
[210,211]. However, cytoplasmic retention of exported mRNPs requires the DEAD-box 
RNA helicase DDX19 (in yeast, Dbp5), which catalyzes the removal of TAP/NXF1, 
thereby remodeling the mRNP and preventing it from returning to the nucleus [212,213]. 
DDX19 is recruited to the NPC by the nucleoporin NUP214 (yeast, Nup159) and there 
binds to the NPC protein GLE1 (yeast, Gle1) [191]. Importantly, DDX19 requires local 
activation by GLE1 and its co-factor inositol hexakisphosphate (IP6) to stimulate ATPase 
activity and thus RNA binding to mediate cytoplasmic mRNP remodeling [214,215]. 
DDX19:GLE1 interactions are the rate-limiting step in nuclear export of mRNPs, as 
mutations in GLE1 interactions with DDX19 result in nuclear accumulation of mature, 
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polyadenylated mRNAs, whereas alterations in the NUP214:DDX19 interaction have no 
effect on nuclear export [215]. Further, IP6 is critical to the stabilization of DDX19:GLE1 
interactions in vivo, and is thus critical to mRNA export [214]. In the absence of IP6 or 
GLE1, DDX19 activity cannot proceed, leading to nuclear accumulation of mRNPs 
[216,217]. Thus, while export through the NPC is relatively fast, mRNP retention within the 
cytoplasm appears to be critically modulated by the activity of DDX19.  
Interestingly, in the context of hippocampal neuroplasticity, IP6 can activate PKA 
[218], specifically participates in AMPA, but not NMDA, receptor localization [219], and is 
critical to L-type Ca2+ channel activity [218]. Thus, it is plausible that a similar role for IP6 
would exist within striatal efferent neurons, likely contributing to striatal neuroplasticity 
processes, as well. While the interactions of DDX19 with RNA and GLE1:IP6 are now quite 
well understood in model systems [220], what remains to be further defined is how 
cytoplasmic mRNP remodeling proceeds in neurons, and how cellular differences in such 
remodeling processes might contribute to phenotypic differences in mRNA expression and 
function, such as the differences observed for Arc mRNA in striatal efferent neurons 
[145,144]. 
Cytoplasmic mRNA Trafficking, Localized Protein Synthesis, and mRNA Stability 
Within neurons, de novo protein translation is critical to the induction, consolidation, 
and maintenance of late-LTP [221-224]. Neurons can tightly regulate the information being 
conveyed at synapses through delivery of mRNP granules for local protein synthesis. 
Importantly, mRNPs are dendritically localized by kinesin motor proteins along 
microtubules to synapses [225,226], and dendritic spines contain the polyribosomes and 
machinery necessary for such local protein synthesis [227]. Furthermore, polyribosomes 
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translocate from dendritic shafts to dendritic spines containing enlarged heads in response to 
LTP-inducing stimulation [228-230]. While only a select fraction of mRNAs are IEGs that 
transcriptionally activate in response to synaptic stimulation [150], many mRNAs undergo 
activity-dependent synaptic localization and protein synthesis [231], including Arc [232], 
COX-2 [233,234], CaMKIIα [235,236], and Map2 [237]. Localized mRNAs such as Arc [238], 
CaMKIIα [239,240], and Map2 [241], contain cis-acting elements within the 3’UTR that signal 
dendritic targeting. These cis-acting elements are critical to normal neuronal function. For 
example, in mice lacking the CaMKIIα cis-acting element, CaMKIIα mRNA is restricted to 
the cell body, and the mice show a significant reduction in late-phase LTP and memory 
impairments [242]. These cis-acting elements interact with transcript-specific, trans-acting 
RNA-binding proteins to target the mRNP to synapses [243,244]. Such trans-acting proteins, 
including FMRPs (FXR1 and FXR2, FMR1 [245]) and Staufen [246], play a critical role in 
delivery of RNA granules [225] and thus directly contribute to neuroplasticity processes 
(Figure 1.3) [247,248]. Future research into the expression and regulation of such trans-acting 
factors within striatal efferent neuron subpopulations could provide valuable understanding 
of the processes by which spiny efferent neurons respond during periods of activation, as 
well as how aberrant plasticity, such as in the context of drug abuse and addiction, may alter 
such signaling [249]. 
Once delivered to the neuronal cytoplasm, mRNAs can be trafficked to and undergo 
rapid protein synthesis at the appropriate synapse or remain translationally dormant until 
recruited to the appropriate synapses. For example, newly synthesized Arc protein is 
detected within the same dendritic regions as newly synthesized Arc mRNA [128], 
demonstrating that Arc mRNA is rapidly trafficked and translated in response to synaptic 
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activation. Conversely, both CaMKIIα and Map2 mRNAs are constitutively expressed in 
neurons [237,250,235,251]. CaMKIIα mRNA is stored in pools of translationally dormant 
mRNA within hippocampal neurons until there is activity-dependent delivery of pre-existing 
mRNAs to synaptic sites [236]. In as little as 5 minutes after high-frequency stimulation 
(HFS), CaMKIIα protein is detected >100 um from the neuronal cell body [235]. As for 
constitutively expressed Map2 [237], HFS results in a two-stage alteration in dendritic 
immunostaining [251]. Brief HFS trains (5 minutes) lead to decreased immunostaining in the 
dendritic region of the dentate gyrus receiving synaptic stimulation, while longer HFS trains 
(2 hr) result in increased Map2 immunostaining on each side of the activated lamina [251], 
demonstrating time-dependent control of Map2 protein degradation (brief HFS) and 
localized mRNA delivery and protein synthesis (long HFS) within activated neurons. 
Whether behavioral activation induces such changes in CaMKIIα and Map2 protein 
synthesis in striatum has yet to be described, but preliminary in situ hybridization 
histochemistry studies suggest that striatal neurons also show activity-dependent trafficking 
of both CaMKIIα and Map2 mRNAs away from the cell soma in response to behavioral 
activation [CaMKIIα, Barker-Haliski and Keefe, unpublished; Map2, Chapter 3]. Thus, 
localized, rapid protein synthesis occurs in response to synaptic activation and is thought to 
critically mediate normal neuronal synaptic plasticity processes.  
As described in detail above, late-LTP and LTD require de novo protein synthesis of 
localized mRNAs. Ribosomes, translation factors (such as the translation initiation complex 
eIF4F and its repressor protein 4E-BP), and plasticity-associated mRNAs are present in 
dendrites and dendritic spines, as well as within the cell body, allowing neurons to tightly 
regulate long-lasting synaptic plasticity even without activation of nuclear transcription 
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[252,227,253]. Such protein translation is dynamically regulated by multiple cell signaling 
events, including activation of mammalian target of rapamycin (mTOR)-mediated 
phosphorylation of 4E-BP and ribosomal S6 kinase (S6K) [254,253], thereby releasing 
inhibition of the eIF4F cap-binding complex and allowing this complex to form on target 
polyadenylated mRNAs, resulting in translation initiation [255,228]. Importantly, LTP-
inducing stimulation activates mTOR, and thus phosphorylation of 4E-BP2 (the 
predominate 4E-BP protein) in the mouse brain, resulting in elevated eIF4F complex 
formation [256,253,257]. Interestingly, 4E-BP knockout mice show a decreased threshold to 
induce late-LTP, likely as a result of the increased eIF4F complex formation and translation 
initiation [257].  Such mice also show deficits in hippocampal-dependent spatial learning and 
memory processes [257]. An additional translational regulatory pathway is the through the 
RNA-binding protein, FMRP [245], with a role in specifically regulating Arc mRNA 
translation and thus LTD recently coming to light [200,258]. FMRP functions as a 
translational repressor for a number of synaptic plasticity-associated mRNAs, including 
CaMKIIα and Map1b [201,138,253], that are essential to endocytosis of AMPARs and LTD. 
Thus, translational control of synaptic plasticity-associated proteins at activated synapses 
contributes to the activity-dependent scaling of neuronal response by LTP and LTD.  
In addition to being translated into protein, once in the cytoplasm, mRNAs in 
mRNPs can also be subject to cytoplasmic regulatory events en route to or at their 
destination. One such mechanism contributing to normal mRNA quality control is nonsense 
mediated mRNA decay (NMD; Figure 1.2) mediated by the EJC [259,171]. Generally during 
the first round of protein translation, the ribosome removes EJCs as it translates through 
exon-exon boundaries [175,260]. However, if the mRNA exists in such a way that an exon-
exon junction falls outside the reading frame and, thus, the EJC persists on the mRNA after 
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the first round of translation, that mRNA is targeted for NMD [261], a process mediated by 
EJC interaction with UPF1 [262-264]. In the classical pathway of NMD [259], UPF1 
phosphorylation initiates recruitment of specific mRNA decay factors (Figure 1.3 
[265,266,262]). Specifically, Dcp1 cleaves the 5’-end cap to allow for the 5’-to-3’ exonuclease 
Xrn-1 and the 3’-to-5’ exonuclease Rrp4 to degrade mRNA transcripts, thereby tightly 
regulating cytoplasmic mRNA stability and mRNA abundance [259,171,261]. What is most 
interesting, however, is that a select fraction of mRNAs are subject to the NMD-like process 
of translation dependent decay (TDD) mediated by the EJC [166], because these transcripts 
contain EJC proteins within the 3'UTR that are not removed during the pioneer round of 
translation [164,166]. In particular, Arc mRNA is a natural target for TDD due to the two 
EJCs within the 3’UTR (Figure 1.2), leading to tight translational control of this mRNA and, 
thus, Arc protein synthesis (Figure 1.3) [166,267]. Given that eIF4A3 is critical to the EJC, it 
may act as a brake on cytoplasmic Arc mRNA availability. Indeed, Giorgi and colleagues 
[166] demonstrated the role of eIF4A3 in TDD of Arc mRNA, as knockdown of eIF4A3 
resulted in a 2-fold increase in Arc mRNA and a 4-fold increase in Arc protein levels in both 
hippocampal somata and dendrites [166]. Knockdown of eIF4A3 also resulted in increased 
miniature excitatory postsynaptic current (mEPSC) amplitude and AMPA receptor levels at 
hippocampal synapses [166]. Thus, eIF4A3 offers an intriguing means to potentially 
modulate synaptic plasticity processes in striatal efferent neurons due to its core role in EJC 
formation and subsequent mRNA degradation.  
The posttranscriptional processes regulated by these proteins may independently, or 
in concert, regulate the subcellular distribution of mRNAs, such as Arc, in striatal efferent 
neuron subpopulations.  Yet how NMD factors are regulated and expressed within the adult 
mammalian brain in general, and striatal efferent neurons in particular, is relatively 
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unexplored, but is of critical interest to advancing our understanding of neuronal signaling in 
vivo. Interestingly, we have recently demonstrated that there is activity-dependent expression 
of eIF4A3 mRNA and protein following exposure to a novel environment and that only 
expression within dorsomedial striatum correlates with behavioral performance on a 
striatally-mediated T-maze task [268], in a manner very similar to Arc mRNA expression 
[144,269] (Chapter 2). Following behavioral performance on this T-maze task, eIF4A3 
protein also colocalizes with Arc mRNA within proximal dendrites of striatal neurons [268] 
(Chapter 2). Furthermore, in an in vivo rodent model of cognitive aging, eIF4A3 protein 
expression within the hippocampus also closely mirrored Arc mRNA levels [270]. Given that 
eIF4A3 critically regulates Arc mRNA availability, these findings critically implicate eIF4A3 
in contributing to Arc mRNA signaling in activated neurons in vivo.  
Summary of Neuronal RNA Regulation 
While it is clear that neurons employ distinct mechanisms to tightly regulate gene 
expression at the levels of transcription, posttranscriptional processing, nuclear export, 
cytoplasmic mRNA localization, and local protein synthesis, the contribution of these 
specific mechanisms are relatively unexplored within the context of striatal neuroplasticity in 
vivo. We have repeatedly demonstrated that striatal efferent neuron subpopulations 
differentially regulate the cytoplasmic expression of Arc mRNA in response to various forms 
of neuronal activation in both normal and disease states [144,271,145,147]. Yet whether this 
differential regulation is a feature unique to Arc mRNA or reflects an additional difference 
between striatal efferent neuron subpopulations at the level of general posttranscriptional 
regulation of mRNA expression is of critical importance to discern so as to improve our 
understanding of neuroplasticity processes within this essential brain region. As detailed in 
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the above sections, given that striatal efferent neurons already show divergent expression of 
neuroanatomical output, dopamine and adenosine receptor subtype expression, 
neuropeptide expression, and induction of LTP and LTD in response to synaptic 
stimulation, such observations regarding the differential subcellular localization of this key 
mRNA essential to the normal regulation of synaptic plasticity processes is less than 
surprising. However, future investigations into the in vivo mRNA regulatory mechanisms 
contributing to such discrepancies in striatal mRNA processing and subcellular distribution 
will significantly improve our understanding of the mechanisms contributing to basal 
ganglia-mediated learning and memory processes. These essential additional investigations 
will therefore provide direction for future therapeutic development strategies contributing to 
basal ganglia-mediated pathologies. 
Examining Striatal Neuron mRNA Regulation In Vivo 
Nowhere else in the brain but striatum do different subclasses of projection neurons 
exist in such a heterogeneous, intermixed fashion while still retaining specific 
neuroanatomical projection pathways. Thus, discrete examination of the cellular processes 
contributing to striatal medium spiny neuron function is somewhat complicated by the need 
to phenotypically identify these neurons prior to examining the subcellular regulatory 
pathways of interest. Novel cellular analysis tools [141], cell sorting techniques [272], and 
genetically-modified animal models [273,91] now exist to afford a more complete 
understanding of the precise signaling differences within striatal efferent neurons. Using 
phenotypic neuropeptide markers of striatal projection neurons (i.e., ppe) and the powerful 
technique of cellular analysis of temporal localization by fluorescence in situ hybridization 
(catFISH) has allowed our laboratory to begin to specifically explore the regulation and 
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function of gene expression in greater detail within wild-type, phenotypically identified 
striatal efferent neurons in vivo [144,147].  
Herein, we examined how striatal efferent neurons may differentially regulate 
cytoplasmic Arc mRNA availability and localization in the adult, rodent brain in vivo. Using 
the rapid neuronal activation paradigm of spatial exploration of a novel environment 
[141,144], we examined these mRNA regulatory processes in vivo. Then, through the targeted 
selection of specific candidate mRNAs and RNA binding proteins, we have begun to tease 
apart a potential mechanism likely contributing to the observed cytoplasmic expression 
differences of Arc mRNA in vivo. We first sought to characterize the expression of the core 
EJC factor, eIF4A3, in the adult mammalian brain in vivo and determine whether this EJC 
factor is activity-regulated within striatum, thus potentially contributing to the activity-
dependent expression of Arc mRNA following striatally-mediated learning (Chapter 2). 
Then, using the mRNAs zif268, CaMKIIa, and Map2, which share specifically matched 
transcriptional activation and cytoplasmic localization characteristics with Arc mRNA, we 
examined whether phenotypic differences in nuclear export, cytoplasmic mRNA trafficking, 
or mRNA stability could contribute to the cytoplasmic expression differences reported 
within striatal efferent neurons [147,144,145] (Chapter 3). Finally, we examined how activity-
dependent Arc mRNA expression is disrupted by pathological conditions, such as following 
partial monoamine depletion induced by the psychostimulant methamphetamine (METH; 
Chapter 4), and how such resulting neurodegeneration may participate in neuronal mRNA 
processing in general (Chapters 3 and 4). Altogether, these specific studies cumulatively 
demonstrate that striatal efferent neurons engage in different posttranscriptional mRNA 
processing. Our present findings hold critical implications for basal ganglia-mediated 
learning and memory processes, as well as pathological conditions of the basal ganglia 
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[131,274,275,147]. Future investigations into the subcellular processes contributing to such 
striatal posttranscriptional mRNA regulation differences are critical to more 
comprehensively understand normal basal ganglia-mediated processing, as well as identify 
novel therapeutic targets for basal ganglia-mediated pathologies. 
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Figure 1.1.  Normal basal ganglia circuitry. The basal ganglia are a collection of subcortical nuclei 
that mediate normal motor behavior and action selection. The striatum is the key input 
nucleus of the basal ganglia and receives glutamatergic input from the cortex. Over 95% of 
neurons within the striatum are divided into two populations of equally expressed, 
GABAergic spiny efferent neurons: the striatopallidal, “indirect pathway” neurons and the 
striatonigral, “direct pathway” neurons. These neurons differ in their phenotypic expression 
of neuropeptides at the cell body level. Striatonigral neurons contain preprotachykinin (ppt) / 
substance P and preprodynorphin / dynorphin. Striatopallidal neurons express 
preproenkephalin (ppe) / met-enkephalin. Furthermore, the striatum receives dopaminergic 
input from the substantia nigra pars compacta, which leads to very different neuronal 
activation profiles depending on the striatal efferent neuron subpopulation. Striatonigral 
neurons express stimulatory Gαs/olf protein-linked D1-type dopamine receptors, which are 
positively coupled to adenylyl cyclase (AC). Conversely, striatopallidal neurons selectively 
express inhibitory Gαi/o protein-coupled D2-type dopamine receptors, which inhibit AC 
activity. Additionally, striatopallidal neurons selectively express the Gαs-coupled adenosine 
2a receptor (A2A). The striatonigral neurons primarily project to the internal segment of the 
globus pallidus and substantia nigra pars reticulata, whereas striatopallidal neurons primarily 
send their axonal projections to the external segment of the globus pallidus. The “direct” 
pathway neurons selectively provide direct input to the internal segment of the globus 
pallidus and substantia nigra, and thus reinforce planned movements. Conversely, the 
“indirect” pathway neurons selectively project to the external segment of the globus pallidus, 
which in turn projects to the subthalamic nucleus to modulate cortical activity and terminate 
movements previously directed by activation of the direct pathway. 
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Figure 1.2. Nuclear mRNA transcription and export. Following transcriptional activation of Arc 
mRNA by NMDA-type glutamate receptors, ERK-phosphorylation, brain-derived 
neurotrophic factor (BDNF), or muscarinic acetylcholine receptors (mACh-R), Arc pre-
mRNA is subject to tight posttranscriptional processing within the nucleus. Arc mRNA 
contains 2 introns within the 3’ UTR, and mRNA splicing within the nucleus removes these 
introns. At the exon-exon junctions, the core components of the exon-junction complex 
bind to the spliced mRNA. First, the DEAD-Box RNA helicase, eIF4A3, binds to create a 
scaffold for Magoh-Y14 to bind. These proteins comprise the minimally stable core of the 
EJC and several other proteins will transiently associate with the EJC during the nuclear 
lifetime of the mRNP (mRNA-protein complex) as it travels through the nucleus and into 
the cell cytoplasm. After the core EJC is deposited on target mRNAs, UPF3 associates with 
the EJC. Additionally, the adaptor protein ALY/REF associates with the EJC. ALY/REF 
and the TREX component Thoc5 (not illustrated) drive NXF1 into an open conformation 
able to bind RNA, thus allowing TAP/NXF1 to bind to spliced mRNPs. Recruitment of 
TAP/NXF1 to spliced mRNPs forms an export-competent mRNA that is now ready to 
travel via Brownian motion to the nuclear pore complex (NPC) for export out of the 
nucleus. Prior to nuclear export, the DEAD-Box RNA helicase, UAP56, another member of 
the TREX complex, remodels the mRNP (some reports suggest that UAP56 dissociates 
ALY/REF from the mRNP, while others suggest ALY/REF remains associated with the 
EJC throughout the mRNP lifecycle), although the precise mechanism for nuclear mRNP 
remodeling by UAP56 is currently unknown. Once an mRNP is presented to the NPC, the 
mRNP rapidly shuttles through the pore where it meets the DEAD-Box protein DDX19 
residing within the cytoplasmic face of the NPC. The ATPase activity of DDX19 is 
stimulated and rate-limited by GLE1 and its cofactor inositol-hexakisphosphate (IP6), 
driving conformational changes in DDX19 and thus RNA binding capabilities. DDX19 
removes the TAP/NXF1 complex from mRNPs at the cytoplasmic face of the NPC, 
remodeling the mRNP and permitting the cytoplasmic retention of the mRNP. Importantly, 
without IP6, DDX19 activity is significantly impaired, causing nuclear mRNA export to be 
slowed and mRNPs to accumulate in the nucleus. 
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Figure 1.3. Cytoplasmic mRNA trafficking, localized protein synthesis, and mRNA stability.  1) 
Nuclear transcriptional activation, mRNA splicing, and posttranscriptional processing, and 
nuclear export occurs as described in Figure 1.2.  2) After exiting the nucleus, cargo mRNA-
protein granules, such as Arc, are trafficked to activated synapses along microtubules by 
kinesin interacting with mRNA-bound proteins, including Staufen and FMRP.  3) Once 
mRNAs are transported to dendritic sites, they can be locally translated to proteins essential 
to LTP and LTD. Dendrites contain all the ribosomal and translational machinery essential 
to protein synthesis. Normally, as the ribosome proceeds through target mRNAs, it removes 
any encountered EJCs prior to the stop codon. Then, after the initial round of translation, 
the translation initiation complex is remodeled to the steady-state translation complex 
containing the eIF4E protein, thus allowing for continued protein synthesis (not illustrated). 
4) However, in the case of Arc mRNA, following the first round of protein translation, EJCs
remain within the 3’UTR, thus targeting the mRNA to the process of translation-dependent 
mRNA decay (TDD) mediated by the nonsense mediated mRNA decay (NMD) pathway.  5) 
These remaining EJC complexes then recruit UPF2 binding to UPF3, and UPF1 binding to 
UPF2. Upon UPF1 binding, phosphorylation by the SMG-1 kinase initiates mRNA decay to 
limit cytoplasmic mRNA availability. NMD decay factors thus target the mRNA for 
degradation: Dcp1 initiates the cleavage of the 5’ end cap, which allows for the recruitment 
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Abstract—Regulation of dendritically localized mRNAs
offers an important means by which neurons can sculpt pre-
cise signals at synapses. Arc is one such dendritically local-
ized mRNA, and it has been shown to contain two exon-
junction complexes (EJCs) within its 30UTR. The EJC has
been postulated to regulate cytoplasmic Arc mRNA
availability through translation-dependent decay and thus
contribute to synaptic plasticity. Core proteins of the EJC
include eIF4A3, an RNA helicase, and Magoh, which stabi-
lizes the interaction of eIF4A3 with target mRNAs. ArcmRNA
expression is activity-regulated in numerous brain regions,
including the dorsal striatum and hippocampus. Therefore
in this study, the in vivo expression of these core EJC com-
ponents was investigated in adult Sprague–Dawley rats to
determine whether there are also behaviorally regulated
changes in their expression. In the present work, there
was no change in the expression of Magoh mRNA following
spatial exploration, a paradigm previously reported to
robustly and reliably upregulate Arc mRNA expression.
Interestingly, however, there were increases in eIF4A3
mRNA levels in the dorsal striatum and hippocampus
following spatial exploration, similar to previous reports
for Arc mRNA. Furthermore, there were activity-dependent
changes in eIF4A3 protein distribution and expression
within the striatum following spatial exploration. Impor-
tantly, eIF4A3 protein colocalized with Arc mRNA in vivo.
Like Arc mRNA expression, eIF4A3 mRNA expression in
the dorsomedial striatum, but not dorsolateral striatum or
hippocampus, significantly correlated with behavioral per-
formance on a striatally-mediated, response-reversal learn-
ing task. This study provides direct evidence that a core
EJC component, eIF4A3, shows activity-dependent changes
in both mRNA and protein expression in the adult mamma-
lian brain. These findings thus further implicate eIF4A3 as
a key mediator of Arc mRNA availability underlying learning
and memory processes in vivo. ! 2012 IBRO. Published by
Elsevier Ltd. All rights reserved.
Key words: exon-junction complex, eIF4A3, striatum, T-maze,
rat, Arc/Arg3.1.
INTRODUCTION
Many dendritically localized mRNAs, including the
immediate-early gene Arc/Arg3.1 (activity-regulated,
cytoskeleton-associated protein), are subjected to
numerous types of intraneuronal processing, including
post-transcriptional regulation and localized protein
synthesis (Ule and Darnell, 2006; Panja et al., 2009).
Such post-transcriptional processing plays a key role in
mediating normal, synapse-specific plasticity (Klann and
Dever, 2004; Sutton and Schuman, 2006). The exon-
junction complex (EJC) is critical to global mRNA
function (Tange et al., 2004), with a role mediating
neuronal Arc mRNA expression recently coming to light
(Giorgi et al., 2007). One postulated mechanism
regulating Arc mRNA availability is translation-
dependent decay (TDD) through the RNA surveillance
process of nonsense-mediated mRNA decay (NMD)
(Giorgi et al., 2007; Soule et al., 2012), wherein mRNAs
can be degraded following the first round of translation if
EJCs remain bound to the transcript (Maquat, 2004).
Arc mRNA is a natural target for TDD due to the two
EJCs within the 30UTR, theoretically leading to tight
control of Arc mRNA availability and protein synthesis
(Giorgi et al., 2007). Thus, the EJC and associated
mRNA decay processes could potentially contribute to
Arc mRNA availability and thus synapse-specific
signaling and plasticity.
The minimally stable core of the EJC consists of
eukaryotic initiation factor 4A3 (eIF4A3), Magoh/Y14
and MLN51 (Ballut et al., 2005; Tange et al., 2005);
absence of eIF4A3 inhibits EJC deposition (Shibuya
et al., 2004). As eIF4A3 is the keystone mRNA-binding
protein of the EJC, it may act as a brake on cytoplasmic
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http://dx.doi.org/10.1016/j.neuroscience.2012.09.003
*Correspondence to: K. A. Keefe, Department of Pharmacology and
Toxicology, University of Utah, 30 South 2000 East, Room 201, Salt
Lake City, UT 84112, United States. Tel: +1-801-585-7989; fax: +1-
801-585-5111.
E-mail address: k.keefe@utah.edu (K. A. Keefe).
Abbreviations: Arc/Arg3.1, activity-regulated, cytoskeleton-associated
protein; BDNF, brain-derived neurotrophic factor; CC, caged control;
DGlb, lower blade of the dentate gyrus; DGub, upper blade of the
dentate gyrus; DIG-UTP, digoxigenin-conjugated UTP; DL,
dorsolateral; DM, dorsomedial; eIF4A3, eukaryotic initiation factor
4A3; EJC, exon-junction complex; ELAV, embryonic lethal, abnormal
vision protein; FISH, fluorescence in situ hybridization; HRP,
horseradish peroxidase; MAPK, mitogen-activated protein kinase;
NMD, nonsense-mediated mRNA decay; PBS-T, PBS/0.1% Triton-X;
PBS-TB, PBS/0.1% Triton-X/0.1% Bovine Serum Albumin; TDD,
translation-dependent decay; TNT, TBS/0.05% Tween-20; TSA,
tyramide signal amplification.
Neuroscience 226 (2012) 51–61
51
63
Arc mRNA availability (Giorgi et al., 2007) and thereby
potentially play a key role in neuroplasticity. Dynamic
regulation of eIF4A3 may thus offer an intriguing means
to modulate synaptic plasticity processes in the adult
mammalian brain due to its core role in EJC formation
(Shibuya et al., 2004; Tange et al., 2005) and known
association with mRNAs critical to neuronal function
(Giorgi et al., 2007). However, whether eIF4A3 mRNA
and protein expression changes in response to neuronal
activation in the adult mammalian brain in vivo has
yet to be fully explored and was thus the goal of the
present work.
In the present study, we demonstrate activity-
dependent increases in the expression of eIF4A3
mRNA, but not the expression of another EJC
component Magoh, in the adult rodent CNS. We also
report brain-region specific relation of eIF4A3 mRNA
expression to behavioral indices of new learning,
consistent with previous observations for Arc mRNA
(Guzowski et al., 1999; Daberkow et al., 2007, 2008).
The present findings thus suggest that the expression of
eIF4A3 is activity-regulated and that eIF4A3 expression
in brain regions being engaged in a particular learning
task correlates with that learning. These results thus
provide evidence that not only do neurons regulate
many effector genes critical for plasticity processes,
they also dynamically regulate the regulatory elements




Male Sprague–Dawley rats (Charles River Laboratories, Raleigh,
NC; 275–300 g) were singly housed in tub cages in a room
controlled for temperature and lighting (12:12 h). Animal care
and experimental procedures conformed to the Guide for the
Care and Use of Laboratory Animals (The National Academies
Press, 8th ed.) and were approved by the Institutional Animal
Care and Use Committee at the University of Utah.
Novel spatial exploration
Rats were divided into five experimental groups of 4–10 rats
each. Rats were handled prior to the experiment to familiarize
them to the experimenter and handling. Rats were exposed to
a 2-ft ! 2-ft plastic tub, novel spatial environment, a paradigm
known to robustly and reliably induce Arc mRNA and other
immediate-early gene expression, as previously described
(Guzowski et al., 1999; Chawla et al., 2005; Vazdarjanova
et al., 2006; Daberkow et al., 2007). Rats were removed from
their home cage after having been isolated in the cage for 24 h.
Caged control (CC) rats (n= 10) were sacrificed immediately
upon removal from the home cage. The ‘‘5 min’’ group rats
(n= 10) were exposed to the novel environment for 5 min and
then immediately sacrificed; ‘‘30 min’’ group rats (n= 10) were
exposed for 5 min to the novel environment and then returned
to the home cage for 25 min before sacrifice; ‘‘60 min’’ group
rats (n= 4) were exposed for 5 min to the novel environment
and then returned to the home cage for 55 min before sacrifice.
Animals were sacrificed by exposure to CO2, decapitated and
brains immediately removed and flash-frozen in 2-methylbutane
(Mallinckrodt Baker, Phillipsburg, NJ) chilled on dry ice.
T-maze, response-reversal learning task
A separate group of rats (n= 11) was habituated to the T-maze
and experimenter as previously described (Daberkow et al.,
2007, 2008; Pastuzyn et al., 2012). After T-maze habituation, the
turn bias of each rat was determined, and acquisition training on
the T-maze proceeded as previously described (Daberkow et al.,
2007; Pastuzyn et al., 2012). During the response-reversal task,
rats were rewarded for turning in the opposite direction from
acquisition with task completion being when the rat reached
criterion (9/10 correct consecutive turns). Each trial on this task
took approximately 1 min. Five minutes after reaching criterion,
animals were sacrificed and brains collected as described
above. As with the novel spatial exploration task, CC rats
(n= 11) associated with this experiment were immediately
sacrificed upon removal from their home cage.
Tissue preparation
Striatal and hippocampal sections (Bregma: +1.2–1.5 mm and
"2.8–3.3 mm, respectively (Paxinos and Watson, 1998)) were
cryosectioned at 12-lm (Cambridge Instruments, Bayreuth,
Germany) and thaw-mounted onto SuperFrost Plus slides
(VWR, Batavia, IL). Slides to be directly compared were
processed in parallel. Slides were postfixed as previously
described (Ganguly and Keefe, 2001), air-dried and stored at
"20 "C until histochemical processing.
Fluorescent immunohistochemistry
Striatal sections to be labeled for eIF4A3 protein were washed
2 ! 5 min in PBS/0.1% Triton-X (PBS-T), blocked for 1 h with
PBS/0.1% Triton X/0.1% Bovine Serum Albumin (PBS-TB), and
then washed 2 ! 5 min in PBS-T. Protein was then detected
with rabbit anti-eIF4A3 antibody (Abcam, Cambridge, MA) at a
concentration of 5 lg/mL overnight at 4 "C. Slides were then
washed 2 ! 5 min in PBS-T followed by incubation with donkey
anti-rabbit Alexa Fluor-488 (1:1000; Invitrogen, Carlsbad, CA)
in PBS-TB for 2 h at 24 "C. Slides were washed 2 ! 5 min in
PBS-T and coverslipped with Prolong Gold mounting media
with DAPI nuclear counterstain (Invitrogen, Carlsbad, CA).
Radioactive in situ hybridization
Full-length rat eIF4A3 and mouse Magoh (93% sequence
homology to rat) cDNA-containing vectors were purchased for
plasmid isolation (eIF4A3 [GenBank: BC105875.1] clone ID
7120292; Magoh [GenBank: BC018176.1] clone ID 3587774;
Open Biosystems, Huntsville, AL). The cDNAs were linearized
(EcoRI; Roche Applied Science, Indianapolis, IN), and probes
transcribed with [35S]-UTP or [33P]-UTP (Perkin-Elmer,
Waltham, MA) with T7 RNA polymerase (Roche Applied
Science, Indianapolis, IN). In situ hybridization was performed
as previously described (Ganguly and Keefe, 2001).
Dual Arc fluorescent in situ hybridization and eIF4A3
immunohistochemistry
Co-expression of Arc mRNA and eIF4A3 protein in the dorsal
striatum was determined by combined fluorescence in situ
hybridization histochemistry (FISH) for Arc mRNA and eIF4A3
protein, as previously described for Arc FISH (Daberkow et al.,
2007, 2008) and as described above (Section Fluorescent
immunohistochemistry) for eIF4A3 protein with minor
modifications to the buffers (TBS/0.05% Tween-20 (TNT)
buffer: 0.1 M Tris–HCl, pH 7.5, 0.15 M NaCl, 0.05% Tween-20).
A full-length ribonucleotide probe complementary to Arc mRNA
(Lyford et al., 1995) was synthesized from cDNAs using
digoxigenin-UTP (DIG-UTP) with T7 RNA polymerase and
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DIG-UTP RNA labeling kit (Roche) (Daberkow et al., 2007,
2008). Slides were hybridized with Arc ribonucleotide probe
overnight (12–18 h) in a humid chamber at 56 "C. Once
removed, slides were vigorously washed at 24 "C four times in
2! SSC buffer (0.15 M NaCl with 0.015 M sodium citrate). Slides
were then washed in ribonuclease A (RNase A; 10 lg/mL;
Roche Applied Science) in 2! SSC for 15 min. After incubation
with RNase A, slides were washed 5 min in 2! SSC, then
4 ! 20 min in 0.2! SSC at 24 "C. Endogenous peroxidase
activity was then quenched with 2% H2O2 for 15 min, slides were
washed 2 ! 5 min in TNT buffer, and then slides were incubated
for 2 h at RT with an anti-digoxigenin antibody (1:1000) coupled
to horseradish peroxidase (HRP; Roche). The Arc probe was
detected by cyanine-3 (cy-3) tyramide signal amplification
(tyramide signal amplification (TSA) Plus; Perkin-Elmer). After
detection of the DIG-labeled Arc ribonucleotide probe, slides
were washed in 2 ! 5 min in TNT and eIF4A3 protein detected
as above (Section Fluorescent immunohistochemistry). The next
day, slides were washed 2 ! 5 min in TNT, incubated for 2 h RT
with a goat anti-rabbit-HRP antibody (Millipore, Billerica, MA),
then washed 2 ! 5 min in TNT. The eIF4A3 protein signal was
detected by fluorescein TSA (Perkin-Elmer) then washed
2 ! 5 min in TNT. Finally, slides were coverslipped with Prolong
Gold mounting media with DAPI (Invitrogen).
Image acquisition and analysis
To determine eIF4A3 protein expression in the dorsomedial (DM)
striatum (+1.2–1.5 mm bregma), 0.6 mm2 fields from two striatal
sections per animal were imaged on a Leica DM4000B
fluorescent microscope at 40!. Each image was analyzed
using ImageJ (NIH) with the inverted LUT threshold set to 15 to
remove background. The mean gray value and percent of the
total field area with eIF4A3 signal were measured.
Film autoradiograms of sections processed for radioactive
in situ hybridization were digitized (ImageJ). For both eIF4A3
and Magoh mRNAs, four sections per animal were imaged
from the dorsal striatum (rostral (+1.2–1.5 mm bregma) and
middle (+0.5 mm bregma)) and dorsal hippocampus ("2.8–
3.3 mm bregma). Film autoradiograms were analyzed using
ImageJ (Ganguly and Keefe, 2001). The mean gray value of
white matter was subtracted from the mean gray value of the
regions of interest. Mean gray values for each animal were
then normalized to the average signal in the CC group.
Combined FISH/immunohistochemistry images (105.5 lm !
105.5 lm) in the DM striatum (+1.2–1.5 mm bregma; Fig. 4A–D)
were captured under 2! zoom magnification with an FV1000
confocal laser-scanning microscope (Olympus) with motorized
stage (Prior Scientific) using a 60!, 1.45 NA oil-immersion lens
(plan APO) and 405-nm Diode, 488-nm Ar, and 543-nm HeNe
lasers (Daberkow et al., 2007, 2008). Areas of analysis were
z-sectioned in 0.5-lm-thick optical sections.
Statistical analyses
Expression of mRNAs and protein in rats after spatial exploration
were compared using one-way ANOVAs followed by post hoc
Dunnett’s tests. Levels of eIF4A3 mRNA expression following
response-reversal learning were compared to CC levels using
two-tailed t-tests and also correlated with performance.
RESULTS
Spatial exploration and expression of EJC
components eIF4A3 and Magoh
Initially, we characterized the in vivo expression of the EJC
factor eIF4A3 in the dorsal striatum of rats following spatial
exploration of a novel environment (Fig. 1). eIF4A3
expression in the dorsal striatum increased above that in
CC rats following novel environment exploration (Fig. 1A;
‘‘5 min’’ = 114.7%± 8.0 of CC; ‘‘30 min’’ = 123.0%±
3.9 of CC; ‘‘60 min’’ = 102.3%± 14.4 of CC; F(3,35) =
3.29, p= 0.03). Post-hoc analysis revealed a significant
increase over CC animals in the ‘‘30 min’’ group
(p= 0.03; Fig. 1D,E). We then asked whether spatial
exploration was associated with an increase in Magoh
expression, which would suggest global changes in the
expression of EJC factors. Although Magoh was also
basally expressed, we did not detect any significant
increases in Magoh mRNA expression in animals that
engaged in the spatial exploration task (‘‘5 min’’=
98.7%± 1.64 of CC; ‘‘30 min’’ = 95.9%± 1.93 of CC;
‘‘60 min’’ = 98.3%± 4.91 of CC; F(3,20) = 0.73,
p> 0.05; Fig. 1B).
Given that Arc mRNA expression is increased in an
activity-dependent manner in numerous brain regions
(Guzowski et al., 1999; Chawla et al., 2005; Daberkow
et al., 2007), we examined whether activity-dependent
eIF4A3 mRNA expression was similarly broadly
distributed in the brains of rats subsequent to spatial
exploration of a novel environment. As in the dorsal
striatum, there was a time-dependent increase in eIF4A3
mRNA expression in the dorsal hippocampus (Fig. 2A–D),
including the CA1 (‘‘5 min’’ = 108.2%± 2.4, ‘‘30 min’’ =
111.4%± 3.0, ‘‘60 min’’ = 128.5%± 8.2; F(3,32) = 3.18,
p= 0.04; Fig. 2A) and CA3 (‘‘5 min’’ = 106.5%± 1.5,
‘‘30 min’’ = 108.3%± 2.1, ‘‘60 min’’ = 119.0%± 5.8;
F(3,32) = 2.97, p= 0.05; Fig. 2B) subregions. Post-hoc
analysis revealed significant increases in eIF4A3 mRNA
expression over CC animals in the CA1 of the ‘‘30 min’’
group (p= 0.02) and a trend for increases in expression
over CC animals in the ‘‘60 min’’ group (p= 0.08).
Likewise, post hoc analysis of the data from CA3
revealed a significant increase over CC animals in the
‘‘30 min’’ group (p= 0.05). Similar to previous reports for
novelty-induced Arc mRNA expression in the dentate
gyrus (DG) subregion of the hippocampus (Chawla et al.,
2005), there was a time-dependent increase in eIF4A3
mRNA expression in the upper blade of the dentate gyrus
(DGub; F(3,32) = 3.22, p= 0.04). Post-hoc analysis
revealed significant increases in eIF4A3 mRNA
expression in the DGub of the ‘‘5 min’’ (116.4%± 4.6,
p= 0.05) and ‘‘30 min’’ (116.5%± 3.4, p= 0.05;
Fig. 2C) groups relative to the CC group, as well as a
trend for increase in expression in the ‘‘60 min’’ group
(119.7%± 3.4, p= 0.07). Conversely, there was no
change in eIF4A3 expression in the lower blade of the
dentate gyrus (DGlb F(3,32) = 1.37, p= 0.3; Fig. 2D) at
any time point.
Aswith the striatum, therewere no significant increases
in Magoh mRNA expression in any regions of the
hippocampus following spatial exploration (Fig. 2E–H;
CA1‘‘5min’’=109.9%±5.3, ‘‘30min’’=105.0±3.1,‘‘60min’’=
115.8%± 4.1; F(3,31) = 1.15, p> 0.05; CA3 ‘‘5 min’’ =
98.3%± 4.2, ‘‘30 min’’ = 103.0%± 3.6, ‘‘60 min’’ = 98.4%
± 4.1; F(3,31) = 0.65, p> 0.05; DGub ‘‘5 min’’ = 103.4%
± 4.0, ‘‘30 min’’ = 106.4%± 1.8, ‘‘60 min’’ = 92.6%± 3.2;
F(3,18) = 0.35, p> 0.05; DGlb ‘‘5 min’’ = 96.8%± 5.4,
‘‘30 min’’ = 100.3± 4.7, ‘‘60 min’’ = 87.1%± 5.0;F(3.18) =
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1.38, p> 0.05). Thus, there were activity-related
increases in eIF4A3, but not Magoh, mRNA in both the
dorsal striatum (Fig. 1) and dorsal hippocampus (Fig. 2).
The activity-related expression of eIF4A3 is similar to the
pattern of exploration-induced Arc mRNA expression
previously reported, including time-dependent increases
in both the dorsal striatum (Daberkow et al., 2007)
and CA1, CA3, and DGub subregions of the
hippocampus (Guzowski et al., 1999; Chawla et al., 2005;
Vazdarjanova et al., 2006).
Activity-related increase in eIF4A3 protein
distribution in striatum
To further assess the activity-dependent regulation of
eIF4A3, we used fluorescence immunohistochemistry to
examine the expression of eIF4A3 protein after animals
engaged in spatial exploration of a novel environment
(Fig. 3). CC animals exhibited low basal distribution of
eIF4A3 protein (percent of total field area with signal)
but high signal intensity (mean gray value of pixels).
Following exploration, there was a significant time-
dependent increase in the percent of the total field area
with signal (F(4,37) = 4.95, p= 0.003; Fig. 3A), with the
‘‘30 min’’ group showing increased distribution of the
eIF4A3 signal relative to the CC group (p< 0.01). This
distribution returned to basal levels by 60 min (Fig. 3A),
such that expression within the ‘‘60 min’’ group was not
significantly different from the CC group (p> 0.9).
Furthermore, there was a significant time-dependent
effect on eIF4A3 protein signal intensity (mean gray
value) within the striatum (F(4,37) = 5.21, p= 0.002;
Fig. 3B). Post-hoc analysis revealed a significant
decrease in the signal intensity in the ‘‘30 min’’ group
(p= 0.02) relative to the CC group. As was the case for
the distribution of the eIF4A3 signal, the increase in
signal intensity returned to basal levels by 60 min, such
that expression in the ‘‘60 min’’ group was not
significantly different from the CC group (p= 0.7).
Correlating the measurement of percent field area with
eIF4A3 signal to the signal intensity (mean gray value of
pixels) revealed a strong inverse correlation (R2 = 0.89,
p< 0.0001; Fig. 3C), suggesting that there is activity-
dependent movement of this protein together with
mRNA granules, such as Arc (Kanai et al., 2004), during
periods of neuronal activation rather than de novo
synthesis of protein.
Colocalization of eIF4A3 protein with Arc mRNA
To examine whether Arc mRNA and eIF4A3 protein
interact in vivo, we performed double-label detection of
Arc mRNA and eIF4A3 by combined FISH/fluorescent
immunohistochemistry followed by confocal imaging in a
subset of rats (n= 3) following response-reversal
learning on the T-maze (Fig. 4). Areas of Arc mRNA
and eIF4A3 protein colocalization are found throughout
the DM striatum under these conditions (Fig. 4A).
To estimate the extent of colocalization, two
separate image fields from each T-maze-trained rat
were analyzed. On average, 43.5%± 0.02 of Arc
Fig. 1. Expression of EJC components in dorsal striatum of rats
engaged in spatial exploration for 5 min. (A) Mean expression
(arbitrary gray value) of eIF4A3 mRNA (±SEM; n= 4–10/group) in
dorsal striatum analyzed via radioactive in situ hybridization histo-
chemistry and expressed as a percent of basal values in caged
control (CC) animals. Rats in the CC group were sacrificed imme-
diately upon removal from their home cage. Rats in the remaining
groups explored a novel spatial environment (see Experimental
procedures) for 5 min and were then either sacrificed immediately
(‘‘5 min’’ group) or returned to the home cage for 25 min before
sacrifice (‘‘30 min’’ group); or 55 min before sacrifice (‘‘60 min’’
group). ⁄Significantly different from CC (p= 0.03). (B) Mean
expression (arbitrary gray value) of Magoh mRNA (±SEM;
n= 4–7/group) in dorsal striatum analyzed via radioactive in situ
hybridization histochemistry and expressed as a percent of basal
values in CC animals. (C) A sense ribonucleotide probe for eIF4A3
gave no signal. (D) Striatal section from a CC rat labeled with the anti-
sense ribonucleotide probe for eIF4A3. (E) Striatal section from a
‘‘30 min’’ group rat labeled with the anti-sense ribonucleotide probe
for eIF4A3.
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mRNA-positive puncta colocalized with eIF4A3 protein-
positive puncta outside of the somatic compartment,
whereas 33.9%± 0.2 of eIF4A3 protein-positive puncta
colocalized with Arc mRNA-positive puncta. A previous
study reported that #59% of Arc mRNA-positive puncta
colocalized with eIF4A3 protein-puncta, whereas 29% of
eIF4A3 protein-positive puncta colocalized with Arc
mRNA-positive puncta in vitro following 6-h incubation
of cultured hippocampal neurons with brain-derived
neurotrophic factor (BDNF) (Giorgi et al., 2007),
Additionally, another study reported that the neuron-
specific RNA-binding protein Smaug-1 also showed
40–60% colocalization with CaMKIIa mRNA following
NMDA receptor stimulation in cultured hippocampal
neurons in vitro, with this protein contributing to
CaMKIIa mRNA availability and activity-dependent
protein synthesis (Baez et al., 2011). Thus, our analysis
of the in vivo colocalization of Arc and eIF4A3 following
learning is in line with previous reports for RNA-
binding proteins colocalizing with target mRNAs
following various pharmacological stimulation paradigms
in vitro.
Fig. 2. Expression of EJC components in dorsal hippocampus of rats engaged in spatial exploration for 5 min. (A–D) Mean expression (arbitrary
gray value) of eIF4A3mRNA (±SEM; n= 4–10/group) in the CA1 (A), CA3 (B), upper blade of the dentate gyrus (DGub; C), and lower blade of the
dentate gyrus (DGlb; D) subregions of dorsal hippocampus analyzed via radioactive in situ hybridization histochemistry and expressed as a percent
of basal values in caged control (CC) animals. ⁄Significantly different from CC. (E–H) Mean expression (arbitrary gray value) of Magoh mRNA
(±SEM; n= 10/group) in CA1 (E), CA3 (F), DGub (G), and DGlb (H) analyzed via radioactive in situ hybridization histochemistry and expressed as
a percent of basal values in CC animals.
Fig. 3. Expression of eIF4A3 protein in dorsal striatum of rats engaged in spatial exploration for 5 min. (A) Mean (±SEM, n= 4–10/group) eIF4A3
protein distribution in dorsal striatum measured as percent of total image area with signal (i.e. percentage of total pixel area in the field with eIF4A3-
labeled pixels). ⁄Significantly different from caged controls (CC; p< 0.01). (B) Signal intensity (average gray area), expressed as mean percent of
control (±SEM, n= 4–10/group), of eIF4A3 protein-labeled pixels in dorsal striatum ⁄Significantly different from CC (p= 0.02). (C) Significant
inverse correlation (p< 0.05) between percent of total field with eIF4A3 protein signal above threshold and the average signal intensity (mean gray
value) of the labeled pixels.
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Correlation between eIF4A3 mRNA expression and
striatally-mediated learning
Previously, we reported that Arc mRNA expression in the
DM, but not dorsolateral (DL), striatum of normal rats
correlates with trials to criterion on a T-maze-based,
response-reversal learning task (Daberkow et al., 2007).
Furthermore, knockdown of Arc mRNA in the DM
striatum impairs consolidation of reversal learning on
this task (Pastuzyn et al., 2012). Thus, we examined
whether eIF4A3 mRNA expression correlates with
behavioral performance. Similar to our prior
observations with Arc mRNA (Daberkow et al., 2007,
Fig. 4. ArcmRNA colocalizes with eIF4A3 protein in vivo following response-reversal learning on a T-maze. (A) Representative photomicrograph of
ArcmRNA in situ hybridization histochemical staining (red) and eIF4A3 protein immunofluorescence (green) in the dorsal striatum of a rat sacrificed
5 min after reaching criterion on a striatally mediated, response-reversal learning task (see Experimental procedures). Scale bar = 20 lm. (B–E)
Higher magnification images of the region delineated in the box in (A) showing colocalization of eIF4A3 protein expression and Arc mRNA
colocalization (B) and the individual channels for the DAPI nuclear counter stain (C), Arc mRNA (D), and eIF4A3 protein (E). Arrows highlight points
of colocalization of Arc mRNA and eIF4A3 signal. Scale bar in B–E = 2 lm.
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2008), eIF4A3 mRNA expression significantly increased
in the DM and DL striatum of animals performing on the
T-maze relative to CC rats (Fig. 5A; CC–DM:
34.9 ± 1.9; DL: 35.5 ± 2.38; T-maze–DM: 43.3 ± 1.1,
t(10) = 6.63, p= 0.0001; DL: 44.0 ± 1.2, t(10) = 6.3,
p= 0.0001). However, only eIF4A3 mRNA expression
in the DM striatum (R2 = 0.39; p= 0.04; Fig. 5B)
significantly correlated with behavioral performance (i.e.
trials to criterion); eIF4A3 mRNA expression in the DL
striatum (R2 = 0.02; p> 0.1; Fig. 5C) or any subregion
of the dorsal hippocampus (CA1, R2 = 0.22; p> 0.1;
CA3, R2 = 0.11; p> 0.1; DGub R2 = 0.16; p> 0.1;
DGlb R2 = 0.11; p> 0.1; Fig. 5D, E) did not correlate
with behavioral performance.
DISCUSSION
We presently demonstrate increased expression of the
EJC factor eIF4A3 in the adult rodent CNS under
conditions of spatial exploration and striatally-mediated
response-reversal learning. The level of eIF4A3, but
interestingly not Magoh, mRNA increased in an
activation-related manner across multiple brain regions,
and expression of eIF4A3 mRNA in the DM striatum
correlated with behavioral performance on a striatally-
based response-reversal learning task. Furthermore,
eIF4A3 protein colocalized with Arc mRNA in vivo
following striatally-mediated learning. Given the complex
signaling required of neurons undergoing activity-
dependent synaptic modifications, it is conceivable that
such plasticity requires activity-dependent expression of
eIF4A3 to facilitate normal mRNA quality control through
NMD (Chang et al., 2007; Shyu et al., 2008) and to
regulate the translation and decay of plasticity-related
mRNAs, such as Arc (Giorgi et al., 2007; Soule et al.,
2012). The present observations are the first to
demonstrate activity-dependent changes in eIF4A3
mRNA and protein levels in the adult mammalian brain
in vivo, further implicating eIFAA3 as a mediator of
activity-dependent neuroplasticity processes.
eIF4A3 likely plays an important role in neuronal mRNA
processing given its core role inEJC formation and function
(Shibuya et al., 2004; Ballut et al., 2005). Numerous
aspects of post-transcriptional mRNA processing are
mediated by the EJC, including nucleocytoplasmic
shuttling (Shibuya et al., 2004), cytoplasmic translational
control (Diem et al., 2007), and NMD/TDD (Maquat,
2004). Specifically, continued presence of the EJC on
spliced mRNAs following the first round of protein
translation can initiate mRNA decay by NMD (Maquat,
2004; Shibuya et al., 2004), thereby tightly limiting mRNA
availability. Given the exclusive role that eIF4A3 plays in
EJC formation (Chan et al., 2004; Shibuya et al., 2004)
and NMD (Ferraiuolo et al., 2004), it is likely a critical
component of mRNA stability underlying normal neuronal
signaling in the adult mammalian CNS.
Numerous neuronal mRNAs are dendritically targeted
for local protein synthesis, indicating a need for tight post-
transcriptional and translational regulation of these
mRNAs to coordinate neuronal signaling (Ule and
Darnell, 2006; Goldie and Cairns, 2012). The EJC, and
eIF4A3 specifically, may thus allow neurons to regulate
the expression of specific effector mRNAs, such as Arc,
through NMD/TDD or through other post-transcriptional
processes involved in the trafficking of such effector
mRNAs to or translational control of those mRNAs at
synapses. Unlike other eIF4A isoforms (Li et al., 1999),
which are components of the eIF4F translation initiation
complex (Klann and Dever, 2004), eIF4A3 plays a
distinct role in mRNA stability. Understanding whether
these other eIF4A isoforms also show activity-
dependent changes in expression will help clarify the
precise contribution made by the EJC and NMD vs.
translational regulation in determining synaptic plasticity
processes. However, given the known role of eIF4A3 in
mRNA regulation and its activity-related expression,
mRNA stability processes mediated by NMD may act as
a potential means by which neurons can regulate
response to synaptic stimuli.
As demonstrated by others (Giorgi et al., 2007; Soule
et al., 2012) and now us (Fig. 4), one potential means for
eIF4A3 to contribute to synaptic plasticity is through
interaction with and regulation of Arc mRNA. As eIF4A3
is critical to the EJC (Chan et al., 2004; Shibuya et al.,
2004; Ballut et al., 2005), it may act as a brake on
cytoplasmic Arc mRNA availability through NMD (Giorgi
et al., 2007). Arc is a target for NMD due to the two
EJCs within the 30UTR, leading to tight control of Arc
protein synthesis (Giorgi et al., 2007; Soule et al.,
2012). Knockdown of eIF4A3 increased Arc mRNA and
protein levels in rat hippocampal somata and dendrites
in vitro and increased miniature excitatory postsynaptic
current (mEPSC) amplitude and synaptic metabotropic
glutamate receptor 1 (mGLUR1) levels (Giorgi et al.,
2007), indicating that eIF4A3 can directly affect Arc-
dependent synaptic plasticity. This present work
demonstrates time-dependent changes in eIF4A3
protein distribution and signal intensity following
exploration of a novel environment. Additionally, eIF4A3
protein colocalized with Arc mRNA in the dorsal striatum
following striatally-mediated learning (Fig. 4), similar to
previous reports in vitro (Giorgi et al., 2007). Thus, one
potential explanation for the observed increase in
distribution of eIF4A3 protein is that neuronal activation
associated with spatial exploration or engagement on a
learning and memory task induces de novo transcription
of effector mRNAs, such as Arc (Guzowski et al., 1999;
Daberkow et al., 2007), which in turn leads to the
formation of eIF4A3-containing protein-mRNA granules
(Kanai et al., 2004) that then distribute out into
dendrites. Such greater distribution of the eIF4A3-
containing granules throughout the neuropil may then
result in the lower signal intensity in any given set of
labeled pixels. However, we cannot presently rule out
the possibility that the observed changes in eIF4A3
protein expression also reflect de novo eIF4A3 protein
synthesis. Many plasticity-associated mRNAs, including
CaMKIIa (Ouyang et al., 1997), zif268 (Zangenehpour
and Chaudhuri, 2002) and even Arc (Vazdarjanova
et al., 2006; Niere et al., 2012), demonstrate rapid
protein synthesis in response to stimuli. Thus, while it
was somewhat surprising that the percent of the total
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field area with eIF4A3 protein increased relatively rapidly
in response to exploration of a novel environment,
this timeframe is not unrealistic for neuronal protein
translation and would thus supply an alternative
interpretation of the presently observed changes in
eIF4A3 protein expression.
Fig. 5. Expression of eIF4A3mRNA in the brains of rats undergoing response-reversal learning. (A) Rats trained to perform on a response-reversal
learning task on a T-maze showed significant increases in eIF4A3 mRNA expression in the dorsomedial (DM) and dorsolateral (DL) striatum
compared to caged control (CC) rats (n= 11 per group). ⁄Significantly different from CC (p= 0.0001). (B–G) Degree of correlation between
behavioral performance (trials to criterion) on the response-reversal task and eIF4A3 mRNA expression (average gray value from densitometric
analysis) in DM striatum (A), DL striatum (B), CA1 of dorsal hippocampus (C), CA3 of dorsal hippocampus (D), upper blade of dentate gyrus (DGub;
E), and lower blade of dentate gyrus (DGlb; F). ⁄Significant correlation (p< 0.05).
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Our novel findings for eIF4A3 mRNA and protein
levels parallel those previously reported for Arc mRNA
(Guzowski et al., 1999; Chawla et al., 2005; Daberkow
et al., 2007). First, eIF4A3 mRNA is rapidly increased in
the dorsal striatum (Daberkow et al., 2007), as well as
in CA1, CA3, and DGub of the dorsal hippocampus
(Guzowski et al., 1999) of adult rats engaged in brief
(5 min) exploration of a novel environment. Second, like
Arc mRNA (Chawla et al., 2005; Vazdarjanova et al.,
2006), eIF4A3 mRNA expression was not increased in
DGlb. Third, there is a significant correlation between
eIF4A3 mRNA levels in the DM striatum, but not
DL striatum or dorsal hippocampal subfields, and trials
to criterion on a striatally-based, response-reversal
learning task (Daberkow et al., 2007, 2008). Fourth, Arc
mRNA colocalized with eIF4A3 protein in vivo following
striatally-based learning, as it has been shown to do in
the hippocampus in vitro as well (Giorgi et al., 2007).
Finally, there was a significant activity-dependent
increase in eIF4A3 protein distribution that returned to
basal levels 60 min after exploration of a novel
environment, in close parallel to the time frame of Arc
transcription, trafficking, and protein translation
(Vazdarjanova et al., 2006; Baez et al., 2011). These
findings suggest that eIF4A3 may critically regulate Arc-
dependent synaptic plasticity. In this regard, it is
interesting that EJC components also regulate mitogen-
activated protein kinase (MAPK) splicing in Drosophila
(Ashton-Beaucage et al., 2010; Roignant and Treisman,
2010). MAPK is critical for ERK phosphorylation, and
thus, Arc mRNA targeting to activated synapses
(Huang et al., 2007; Wang et al., 2009). The in
vivo observations reported herein are the first to
demonstrate activity-related regulation of the core EJC
component eIF4A3, with the expression of eIF4A3
mRNA showing notable similarities to the behaviorally-
induced expression of Arc mRNA previously reported by
others (Guzowski et al., 1999; Chawla et al., 2005;
Vazdarjanova et al., 2006) and us (Daberkow et al.,
2007, 2008; Pastuzyn et al., 2012). The extent to which
eIF4A3 is necessary for Arc-dependent neuroplasticity
in the brain in vivo is currently under further investigation.
Presently, the basis for the activity-related expression
of eIF4A3 mRNA levels is unknown, but the current
findings further highlight that neurons dynamically
regulate mRNAs involved in post-transcriptional
processing, such as RNA binding. For example, the
mediator of cap-binding activity during protein
translation initiation, eIF4E mRNA, shows dendritic
localization and increased association with PSD-95
upon KCl stimulation in vitro (Moon et al., 2009),
demonstrating that neurons not only dendritically
localize effector genes, but also the factors that facilitate
local translation of those effector genes. Additionally, the
brain-specific, embryonic lethal, abnormal vision protein
(ELAV)/Hu family of RNA-binding proteins, which are
known to contribute to growth-associated protein 43
(GAP-43) mRNA localization and cytoplasmic
stabilization, also show dendritic localization (Bolognani
et al., 2004) and activity-dependent expression following
spatial learning (Pascale et al., 2004). Furthermore,
ELAV/Hu expression is modulated by glutamatergic
(seizures) or dopaminergic (cocaine) signaling
(Tiruchinapalli et al., 2008), thereby demonstrating a
role of classical neurotransmitter systems converging
onto activity-dependent, post-transcriptional regulatory
elements to modulate neuronal responses. Thus, future
work will clarify whether neuronal stimulation results in
new transcriptional activation of eIF4A3 or alternative
post-transcriptional processing of eIF4A3, so as to
determine the basis for the observed activity-dependent
changes in eIF4A3 mRNA and protein levels.
CONCLUSIONS
Our present findings reveal activity-related increases in
eIF4A3 mRNA and protein distribution in the adult
mammalian CNS in vivo. Previous reports indicate a
unique function for eIF4A3 in regulating expression of
Arc mRNA (Giorgi et al., 2007), a key mediator of
synaptic plasticity (Guzowski et al., 2000; Chowdhury
et al., 2006; Rial Verde et al., 2006) and basal ganglia-
mediated learning consolidation (Pastuzyn et al., 2012).
Herein, we demonstrate that eIF4A3, but not Magoh,
mRNA shows striking similarities to Arc mRNA in terms
of patterns of expression in the context of spatial
exploration (Guzowski et al., 1999; Chawla et al., 2005)
and the correlation of mRNA expression with learning
(Daberkow et al., 2007, 2008), implicating eIF4A3 as a
potential regulator of Arc expression in vivo. These
present observations suggest that neurons coordinate
the expression of not only effector genes, such as Arc,
but also post-transcriptional regulatory factors and
pathways required by those specific effector genes.
Dysfunction in these factors and pathways potentially
disrupts neuroplasticity processes and can lead to
neurological disorders (Dahm and Macchi, 2007; Tarpey
et al., 2007). However, how these regulatory elements
are themselves expressed and behaviorally activated in
the adult, mammalian brain is currently less clear.
Future studies are thus needed to determine the precise
mechanisms by which eIF4A3 is regulated in vivo, as
well as the functional roles that eIF4A3 may be playing
in the post-transcriptional regulation of select effector
genes within activated neurons. Such knowledge will
afford a more complete understanding of both normal
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CHAPTER 3 
DIFFERENCES IN ACTIVITY-INDUCED CYTOPLASMIC MRNA 
LOCALIZATION IN STRIATAL EFFERENT NEURONS AND 
DISRUPTION BY METHAMPHETAMINE 
Abstract 
Striatal efferent neurons differ on many levels: neuroanatomical projections, 
neurotransmitter receptors, and neuropeptide expression. We have previously reported that 
following novel environment exploration, more striatonigral than striatopallidal neurons 
have cytoplasmic Arc mRNA despite equivalent induction of the Arc gene and that such 
localization is disrupted subsequent to partial monoamine loss induced by 
methamphetamine. Thus, to assess whether these phenotypic localization differences reflect 
intrinsic posttranscriptional processing differences between striatal efferent neurons, or 
differences unique to rapidly induced, dendritically localized Arc, we examined the in vivo 
expression of the similarly activated mRNA, zif268/egr-1 in normal animals and animals with 
methamphetamine-induced neurotoxicity. As a control mRNA, we examined the expression 
of constitutively expressed Map2 (microtubule-associated protein 2). Similar to Arc, more 
striatonigral neurons had zif268 in the peri-nuclear cytoplasm after novel environment 
exploration. However, closer examination of zif268 mRNA distribution 30 minutes after 
novelty revealed that more striatopallidal neurons had zif268 in the nucleus. Furthermore, 
partial monoamine loss disrupted activity-induced cytoplasmic zif268 localization in both 
neuron subpopulations. Conversely, there were no significant phenotypic differences in 
Map2 subcellular localization at any time point. These present data suggest that striatonigral 
vs. striatopallidal neurons may utilize differential activity-dependent regulation of nuclear 
posttranscriptional mRNA processing and/or nuclear mRNA export in vivo.  
 
Introduction 
The basal ganglia critically mediate normal motor behavior and action selection by 
linking cortical activation to the output systems necessary to execute such intended behavior 
(DeLong and Wichmann, 2009), with the striatum being the key input nucleus regulating 
such behaviors. The dorsal striatum is involved in reward and goal-directed behaviors 
(Graybiel, 1995; DeCoteau and Kesner, 2000; Balleine et al., 2007), and synaptic plasticity 
within this brain region is critical to the maintenance of such learned behaviors (Calabresi et 
al., 2007; Surmeier et al., 2009). Approximately 95% of neurons in striatum are medium 
spiny neurons, and these efferent neurons can be divided into two subpopulations: 
striatonigral "direct" pathway neurons and striatopallidal "indirect" pathway neurons 
(Grillner et al., 2005; DeLong and Wichmann, 2009). While much of our understanding of 
synaptic plasticity processes in general have been elucidated within hippocampal and cortical 
systems (c.f. (Bramham et al., 2008; Shepherd and Bear, 2011)), the heterogeneous 
distribution of spiny efferent neurons within striatum has slowed our understanding of these 
essential cellular processes within this brain structure in vivo. Therefore, examining the 
precise cellular and molecular processes mediating such striatal neuroplasticity is crucial to 
understanding both normal, as well as aberrant, functions of the basal ganglia so as to 
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identify novel therapeutic targets and direct treatment strategies underlying basal ganglia-
mediated pathologies.  
The immediate-early gene, Arc/Arg3.1 (activity-regulated, cytoskeleton associated 
protein) is heavily implicated in learning and memory processes (Guzowski et al., 2001; 
Messaoudi et al., 2007), including those mediated by the basal ganglia (Hearing et al., 2011; 
Pastuzyn et al., 2012). We have routinely demonstrated that following spatial exploration of a 
novel environment by normal rats, more striatonigral than striatopallidal neurons contain 
cytoplasmic Arc mRNA expression, despite equivalent numbers of the two neuron 
populations showing transcriptional activation of the Arc gene (Daberkow et al., 2007; 
Barker-Haliski et al., 2012b). Furthermore, in the context of partial monoamine loss induced 
by methamphetamine (METH), such phenotypic differences are lost both in response to 
novelty (Barker-Haliski et al., 2012b) and to response-reversal learning on a striatally 
mediated task (Daberkow et al., 2008). Thus, striatal efferent neurons either differentially 
regulate cytoplasmic Arc mRNA localization or possess intrinsic differences in nuclear post-
transcriptional processing and/or mRNA export dynamics that have, heretofore, remained 
relatively unexplored in vivo. Thus, to begin to understand the phenotypic differences in 
nuclear posttranscriptional processing and mRNA export within striatal efferent neurons, we 
investigated the expression of candidate mRNAs that share discrete expression and 
trafficking characteristics with Arc mRNA. To this end, we examined the subcellular 
localization of these mRNAs following spatial exploration of a novel environment, a 
paradigm routinely used to examine subcellular distribution of Arc mRNA (Guzowski et al., 
1999; Daberkow et al., 2007; Barker-Haliski et al., 2012b). Furthermore, we selectively 
disrupted normal striatal function by using a partial monoamine depletion induced by the 
psychostimulant, methamphetamine (METH), so as to more closely examine how 
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dopaminergic tone may regulate subcellular mRNA distribution within striatal efferent 
neurons. 
Like Arc, zif268 mRNA is subject to a similar time-course of transcriptional 
regulation (Richardson et al., 1992; Guzowski et al., 1999; Guzowski et al., 2001; Saha et al., 
2011), can be induced by NMDA receptor activation in striatum (Gass et al., 1993), and is 
heavily implicated in long-term synaptic plasticity (Jones et al., 2001), including striatal 
learning and memory processes (Valjent et al., 2006). Unlike Arc, however (Steward et al., 
1998), zif268 is not trafficked to dendrites for local protein translation, but rather encodes a 
transcription factor essential to the induction of other neuronal mRNAs (Davis et al., 2003; 
Knapska and Kaczmarek, 2004). Additionally, Arc and zif268 mRNAs differ at the level of 
cytoplasmic mRNA regulation. Arc mRNA is subject to cytoplasmic mRNA decay mediated 
by the exon-junction complex component, eIF4A3 (Giorgi et al., 2007), and we have 
recently demonstrated that eIF4A3 colocalizes with Arc in striatum in vivo (Barker-Haliski et 
al., 2012a). However, zif268 mRNA is not subject to such translation-dependent decay 
processes (TDD (Giorgi et al., 2007)) that could contribute to differences in cytoplasmic 
mRNA levels within striatal efferent neurons. Because zif268 is subject to similar 
transcriptional regulation as Arc, but is not subject to cytoplasmic TDD, it is an effective 
tool to explore the possibility that there are differences in posttranscriptional mRNA 
regulation within striatal efferent neurons in both normal states and in the context of partial 
monoamine depletion. 
We also examined Map2 mRNA expression within identified striatal efferent 
neurons, because of the subcellular distribution profile Map2 shares with Arc, as well as the 
role of Map2 protein in mediating normal and aberrant neuroplasticity within striatum. Map2 
is a constitutively expressed, dendritically localized mRNA that is subject to activity-
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dependent protein translation (Garner et al., 1988; Blichenberg et al., 1999; Steward and 
Halpain, 1999). Importantly for this present study, Map2 mRNA associates with eIF4A3 and 
the EJC, but is not subject to cytoplasmic regulation by TDD (Giorgi et al., 2007), thus also 
differentiating it from Arc mRNA in the possible contribution of TDD to cytoplasmic 
mRNA expression differences within striatal efferent neurons. Map2 protein plays a critical 
role regulating cytoskeletal architecture in response to synaptic activity, and Map2 
dysfunction has been implicated in several neurological and neurodegenerative diseases 
(Benitez-King et al., 2004). Additionally, Arc protein interacts with Map2 protein in 
dendrites in response to synaptic activation (Fujimoto et al., 2004). Interestingly, both a 
neurotoxic regimen of METH (Zhang et al., 2007) or selective serotonin depletion 
(Whitaker-Azmitia et al., 1995) reduces Map2 immunoreactivity in the rat brain, and mutant 
mice that selectively lose nigrostriatal dopamine show deficits in striatal Map2 gene 
expression (Sola et al., 1993). Therefore, Map2 differs from Arc mRNA at the level of 
transcriptional activation, but interacts with Arc protein to mediate normal synaptic plasticity 
processes. Also, much like Arc, Map2 mRNA expression in rat striatum can be severely 
disrupted by monoamine depletion. Yet, whether there are phenotypic differences in the 
expression and activity-dependent subcellular localization of Map2 mRNA within striatal 
efferent neuron subpopulations of normal animals is currently unknown and was thus a goal 
of the present study.   
The differences between Arc and both zif268 and Map2 mRNAs presently 
investigated in this study offer an intriguing means to begin to examine activity-dependent, 
posttranscriptional mRNA nuclear export dynamics in striatal efferent neurons. Determining 
the phenotypic subcellular localization of these mRNAs in normal animals thus attempted to 
clarify whether cytoplasmic expression differences previously observed for Arc mRNA arise 
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as a consequence of neuronal phenotype-specific differences in mRNA regulation or 
whether such differences present a further unique characteristic of striatal Arc mRNA 
expression. Thus, the goal of the present studies was to apply targeted properties of Arc 
mRNA activation and cytoplasmic localization to selectively examine candidate mRNAs that 
share such lifecycle characteristics with Arc so as to tease apart the precise means by which 
phenotypic expression differences in cytoplasmic Arc mRNA localization arise within striatal 
efferent neuron subpopulations (Daberkow et al., 2007, 2008; Barker-Haliski et al., 2012b). 
Additionally, we disrupted normal dopaminergic input into the striatum using a neurotoxic 
regimen of METH so as to more clearly determine the potential role of dopamine in 
mediating such normal subcellular processing. These studies were carried out to ultimately 
address the precise subcellular processing differences present within striatal efferent neurons 
so as to further understand both normal and aberrant neuroplasticity processes within the 




Male Sprague-Dawley rats (Charles River Laboratories, Raleigh, NC; 275-300g) were 
singly housed in tub cages in a room controlled for temperature and lighting (12:12 hr). All 
animal care and experimental procedures conformed to the Guide for the Care and Use of 
Laboratory Animals (8th Ed.), followed the ARRIVE guidelines (Kilkenny et al., 2010), and 






Rats were treated with a neurotoxic regimen of (±)-methamphetamine hydrochloride 
(NIDA, Research Triangle Park, NC) so as to induce long-term, partial monoamine 
depletion in dorsal striatum, as previously described (Daberkow et al., 2008; Son et al., 2011; 
Barker-Haliski et al., 2012b). On the METH treatment day, rats were housed 5-6 animals per 
cage. Rats received four injections of either (±)-METH (10 mg/kg free base, s.c.) or 0.9% 
saline (1 mL/kg, s.c.) at 2-hr intervals, with rectal temperatures recorded hourly. If core 
temperature exceeded 41°C, the rat was removed and placed in a separate cage over ice to 
decrease hyperthermia. Twelve hours after the final injection, rats were returned to home 
cages and given free access to food and water until behavioral manipulations three weeks 
later. 
 
Behavioral Activation via Novel Environment Exploration 
Three weeks after saline- or METH-pretreatment, rats were divided into three 
experimental groups (caged controls (CC), "5-min", "30-min"), as previously described 
(Guzowski et al., 1999; Daberkow et al., 2007; Barker-Haliski et al., 2012b). Each group 
consisted of 8-9 rats / time point (saline-pretreated) or 5-12 rats / time point (METH-
pretreated), Animals were sacrificed by CO2 exposure, decapitated, and brains immediately 
removed and flash-frozen in 2-methylbutane (Mallinckrodt Baker, Phillipsburg, NJ) chilled 
on dry ice.   
Upon observing phenotypic differences in cytoplasmic expression of zif268 mRNA, 
we generated a second cohort of animals with longer time points between novel 
environment exploration and sacrifice, so as to investigate the expression of Map2 mRNA in 
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normal animals. Rats in this cohort were divided into 5 experimental groups (CC, "5-min", 
"30-min", “60-min”, “90-min”), each consisting of 4 rats / time point. 
 
Tissue Preparation  
Twelve-µm cryosections of striatum (Cambridge Instruments, Bayreuth, Germany; 
Bregma: +1.60 to -0.8 mm) (Paxinos and Watson, 1998) were thaw-mounted onto 
SuperFrost Plus slides (VWR, Batavia, IL), then postfixed as previously described (Ganguly 
and Keefe, 2001). 
 
DAT Autoradiography  
METH-induced DA depletions in striatum were analyzed using [I125]RTI-55 binding 
to the dopamine transporter (DAT), as described previously (Boja et al., 1992; Pastuzyn et 
al., 2012). DAT binding levels were normalized to percent of saline controls. 
 
Dual Fluorescent In Situ Hybridization Histochemistry 
 Expression of zif268 mRNA in striatal efferent neurons was determined by 
double-label fluorescence in situ hybridization histochemistry (FISH) for zif268 or Map2 and 
ppe mRNAs, as previously described for Arc (Daberkow et al., 2007, 2008; Barker-Haliski et 
al., 2012b; Barker-Haliski et al., 2012a; Howard et al., 2013). Full-length ribonucleotide 
probes complementary to mRNAs for zif268 (Milbrandt, 1987) and ppe (Yoshikawa et al., 
1984) were synthesized from cDNAs using digoxigenin-UTP (DIG-UTP) and fluorescein-
UTP (FITC-UTP) with T7 and SP6 RNA polymerases and DIG- and FITC-UTP RNA-
labeling kits, respectively (Roche Applied Science, Indianapolis, IN). A full-length rat Map2 
cDNA-containing vector was purchased for plasmid isolation ([GenBank: BC081835]; Open 
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Biosystems, Huntsville, AL), cDNA linearized (EcoRI; Roche Applied Science, Indianapolis, 
IN), and probe transcribed with DIG-UTP and T7 RNA polymerase (Roche Applied 
Science, Indianapolis, IN). Ribonucleotide probes were hybridized and detected as 
previously described (Daberkow et al., 2007, 2008; Barker-Haliski et al., 2012b; Barker-
Haliski et al., 2012a).   
 
Image Acquisition 
For zif268/ppe or Map2/ppe dual in situ hybridization histochemistry, a 0.18 mm2 
montage from dorsomedial (DM) striatum was captured with an FV1000 confocal laser-
scanning microscope (Olympus) with motorized stage (Prior Scientific) using a 60x, 1.45 NA 
oil-immersion lens (plan APO) and 488-nm Ar and 543-nm and 633-nm HeNe lasers. Areas 
of analysis were z-sectioned in 1-µm-thick optical sections (10 z-sections per image; 
(Daberkow et al., 2007, 2008; Barker-Haliski et al., 2012b). The numbers of ppe-pos and ppe-
neg neurons with zif268 or Map2 mRNA staining as 1-2 foci of intranuclear staining ("foci") 
or labeling in the cytoplasm only ("cytoplasmic") were determined (Guzowski et al., 1999; 
Daberkow et al., 2007, 2008). Additionally, we generated two new dependent measures to 
fully capture the nature of the subcellular distribution of the mRNA signals. Cells with 
diffuse mRNA expression throughout the nucleus only across 2 or more z-sections were 
counted as “full nucleus”, whereas cells simultaneously containing diffuse nuclear and 
cytoplasmic labeling across 2 or more consecutive z-sections were labeled “whole cell”. The 
phenotypic identity of striatal efferent neurons (ppe +/-) was withheld from image analysis 
until after making subcellular zif268 and Map2 expression assignments. As previously 
justified (Daberkow et al., 2007), phenotypic ppe expression was implemented to differentiate 
striatal efferent neuron subtypes because approximately 95% of neurons within striatum are 
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spiny efferent neurons (Gerfen and Young, 1988; Le Moine and Bloch, 1995). Furthermore, 
previous work by Vazdarjanova and colleagues demonstrated that Arc mRNA is only 
expressed in GAD-67 positive striatal neurons (Vazdarjanova et al., 2006), with GAD-67 
only expressed in striatal efferent neurons and a small subpopulation of striatal interneurons 
that comprises ~1% of the entire striatal neuron population (Mercugliano et al., 1992), thus 
making ppe an effective phenotypic marker to differentiate striatonigral (ppe-neg) and 
striatopallidal (ppe-pos) neurons (Daberkow et al., 2007). 
 
Statistical Analysis 
Analysis of DAT binding was accomplished by two-sample t-tests. Expression of 
mRNA in each subcellular compartment in normal and METH-pretreated rats was 
compared across neuronal phenotype by MANOVA (time, phenotype). Post-hoc analyses of 
significant interactions were achieved via Tukey-Kramer test for between-subjects factors 
(time) or post-hoc t-tests for the within-subjects factor (phenotype). For all analyses, p-values 
<0.05 were considered to be significant.   
 
Results 
In Normal Animals, More Striatonigral Neurons Have Cytoplasmic  
Localization of zif268 after Novel Environment Exploration 
 We have previously investigated the subcellular distribution of Arc mRNA within 
identified striatal efferent neurons in response to novel environment exploration (Daberkow 
et al., 2007; Barker-Haliski et al., 2012b), and previous reports by others have demonstrated a 
similar time course of activation for zif268 mRNA within the hippocampus using such a 
novel environment exploration paradigm (Guzowski et al., 2001). So, we presently employed 
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this novel environment exploration paradigm to examine zif268 transcriptional activation 
and cytoplasmic localization within identified striatal efferent neurons in saline-pretreated 
rats (Figure 3.1). Exposure of saline-pretreated rats to a novel environment resulted in a 
trend to induce transcriptional activation of zif268 above baseline expression levels (Figure 
3.1B; F(2,21)=3.04, p=0.07). However, there was no effect of phenotype (F(1,21)=0.33, p>0.5) or 
phenotype x time interaction (F(2,21)=0.25, p>0.7) in the numbers of cells with intranuclear 
zif268 foci.  
We observed a significant time-dependent increase in cytoplasmic localization of 
zif268 mRNA in response to novel environment exploration (Figure 3.1C; F(2,21)=4.27, 
p=0.03). Furthermore, like Arc mRNA (Daberkow et al., 2007; Barker-Haliski et al., 2012b), 
there was a significant effect of phenotype on numbers of cells with zif268 in the cytoplasm 
(F(1,21)=10.85, p=0.004), with more ppe-neg neurons having cytoplasmic zif268 than ppe-pos 
striatopallidal neurons. There was no significant time x phenotype interaction (F(2,21)=0.91, 
p>0.4). Post-hoc analysis of main effect of time revealed that there was an increase in the 
numbers of neurons with cytoplasmic zif268 mRNA in the 30-min group relative to the CC 
group (p=0.02), but not relative to the 5-min group (p=0.16). Thus, spatial exploration of a 
novel environment induced a robust subcellular distribution of zif268 mRNA, with more ppe-
neg neurons displaying cytoplasmic zif268 expression than ppe-pos neurons.  
 
In Normal Animals, More Striatopallidal Neurons Have zif268 in the 
Nucleus 30 Minutes after Novel Environment Exploration 
 The divergent numbers of ppe-neg neurons with cytoplasmic zif268 in normal animals 
is intriguing, particularly in relation to our previous observations that greater numbers of ppe-
neg cells also have cytoplasmic Arc mRNA expression (Daberkow et al., 2007; Barker-Haliski 
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et al., 2012b). Importantly, unlike Arc, zif268 mRNA is not subject to regulation by 
cytoplasmic TDD (Giorgi et al., 2007); therefore, the present data with zif268 suggest that 
differences in cytoplasmic mRNA stability between striatal efferent neuron subpopulations 
are not likely contributing to the greater number of ppe-neg cells with cytoplasmic zif268 and 
Arc mRNA expression. Thus, we examined more closely the subcellular distribution of 
zif268 mRNA in striatonigral efferent neurons by performing a subsequent, more stringent 
analysis of mRNA distribution within striatal efferent neurons within the 30-min group only. 
For this analysis, cells were classified as having "full nucleus", "cytoplasmic-only", or 
"whole cell" labeling (Figure 3.2A; see Methods). When numbers of cells with "full nucleus" 
staining for zif268 were analyzed, there was a significant effect of phenotype (t=-2.51, 
p=0.04), with neurons with full nuclei being approximately 2:1 ppe-pos (Figure 3.2B). 
However, when this more stringent analysis was used to assess cells with zif268 throughout 
the cell ("whole cell" labeling), there was a significant effect of phenotype in the opposite 
direction, such that there were more ppe-neg neurons positive for "whole cell" labeling of 
zif268 (Figure 3.2B; t=3.07, p<0.02). This analysis also confirmed our prior observations for 
cells positive for cytoplasmic zif268 in the 30-min group, with more ppe-neg neurons 
containing cytoplasmic zif268 than ppe-pos (Figure 3.2B; t=6.14, p<0.001). Thus, a more 
stringent analysis of the subcellular distribution of activity-induced mRNAs revealed a 







Constitutively Expressed Map2 Shows No Phenotype-specific Cytoplasmic  
Expression Differences in Normal Animals 
 Upon observing the differential cytoplasmic expression of zif268 in striatal efferent 
neurons of saline-pretreated rats, we then investigated the subcellular expression of Map2, a 
constitutively expressed mRNA that is subject to activity-dependent dendritic transport and 
protein synthesis (Torre and Steward, 1992; Steward and Halpain, 1999). Because Steward 
and colleagues demonstrated time-dependent fluctuations in Map2 protein immunoreactivity 
in the dentate gyrus of normal animals (Steward and Halpain, 1999), additional time points 
were examined to assess cell body-level Map2 mRNA localization at similar periods after 
neuronal activity (Figure 3.3A). We initially examined signal intensity (mean gray value) and 
percent field area with pixels positive for Map2 signal to determine whether there was any 
detectable change in Map2 localization following novel environment exploration (Figure 
3.3B and 3.3C). Such densitometric analysis revealed a significant time-dependent change in 
signal intensity (Figure 3.3B; F(4,18)=3.78, p<0.03) and a strong trend for an activity-
dependent change in percent field area (Figure 3.3C; F(4,18)=2.92, p=0.06). Post-hoc analysis of 
mean gray values revealed that the 5-min group differed significantly from the CC (p<0.03) 
and 30-min (p=0.03) groups, with a strong trend to differ from the 60-min (p<0.06) and 90-
min (p<0.08) groups as well. Thus, densitometric analysis of Map2 mRNA signal within 
dorsal striatum followed a similar time course of mRNA distribution that was previously 
reported for changes in Map2 protein immunoreactivity in hippocampus (Steward and 
Halpain, 1999).  
To determine whether Map2 mRNA also had differential cytoplasmic localization in 
striatal efferent neurons in response to behavioral activation in normal animals, we counted 
Map2 positive cells, as performed above for zif268 and as previously for Arc mRNA 
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(Guzowski et al., 1999; Daberkow et al., 2007; Barker-Haliski et al., 2012b). Map2 nuclear 
foci were not detected in medium spiny neurons (data not shown), as cells predominately 
displayed either cytoplasmic or whole cell labeling (Figure 3.3A). Analysis of the numbers of 
cells with cytoplasmic-only Map2 labeling revealed no significant main effect of time (Figure 
3.3D; F(4,14)=1.38, p>0.2), no significant effect of phenotype (F(4,14)=0.83, p>0.3), and no 
significant phenotype x time interaction (F(4,14)=1.25, p>0.3). However, analysis of the 
numbers of cells with "whole cell" labeling of Map2 mRNA expression showed a significant 
main effect of time (Figure 3.3E; F(4,14)=3.64, p=0.03), with post-hoc analysis revealing that the 
5-min group was significantly different from all other groups (p<0.05). There was no 
significant effect of phenotype on the numbers of cells with "whole cell" labeling for Map2 
(F(1,14)=1.63, p>0.2) and no significant phenotype x time interaction (F(4,14)=0.26, p=0.9). 
Thus, subcellular distribution of the constitutively expressed, non-IEG Map2 was not 
different between striatonigral and striatopallidal neurons. These data suggest that the 
phenotypic differences in Arc (Daberkow et al., 2007; Barker-Haliski et al., 2012b) and zif268 
mRNA localization in striatonigral vs. striatopallidal neurons of normal animals may reflect 
differential posttranscriptional processing and nuclear export of rapidly induced mRNAs. 
 
METH-Induced Partial Monoamine Depletion Disrupts Cytoplasmic  
Localization of zif268 mRNA 
 Given that the data above suggested the possibility of differential regulation of post-
transcriptional processing and nuclear export of rapidly induced mRNAs in striatal efferent 
neurons, and given the differential effects of DA on these two populations of neurons 
(Gerfen and Surmeier, 2011), we next investigated how disruption of normal dopaminergic 
input onto striatal efferent neurons affected zif268 subcellular distribution, as previous 
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reports have demonstrated significant impairments in striatal IEG expression after METH-
induced neurotoxicity (Horner and Keefe, 2006; Daberkow et al., 2008; Belcher et al., 2009; 
Barker-Haliski et al., 2012b). A neurotoxic regimen of METH decreased DAT binding to 
52.6±4.1% (t=8.32, p<0.0001) of control levels in DM striatum and to 67.8±3.6% (t=6.46, 
p<0.0001) of control levels in dorsolateral (DL) striatum (Figure 3.4A; (Chapman et al., 
2001; Daberkow et al., 2008; Barker-Haliski et al., 2012b)).  
 Analysis of the numbers of cells with intranuclear foci of zif268 mRNA expression in 
rats with METH-induced DA loss that explored a novel environment for 5 minutes revealed 
a slight trend toward a main effect of time (Figure 3.4B; F(1,19)=2.11, p=0.15), as was seen in 
saline-pretreated rats (Figure 3.1B). As was also the case for the saline-pretreated rats, there 
was no significant effect of neuronal phenotype (F(1,19)=0.18, p>0.6) and no significant 
phenotype x time interaction (F(2,19)=1.19, p>0.3).  
Analysis of the numbers of cells with cytoplasmic-only expression of zif268 mRNA 
expression in rats with METH-induced DA loss that explored a novel environment for 5 
minutes revealed an interesting divergence from saline-pretreated rats. There was a 
significant effect of time (F(2,19)=5.13, p<0.02), a significant main effect of phenotype 
(F(1,19)=9.06, p<0.008), and a significant phenotype x time interaction (Figure 3.4C; 
F(2,19)=5.68, p<0.02). Post-hoc analysis of the significant interaction revealed that activity-
dependent increases in cytoplasmic zif268 mRNA localization were disrupted by partial 
monoamine depletion. Although all groups had more ppe-neg neurons with zif268 mRNA in 
the cytoplasm, this difference was only significant in the CC group (t=4.93, p<0.001).  
Furthermore, only ppe-neg neurons had a time-dependent change in cytoplasmic zif268 
localization (ppe-pos: F(2,19)=1.47, p>0.2; ppe-neg: F(2,19)=6.84, p<0.01); however, unlike the 
case in saline-pretreated rats, in these METH-pretreated rats, there were more ppe-neg 
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neurons with zif268 in the cytoplasm in the CC group than in the 5- and 30-min groups 
(Figure 3.3C; 5-min, p<0.03; 30-min, p<0.02). Interestingly, the numbers of cells positive for 
zif268 expression in the cytoplasm of METH-pretreated CC was not different from the 
numbers of neurons with zif268 mRNA expression in the cytoplasm of the normal CC rats  
(ppe-pos: t=-1.41, p>0.1; ppe-neg: t=-0.48, p>0.6; compare Figures 3.1C and 3.4C). Thus, 
partial DA depletion significantly impairs activity-dependent cytoplasmic localization of 
zif268 in ppe-pos and ppe-neg neurons, as well as ablating the phenotypic expression 
difference in cytoplasmic zif268 mRNA localization 30 minutes after novel environment 
exploration (Figure 3.4D). These data thus suggest that DA may normally critically mediate 
nuclear mRNA export within striatal efferent neurons, as partial DA depletion disrupts 
activity-induced cytoplasmic localization of zif268 mRNA, in line with our previous 
observations for Arc mRNA under similar circumstances (Daberkow et al., 2007; Barker-
Haliski et al., 2012b). 
 
Discussion 
 We presently report differential subcellular distribution of the IEG zif268 mRNA, 
but not of the constitutively expressed, non-IEG MAP2 mRNA, in striatonigral vs. 
striatopallidal neurons of rats subsequent to exploration of a novel environment. While our 
results for transcriptional activation of zif268 were less robust than previous reports for 
zif268 expression in the hippocampus (Guzowski et al., 2001), other reports indicate 
significant basal expression of zif268 (Worley et al., 1991; Roberts et al., 1996; Zangenehpour 
and Chaudhuri, 2002; Knapska and Kaczmarek, 2004), which likely decreased our ability to 
detect the de novo transcription occurring in response to novelty-induced exploration. 
Importantly, our findings that more striatonigral neurons contain cytoplasmic zif268 
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expression relative to striatopallidal neurons despite equivalent mRNA transcription mirrors 
our previous reports of the differential cytoplasmic localization of Arc within striatal efferent 
neurons (Daberkow et al., 2007, 2008; Barker-Haliski et al., 2012b). Furthermore, our 
additional analysis of the discrete subcellular distribution of zif268 mRNA 30 minutes after 
novel environment exploration revealed that more striatopallidal nuclei were diffusely filled 
with zif268 mRNA signal relative to striatonigral neurons. Interestingly, Map2 did not show 
such differences in activity-dependent cytoplasmic distribution within striatal efferent 
neurons subpopulations, suggesting that activity-induced distribution of IEGs per se from the 
nucleus to the cytoplasm is different in striatopallidal and striatonigral neurons. Additionally, 
in the context of partial DA depletion, normal activity-dependent cytoplasmic localization of 
zif268 is disrupted, as previously observed for Arc (Daberkow et al., 2008; Barker-Haliski et 
al., 2012b). Thus, these data further suggest that there may be differential post-
transcriptional mRNA processing or nucleocytoplasmic transport of IEGs in striatonigral vs. 
striatopallidal neurons in vivo, and that DA may participate in regulating such functions. Our 
present observations thus demonstrate a novel difference between distinct neuronal subtypes 
in the same brain region at the level of nuclear mRNA regulation or nucleocytoplasmic 
transport and further emphasize fundamental differences in neuroplasticity processes within 
these two efferent neuron populations of the striatum.  
It is well established that zif268 plays a critical role meditating normal LTP processes 
in vivo, thus providing functional significance for the observed changes in subcellular 
localization of zif268 mRNA within striatal efferent neuron subpopulations in response to 
exploration of a novel environment. First, tetanic stimulation to induce LTP in hippocampal 
slice cultures robustly upregulates of zif268 expression (Mackler et al., 1992; Roberts et al., 
1996). Second, zif268 upregulation specifically correlates with the persistence of LTP 
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(Richardson et al., 1992; Abraham et al., 1993). Finally, zif268 mutant mice show no changes 
in the induction of and early phases of LTP within the dentate gyrus, but maintenance of late 
LTP in these animals is disrupted, thereby demonstrating the critical role zif268 plays in 
stabilizing late LTP (Jones et al., 2001). Thus in normal animals, it is likely that spatial 
exploration of a novel environment is associated with activation zif268 transcription and 
cytoplasmic distribution in striatal efferent neurons so as to mediate neuroplasticity essential 
to learning arising in the context of such novelty exposure. 
We presently demonstrate that striatal efferent neuron subpopulations differentially 
regulate the cytoplasmic localization of activity-regulated zif268, similar to our previous 
observations for Arc mRNA expression and subcellular distribution (Daberkow et al., 2007; 
Barker-Haliski et al., 2012b). However, unlike Arc, zif268 is not a substrate for cytoplasmic 
TDD (Giorgi et al., 2007), which could have been a basis for diminished detectable levels of 
cytoplasmic mRNA within striatopallidal vs. striatonigral neurons, and thereby contribute to 
the observed phenotypic differences.  Furthermore, the present results also show that 
whereas more striatonigral neurons have zif268 mRNA expression in the cytoplasm, more 
striatopallidal neurons have nuclei full of zif268 mRNA. We then asked whether such 
subcellular differences were also present for Arc mRNA. Conducting this same analysis for 
“full” and “whole cell” labeling on existing 30-min group Arc/ppe images shown to have 
more striatonigral than striatopallidal neurons with Arc mRNA in the cytoplasm (Barker-
Haliski et al., 2012b) demonstrated that more striatopallidal cells contained diffuse, whole 
cell labeling for Arc mRNA (t=-4.48, p=0.001; data not shown), but no phenotype-specific 
difference in numbers of cells with full nuclei (t=1.73, p>0.1; data not shown). Altogether, 
these observations suggest that there are differences between striatonigral and striatopallidal 
neurons with respect to posttranscriptional processing in the nucleus or nucleocytoplasmic 
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transport of these IEG mRNAs. How nuclear export proceeds in neurons in general, and in 
striatal efferent neurons in particular, thus requires further scrutiny. While it is known that 
Arc forms an mRNA-protein complex that contributes to nuclear export and cytoplasmic 
trafficking (Le Hir et al., 2001; Kanai et al., 2004; Giorgi et al., 2007), whether such post-
transcriptional processing occurs for the regulation of zif268 mRNA is currently unknown. 
The fact that there is differential regulation of zif268 mRNA localization in 
striatonigral vs. striatopallidal neurons is not immediately surprising given the opposing 
functionality of these neuronal subpopulations and known cellular differences (DeLong and 
Wichmann, 2009). Striatal efferent neuron subpopulations selectively express DA and 
adenosine receptors (Gerfen et al., 1990; Ferre and Fuxe, 1992; Surmeier et al., 1992; Tozzi 
et al., 2007), thus leading to neuron-specific differential activation of intracellular signaling 
cascades, such as PKA, which could contribute to the observed phenotypic differences in 
the subcellular localization of zif268 (present data) and Arc (Daberkow et al., 2007; Barker-
Haliski et al., 2012b) mRNAs. The data presented herein from rats with METH-induced 
monoamine loss support the possibility DA signaling may in fact play a role in the 
differential processes.  Prior work from our lab has established that METH-induced DA loss 
is associated with disruption of phasic DA neurotransmission (Howard et al., 2011), and 
recent modeling work suggests that D1 dopamine receptors may be preferentially affected by 
changes in phasic DA signaling (Dreyer et al., 2010).  Interestingly, in the present study, the 
basal numbers of cells with cytoplasmic zif268 mRNA localization (i.e., those in the CC 
group) were not significantly different between saline- and METH-pretreated rats (Figures 
3.1C and 3.4C). However, the normal increase in the numbers of striatonigral neurons, 
which selectively express the D1 subtype of DA receptors (Gerfen and Surmeier, 2011), with 
zif268 mRNA in the cytoplasm induced by spatial exploration of a novel environment, was 
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abolished in METH-pretreated rats. Interestingly, we have previously demonstrated similar 
disruption of cytoplasmic Arc mRNA localization in striatonigral neurons of rats with 
METH-induced DA loss (Daberkow et al., 2008; Barker-Haliski et al., 2012b), and the 
magnitude of that disruption correlates with the degree of DA loss (Barker-Haliski et al., 
2012b), as does the disruption of phasic DA signaling (Bergstrom and Garris, 2003). Our 
present results thus suggest an intriguing role for DA in general, and perhaps phasic DA 
signaling through D1 DA receptors in particular, in mediating normal activity-dependent 
mRNA cytoplasmic localization in striatonigral efferent neurons.  
As noted above, phasic DA signaling is disrupted in rats with METH-induced DA 
loss, and phasic DA signaling is predicted to selectively affect signaling through the D1 
subtype of DA receptors. The D1 DA receptor is positively coupled to adenylyl cyclase 
(Herve et al., 1995; Gerfen and Surmeier, 2011) and, thus, PKA. PKA mediates nuclear 
export of several cellular factors critically involved in cytoskeletal rearrangement and 
signaling underlying neuroplasticity processes. For example, PKA induces nuclear export of 
the MAPK-activated protein kinase, MK5 (Gerits et al., 2007; Kostenko et al., 2011), and 
such MK5 export induces F-actin rearrangement in PC12 cells (Gerits et al., 2007). 
Additionally, PKA regulates the nuclear export of the polypyrimidine tract-binding protein 
(PTB) and association of PTB with β-actin, which is essential to neurite outgrowth in PC12 
cells (Ma et al., 2007). Furthermore, PKA phosphorylates histone deacetylase 5 (HDAC5), 
thereby preventing its nuclear export (Ha et al., 2010), and HDAC5 was recently reported to 
undergo activity-dependent nucleocytoplasmic shuttling within cultured hippocampal 
neurons (Schlumm et al., 2013). Thus, the regulation of PKA by DA D1 receptor activation 
is an attractive target for exploration of the processes potentially mediating the differential 
subcellular distribution of IEG mRNAs in striatal efferent neuron subpopulations.   
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In model organisms, distribution of mRNA-protein (mRNP) complexes from the 
nucleus to the cytoplasm requires complex intracellular signaling and could thus be a critical 
processing point whereby neuronal mRNA transport is regulated (Oeffinger and Zenklusen, 
2012). Most evidence suggests that export through the nuclear pore complex (NPC) itself 
occurs relatively quickly in metazoans (Ribbeck and Gorlich, 2001; Smith et al., 2002). 
However, once in the cytoplasm, exported mRNPs are prevented from returning to the 
nucleus by the DEAD-box RNA helicase DDX19 (Tran et al., 2007; Stewart, 2010; 
Folkmann et al., 2011). DDX19 requires local activation by GLE1 and its co-factor inositol 
hexakisphosphate (IP6), to stimulate RNA binding necessary for cytoplasmic mRNP 
remodeling and retention (Tran et al., 2007; Hodge et al., 2011; Montpetit et al., 2011). IP6 is 
highly expressed in striatum, can be activated in response to electroconvulsive shock, and 
can activate PKA (Yang et al., 2001). Thus, while export through the NPC is relatively fast, 
cytoplasmic retention of mRNPs such as Arc and zif268 may be differentially modulated by 
IP6-mediated regulation of DDX19 activity within striatal efferent neurons. How such 
cytoplasmic mRNP remodeling may proceed in neurons, as well as how such cytoplasmic 
directionality could contribute to Arc (Daberkow et al., 2007; Barker-Haliski et al., 2012b) 
and zif268 phenotypic expression differences within striatal efferent neurons, is currently 
unknown, but could be a basis for the phenotypic differences in cytoplasmic mRNA 
expression. 
Our prior observations that more striatonigral than striatopallidal neurons contain 
cytoplasmic Arc mRNA suggested divergent mRNA regulatory mechanisms within these 
efferent neuron subpopulations (Daberkow et al., 2007, 2008; Barker-Haliski et al., 2012b). 
Furthermore, our present observations emphasize that this cytoplasmic expression 
difference is not unique to Arc, but may rather be a function of global differences in IEG 
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mRNA regulation within striatal efferent neuron subpopulations. Additionally, we 
demonstrate that partial DA depletion significantly disrupts cytoplasmic localization 
dynamics, thus suggesting a role for DA in mediating normal posttranscriptional mRNA 
regulation in striatal neurons. While much of our understanding of mRNA regulation and 
synaptic plasticity processes in general have been skillfully elucidated in hippocampal 
preparations (Guzowski et al., 1999; Guzowski et al., 2006; Bramham et al., 2008; Lebeau et 
al., 2008; Bramham et al., 2009), it is essential that such meticulous studies are similarly 
performed in striatal efferent neurons given the recent findings demonstrating vast 
differences in synaptic plasticity-associated factor expression between striatum and 
hippocampus (Baucum et al., 2013). Our present results suggest that while much work has 
already demonstrated significant signaling differences between striatal efferent neurons 
(Surmeier et al., 2009; Gerfen and Surmeier, 2011; Kreitzer and Berke, 2011), additional 
investigation into the posttranscriptional regulation of mRNA expression in striatal efferent 
neuron subpopulations will be necessary to fully understand how these neuronal phenotypes 
modulate synaptic plasticity signaling processes under both normal, as well as aberrant, 
conditions. Such investigations into the subcellular mechanisms underlying neuroplasticity in 
striatal efferent neurons will be critical for advancing our ability to prevent or manage 
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Figure 3.1. Activity-dependent expression of zif268 mRNA within striatal efferent neurons of normal rats. 
A) Representative photomicrographs from in situ hybridization histochemistry for zif268 and 
ppe mRNA in dorsomedial striatum in caged control animals (CC), or after spatial 
exploration of a novel environment for 5 minutes then immediate sacrifice (“5-min”), or 
sacrifice 25 minutes later (“30-min”). Arrows indicate neurons positive for zif268 mRNA 
intranuclear foci; arrowheads indicate neurons positive for zif268 mRNA cytoplasmic 
localization. Blue is preproenkephalin mRNA, red is zif268 mRNA, and green is SYTOX 
nuclear counterstain. Scale bar = 10 µm B) Numbers of cells with intranuclear zif268 foci 
following spatial exploration of a novel environment. Data are mean (± SEM; 8-9 animals / 
time point) numbers of neurons per 0.5 mm2 determined from double fluorescent in situ 
hybridization for zif268 and preproenkephalin mRNAs. C) Numbers of cells with cytoplasmic 
zif268 expression following spatial exploration of a novel environment. Data are mean (± 
SEM; 8-9 animals / time point) numbers of neurons per 0.5 mm2 determined from double 
fluorescent in situ hybridization for zif268 and preproenkephalin mRNAs. * Significant main 







Figure 3.2. Striatal efferent neurons show differences in numbers of cells with cytoplasmic localization of 
zif268 mRNA 30 minutes after spatial exploration of a novel environment. A) Representative 
photomicrographs of two consecutive confocal z-stacks illustrating “full” nucleus labeling 
(arrows), “whole cell” labeling (arrowheads), or “cytoplasmic” labeling (asterisks). Red is 
zif268 mRNA and green is SYTOX nuclear counterstain. Scale bar = 10 µm. B) 
Striatopallidal, ppe-pos neurons are more frequently positive for nuclei “full” of zif268 
mRNA 30 minutes after spatial exploration of a novel environment, whereas striatonigral, 
ppe-neg neurons are more frequently positive for “whole cell” or “cytoplasmic”-only zif268 
mRNA labeling. Data are mean (± SEM; 8-9 animals / time point) numbers of neurons per 
0.5 mm2 determined from double fluorescent in situ hybridization for zif268 and 
preproenkephalin mRNAs. # Significantly greater than ppe-neg neurons. * Significantly greater 




Figure 3.3. There is no phenotypic difference in the numbers of cells with cytoplasmic localization of 
constitutively expressed Map2 mRNA. A) Representative photomicrographs of Map2 and ppe 
mRNA within efferent neurons of dorsomedial striatum following spatial exploration of a 
novel environment. Rats were either immediately sacrificed as caged controls (CC), or 
allowed to explore a novel environment for 5 minutes then immediately sacrificed (“5-min”), 
or sacrificed 25 minutes later (“30-min”), 55 minutes later (“60-min”) or 85 minutes later 
(“90-min”). Blue is preproenkephalin mRNA, red is Map2 mRNA, and green is SYTOX nuclear 
counterstain. B) Densitometric analysis of average Map2 pixel intensity in dorsomedial 
striatum. *Significantly different from CC and 30-min. C) Percent image area with Map2-
positive pixels in dorsomedial striatum. D) Numbers of labeled neurons with cytoplasmic 
Map2 mRNA following spatial exploration of a novel environment. Data are mean (± SEM; 
4 animals / time point) numbers of neurons per 0.5 mm2 determined from double 
fluorescent in situ hybridization for Map2 and preproenkephalin mRNAs. E) Numbers of 
labeled neurons with whole cell Map2 mRNA labeling following spatial exploration of a 
novel environment. Data are mean (± SEM; 4 animals / time point) numbers of neurons per 
0.5 mm2 determined from double fluorescent in situ hybridization for Map2 and 
preproenkephalin mRNAs. * Significantly different from numbers of neurons in CC and 30-





Figure 3.4. Activity-dependent zif268 mRNA expression within striatal efferent neurons of rats with 
partial monoamine depletion induced by METH. A) Three weeks after a neurotoxic regimen of 
METH, METH-pretreated rats have significant decreases in dorsomedial (DM) and 
dorsolateral (DL) striatum DA transporter binding relative to saline-pretreated controls. * 
Significantly less than saline-pretreated rats. B) Numbers of labeled neurons with 
intranuclear zif268 foci following spatial exploration of a novel environment in METH-
pretreated rats. Data are mean (± SEM; 5-12 animals / time point) numbers of neurons per 
0.5 mm2 determined from double fluorescent in situ hybridization for zif268 and 
preproenkephalin mRNAs. C) Numbers of labeled neurons with cytoplasmic zif268 expression 
following spatial exploration of a novel environment in METH-pretreated rats. Data are 
mean (± SEM; 5-12 animals / time point) numbers of neurons per 0.5 mm2 determined 
from double fluorescent in situ hybridization for zif268 and preproenkephalin mRNAs. * 
Significantly different from numbers of ppe-neg neurons in 5- and 30-min groups. + 
Significantly different from numbers of ppe-pos neurons in CC group. D) Comparing saline- 
and METH-pretreated rats 30 minutes after novel environment exploration reveals 
profound disruption of cytoplasmic mRNA distribution subsequent to METH-induced 
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Abstract
The immediate-early gene Arc (activity-regulated cytoskele-
ton-associated protein) is provocative in the context of
neuroplasticity because of its experience-dependent regula-
tion and mRNA transport to and translation at activated
synapses. Normal rats have more preproenkephalin-negative
(ppe-neg; presumed striatonigral) neurons with cytoplasmic
Arc mRNA than ppe-positive (ppe-pos; striatopallidal) neu-
rons, despite equivalent numbers of these neurons showing
novelty-induced transcriptional activation of Arc. Furthermore,
rats with partial monoamine loss induced by methamphet-
amine (METH) show impaired Arc mRNA expression in both
ppe-neg and ppe-pos neurons relative to normal animals
following response-reversal learning. In this study, Arc expres-
sion induced by exposure to a novel environment was used to
assess transcriptional activation and cytoplasmic localization
of Arc mRNA in striatal efferent neuron subpopulations
subsequent to METH-induced neurotoxicity. Partial mono-
amine depletion signiﬁcantly altered Arc expression. Speciﬁ-
cally, basal Arc expression was elevated, but novelty-induced
transcriptional activation was abolished. Without novelty-
induced Arc transcription, METH-pre-treated rats also had
fewer neurons with cytoplasmic Arc mRNA expression, with
the effect being greater for ppe-neg neurons. Thus, METH-
induced neurotoxicity substantially alters striatal efferent
neuron function at the level of Arc transcription, suggesting a
long-term shift in basal ganglia neuroplasticity processes
subsequent to METH-induced neurotoxicity. Such changes
potentially underlie striatally based learning deﬁcits associated
with METH-induced neurotoxicity.
Keywords: Arc/Arg 3.1, dopamine, immediate-early gene,
methamphetamine, striatum.
J. Neurochem. (2012) 123, 845–855.
Methamphetamine (METH) is a highly addictive psycho-
stimulant that can induce substantial forebrain dopamine
(DA) and serotonin depletions when administered at high
doses (Wagner et al. 1980; Woolverton et al. 1989).
Although METH-induced monoamine depletions are signif-
icantly less than those observed in Parkinson’s disease, these
partial depletions lead to impairments in basal ganglia-
mediated behavioral and cognitive abilities in both rodents
and humans (Chapman et al. 2001; Volkow et al. 2001;
Kalechstein et al. 2003; Johanson et al. 2006). Furthermore,
recent data show that individuals with a history of metham-
phetamine or other amphetamine abuse are more likely to
develop Parkinsonism (Callaghan et al. 2012), suggesting
that METH exposure may be associated with a signiﬁcant
pre-clinical period of partial striatal DA loss and associated
consequences.
The bases for the cognitive and behavioral sequelae of
METH-induced partial DA loss remain unknown. Approx-
imately, 95% of neurons in striatum are medium spiny
neurons, and these efferent neurons can be divided into
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two equal subpopulations: striatonigral ‘direct’ pathway
neurons and striatopallidal ‘indirect’ pathway neurons (Wich-
mann and DeLong 1996; Obeso et al. 1997; Grillner et al.
2005). These efferent neurons can be phenotypically differen-
tiated at the cell body level by their selective expression of
neuropeptides: striatopallidal neurons express preproenkeph-
alin (ppe-pos), whereas striatonigral neurons do not [ppe-neg
(Gerfen and Young 1988)]. Striatonigral neurons predomi-
nately express D1-DA receptors, whereas striatopallidal
neurons predominately express D2-DA receptors. Prior work
suggests that METH-induced functional impairments are
substantially more pronounced in striatonigral neurons (Chap-
man et al. 2001; Johnson-Davis et al. 2002; Daberkow et al.
2008), consistent with ﬁndings reported for rats with partial
DA loss induced by 6-hydroxydopamine (Nisenbaum et al.
1996). Such changes may be because, in part, of impairments
in phasic DA signaling associated with the METH-induced
neurotoxicity (Howard et al. 2011), as the D1-DA receptor
may be particularly sensitive to such changes (Floresco et al.
2003; Dreyer et al. 2010).
The immediate-early gene Arc/Arg3.1 (activity-regulated
cytoskeleton-associated protein) is a critical mediator of
normal neuroplasticity processes and is induced by N-
methyl-D-asparate (NMDA)-receptor activation before being
trafﬁcked to activated synapses, where it is locally translated
(Lyford et al. 1995; Bramham et al. 2008). Arc mRNA
expression is induced in an experience-dependent manner
(Guzowski et al. 1999; Daberkow et al. 2007) within
GABAergic striatal neurons (Vazdarjanova et al. 2006).
Arc protein itself is critical to modulating excitatory gluta-
matergic inputs via endocytosis of a-amino-3-hydroxy-5-
methylisoxazole-4-propionate (AMPA)-type glutamate
receptors (Chowdhury et al. 2006; Rial Verde et al. 2006)
and to maintaining synaptic plasticity via modulation of
long-term potentiation (LTP) and long-term depression
(LTD) (Bloomer et al. 2008; Bramham et al. 2008).
Blocking Arc translation via antisense oligonucleotide infu-
sions impairs consolidation of learning (Guzowski et al.
2000), including basal ganglia-mediated learning (Hearing
et al. 2011; Pastuzyn et al. 2012). Thus, Arc is critical for
consolidation of learning, including those processes mediated
by dorsal striatum.
We have previously reported that despite equivalent
numbers of neurons showing transcriptional activation of
the Arc gene, there are more striatonigral neurons with Arc
mRNA in the cytoplasm than striatopallidal neurons in
normal animals following exploration of a novel environ-
ment (Daberkow et al. 2007) – the prototypical behavioral
paradigm used to assess Arc expression (Guzowski et al.
1999; Chawla et al. 2005; Vazdarjanova et al. 2006).
Furthermore, we have previously reported that rats with
prior exposure to a neurotoxic regimen of METH show
decreased numbers of striatal neurons with cytoplasmic Arc
mRNA expression after engaging in a striatally-mediated,
response-reversal learning task, with the greatest impairment
being in the numbers of striatonigral neurons (Daberkow
et al. 2008). Also, the correlation between Arc mRNA
expression in dorsomedial (DM) striatum and trials to
criterion on the response-reversal learning task observed in
normal animals (Daberkow et al. 2007, 2008) is lost in
METH-pre-treated animals (Daberkow et al. 2008).
Furthermore, reversal learning in METH-pre-treated rats is
no longer sensitive to antisense oligonucleotide-mediated
disruption of Arc translation in DM striatum (Pastuzyn et al.
2012). However, the paradigms examined to date do not
allow us to discern whether the decreased numbers of striatal
neurons with Arc mRNA expression in the cytoplasm in
METH-pre-treated rats arises because of deﬁcits in transcrip-
tional activation of the Arc gene or deﬁcits in the trafﬁcking
of Arc mRNA into the cytoplasm. Thus, the goal of the
present studies was to determine whether METH-induced
neurotoxicity is associated with acute disruption of Arc
transcriptional activation versus longer duration processes
regulating Arc trafﬁcking/cytoplasmic stability. Furthermore,
an additional goal of the present work was to examine further
whether there are phenotypic differences in the acute
regulation of Arc mRNA transcriptional activation and
cytoplasmic expression following METH-induced neurotox-
icity so as to better deﬁne how partial DA depletion impacts
upon striatal efferent neuron function. Clarifying the impact
of METH-induced neurotoxicity on the transcriptional
activation and cytoplasmic regulation of Arc mRNA in
striatum is critical so as to better inform treatment strategies
to ameliorate cognitive and behavioral impairments in human
METH abusers (Volkow et al. 2001; Kalechstein et al.
2003; Johanson et al. 2006).
Methods
Animals
Male Sprague-Dawley rats (Charles River Laboratories, Raleigh,
NC, USA; 275–300 g) were singly housed in tub cages in a room
controlled for temperature and lighting (12 : 12 h). All animal care
and experimental procedures conformed to the Guide for the Care
and Use of Laboratory Animals (8th Ed.), followed the ARRIVE
guidelines (Kilkenny et al. 2010) and were approved by the
Institutional Animal Care and Use Committee at the University of
Utah.
Methamphetamine treatment
Rats were treated with (±)-methamphetamine hydrochloride (NIDA,
Research Triangle Park, NC, USA) as previously described
(Daberkow et al. 2008; Son et al. 2011). This speciﬁc regimen
was chosen to model METH-induced damage to striatal monoamine
systems. Although METH self-administration models may more
closely mimic human exposure by self-administration, such contin-
gent models typically do not recapitulate long-lasting striatal DA
toxicity (Schwendt et al. 2009; Brennan et al. 2010; McFadden
et al. 2012; Reichel et al. 2012), perhaps because of the duration of
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the exposure, as one study (Krasnova et al. 2010), with much longer
daily access (15 h/day for 8 days) did report DA neuron toxicity.
Thus, the single day, non-contingent binge regimen implemented in
this study serves as a more rapid and reproducible model with face
validity to the striatal DA depletions present in individuals with a
history of METH exposure and who may, in fact, be in a pre-clinical
Parkinsonian state. On the METH treatment day, rats were housed
ﬁve to six animals per cage. Rats received four injections of either
(±)-METH (10 mg/kg free base, s.c.) or 0.9% saline (1 mL/kg, s.c.)
at 2-h intervals, with rectal temperatures recorded hourly (Fig. 1a).
If core temperature exceeded 41°C, the rat was removed and placed
in a separate cage over ice to decrease hyperthermia. Twelve hours
after the ﬁnal injection, rats were returned to home cages and given
free access to food and water until behavioral manipulations
3 weeks later.
Behavioral activation via novel environment exploration
Rats were divided into three experimental groups [‘5-min’, ‘30-
min’, caged controls (CC)], each consisting of 6–8 saline- or 10–11
METH-pre-treated rats. After initially observing elevated basal Arc
expression in CC METH rats, an additional seven rats were treated
with METH as described above and killed as CC. Thus, the METH
CC group consisted of 18 animals. Rats were removed from their
home cage after having been isolated for 24 h. CC rats were killed
immediately upon removal from the home cage. Rats in the ‘5-min’
group were exposed to a novel environment [50 9 40 9 40 cm tall
Rubbermaid tub with pictures on two walls, as previously described
(Daberkow et al. 2007; Guzowski et al. 1999)] for 5 min, then
immediately killed. Rats in the ‘30-min’ group were exposed for
5 min to the novel environment, returned to the home cage for
25 min, and then killed. Animals were killed by CO2 exposure,
decapitated, and brains immediately removed and ﬂash-frozen in 2-
methylbutane (Mallinckrodt Baker, Phillipsburg, NJ, USA) chilled
on dry ice.
Tissue preparation
Twelve-micrometer cryosections of striatum [Cambridge Instru-
ments, Bayreuth, Germany; Bregma: +1.60 to !0.8 mm (Paxinos
and Watson, 1998)] were thaw-mounted onto SuperFrost Plus slides
(VWR, Batavia, IL, USA), then post-ﬁxed as previously described
(Ganguly and Keefe 2001).
DAT Autoradiography
METH-induced DA depletions in dorsal striatum were analyzed
using [I125]RTI-55 binding to the dopamine transporter (DAT), as
described previously (Boja et al. 1992; Pastuzyn et al. 2012). DAT
binding levels were normalized to percent of saline controls for DM
and dorsolateral (DL) striatum (Fig. 1b).
Fluorescent in situ hybridization for Arc/ppe mRNAs
Expression of Arc mRNA in striatal efferent neurons was deter-
mined by double-label ﬂuorescence in situ hybridization histochem-
istry (FISH) for Arc and ppe mRNAs, as previously described
(Daberkow et al. 2007, 2008). Full-length ribonucleotide probes
complementary to mRNAs for Arc (Lyford et al. 1995) and ppe
(Yoshikawa et al. 1984) were synthesized from cDNAs using
digoxigenin-UTP (DIG-UTP) and ﬂuorescein-UTP (FITC-UTP)
with T7 and SP6 RNA polymerases and DIG- and FITC-UTP
RNA-labeling kits, respectively (Roche Applied Science, Indianap-
olis, IN, USA). Ribonucleotide probes were hybridized and detected
as previously described (Daberkow et al. 2007, 2008).
Image acquisition
DAT ﬁlm autoradiograms were digitized, and four sections per
animal in rostral (+1.6 mm from bregma), middle (+0.5 mm from
bregma), and caudal (!0.8 mm from bregma) dorsal striatum
analyzed with ImageJ (Pastuzyn et al. 2012).
For FISH, a 0.18 mm2 montage from DM striatum was captured
with an FV1000 confocal laser-scanning microscope (Olympus,
Center Valley, PA, USA) with motorized stage (Prior Scientiﬁc,
Rockland, MA, USA) using a 60x, 1.45 NA oil-immersion lens
(plan APO) and 488-nm Ar and 543-nm and 633-nm HeNe lasers.
Areas of analysis were z-sectioned in 1-lm-thick optical sections
(10 z-sections per image) (Daberkow et al. 2007, 2008). The
numbers of ppe-pos and ppe-neg neurons with Arc mRNA staining
in the nucleus and in the cytoplasm were determined, as previously
described (Guzowski et al. 1999; Daberkow et al. 2007, 2008).
Statistical analysis
Analysis of DAT binding was accomplished by two-sample t-tests.
METH and saline effects on body temperature were analyzed by
MANOVA. Expression of Arc mRNA in each subcellular compartment
was ﬁrst compared across saline- and METH-pre-treated rats using
MANOVA (treatment 9 time 9 phenotype), although for clarity, Arc
expression data are shown in separate, side-by-side graphs for
saline- and METH-pre-treated rats (Figs 3, 4). Post hoc analyses of
signiﬁcant interactions were achieved via Tukey–Kramer test for
between-subjects factors (treatment, time) or post hoc t-tests for the
within-subjects factor (phenotype). For all analyses, p-values < 0.05
were signiﬁcant.
Results
METH-induced partial dopamine depletions
Treatment with METH resulted in hyperthermia necessary to
produce long-term neurotoxicity (Ali et al. 1994). METH-
treated rats reached maximum temperatures of 39.7°C
(± 0.8°C; Fig. 1a), whereas saline-treated rats achieved
maximum temperatures of 36.8°C (± 0.5°C). There were
signiﬁcant main effects of treatment (F(1,54) = 192.9,
p < 0.0001) and time (F(3,54) = 102.1, p < 0.0001) and a
signiﬁcant time 9 treatment interaction (F(3,54) = 113.0,
p < 0.0001). At all time points after baseline, core temper-
atures in METH-treated rats were signiﬁcantly elevated over
saline (baseline, p = 0.3; temp 1-temp 7, p < 0.0001). Three
weeks later, DAT binding in DM striatum was 57.2 ± 4.2%
of control (mean ± SEM; n = 40 METH, n = 23 saline;
t(1,26) =!9.51, p < 0.0001), and that in DL striatum was 65.5
± 3.7% of control (t(1,26) = !10.14, p < 0.0001; Fig. 1b).
METH-induced neurotoxicity is associated with impaired
transcriptional activation of Arc mRNA
Using catFISH (Guzowski et al. 1999; Daberkow et al.
2007, 2008), we determined the subcellular localization of
Arc mRNA in striatal efferent neurons following spatial
© 2012 The Authors
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exploration of a novel environment (Fig. 2a–f). As previ-
ously reported in normal animals (Guzowski et al. 1999;
Daberkow et al. 2007), exposure to the novel environment
increased nuclear Arc mRNA expression within 5 min
(Figs 2 and 3a). MANOVA revealed signiﬁcant main effects
of time (F(2,54) = 6.0, p < 0.005) and treatment
(F(1,54) = 5.96, p < 0.02) and a signiﬁcant time x treatment
interaction (F(2,54) = 4.99, p < 0.02). There was no main
effect of phenotype (F(1,54) = 2.72, p = 0.1) and no pheno-
type 9 time (F(2,54) = 0.7, p = 0.5), phenotype 9 treatment
(F(1,54) = 0.5, p = 0.5) or phenotype 9 time 9 treatment
(F(2,54) = 0.6, p = 0.6) interactions. Post hoc analysis of the
time 9 treatment interaction revealed that in saline-pre-
treated rats the number of cells with nuclear Arc mRNA
expression was signiﬁcantly greater in the 5-min group than
in the CC (p < 0.01) or 30-min (p < 0.001) groups. There
were no such effects in METH-pre-treated rats, as the
numbers of cells with intranuclear foci of Arc mRNA in the
METH-pre-treated groups were not different from each other
(p > 0.1). However, overall (main effect of treatment)
there were more cells with nuclear Arc mRNA in the
METH- versus saline-pre-treated rats (p < 0.02; Fig. 3a vs.
b). Thus, rats with METH-induced neurotoxicity have higher
basal Arc transcription, but fail to induce Arc transcription in
response to behavioral activation.
METH-induced neurotoxicity is associated with impaired
cytoplasmic Arc mRNA expression
As previously reported (Daberkow et al. 2007), saline-pre-
treated rats in the 30-min group had a signiﬁcant increase in
the number of striatal efferent neurons with Arc mRNA in the
cytoplasm (Figs 4, 5). Furthermore, as we have previously
reported (Daberkow et al. 2007, 2008), normal animals had
more striatonigral (ppe-neg) than striatopallidal (ppe-pos)
neurons with cytoplasmic Arc mRNA expression (Figs 4 and
5a). Speciﬁcally, MANOVA revealed a signiﬁcant main effect
for time (F(2,54) = 16.9, p < 0.0001) and signiﬁcant
time 9 treatment (F(2,54) = 3.3, p < 0.05) and pheno-
type 9 time 9 treatment (F(2,54) = 3.8, p < 0.03) interac-
tions. There was no signiﬁcant main effect of treatment
(F(1,54) = 0.7, p = 0.4) or phenotype (F(1,54) = 3.1,
p = 0.08) and no signiﬁcant phenotype 9 time
(F(2,54) = 0.6, p = 0.5) or phenotype 9 treatment
(F(1,54) = 0.8, p = 0.4) interactions. Post hoc analysis of
the time 9 treatment interaction revealed greater numbers of
neurons with cytoplasmic Arc mRNA expression in saline-
pre-treated, 30-min rats relative to saline-pre-treated, CC
(p = 0.002) and 5-min (p < 0.001) groups, consistent with
previous reports regarding the time course of normal Arc
trafﬁcking (Guzowski et al. 1999; Daberkow et al. 2007).
Conversely, there were no signiﬁcant differences between the
numbers of cells with cytoplasmic Arc mRNA expression in
the METH-pre-treated, 30-min group relative to the METH-
pre-treated, CC (p = 0.6) and 5-min (p = 0.1) groups, again
indicating a general overall lack of Arc mRNA induction
associated with spatial exploration in METH-pre-treated rats.
To examine the phenotypic differences, post hoc t-tests
were performed on the numbers of ppe-neg and ppe-pos
neurons with cytoplasmic Arc mRNA in saline- and METH-
pre-treated rats. Paired t-tests conﬁrmed (Daberkow et al.
2007) greater numbers of both ppe-neg (t = 3.9, p = 0.003)
and ppe-pos (t = 3.9, p = 0.001) neurons with cytoplasmic
Arc in the saline-pre-treated, 30-min group relative to saline-
pre-treated, CC group (Fig. 4a) and that there were more
ppe-neg than ppe-pos neurons with cytoplasmic Arc mRNA
expression in the saline-pre-treated, 30-min group (Figs 4a
and 5a; t = 2.5, p = 0.02). In METH-pre-treated, CC rats,
there was no signiﬁcant difference from saline-pre-treated,
CC rats in the numbers of ppe-neg neurons with cytoplasmic
Arc mRNA (Fig. 4; t = !0.28, p > 0.1). Additionally, in
METH-pre-treated rats, there was no signiﬁcant increase in
numbers of ppe-neg neurons with cytoplasmic Arc at 30 min
(Fig. 4b; t = 0.44, p = 0.31) relative to METH-pre-treated,
CC group, whereas there was a signiﬁcant increase in the
numbers of ppe-pos neurons (Fig. 4b; t = 2.2, p = 0.02).
(a)
(b)
Fig. 1 Methamphetamine pre-treatment and subsequent dopamine
(DA) depletions. (a) A neurotoxic regimen of methamphetamine
(METH; 4 9 10 mg/kg) leads to a signiﬁcant elevation of core body
temperature relative to saline-treated animals (treatment effect
F(1,54) = 192.9, p < 0.0001). (b) METH-pre-treated rats (n = 40) show
signiﬁcant DA depletions in both dorsomedial (DM) and dorsolateral
(DL) striatum as measured by [125I]RTI-55 dopamine transporter
autoradiography 3 weeks later [mean gray values (arbitrary
units) ± SEM expressed as% of saline control (n = 23)]. *Signiﬁcantly
different from saline control, p " 0.05.
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Thus, in the METH-pre-treated, 30-min group, there was no
longer a phenotypic difference between the numbers of ppe-
neg and ppe-pos neurons with cytoplasmic Arc (Figs 4b and
5a; t = !0.95, p = 0.82), but there were signiﬁcantly fewer
ppe-neg neurons with cytoplasmic Arc mRNA expression
relative to the saline-pre-treated, 30-min group (Figs 4b and
5a; t = 3.0, p = 0.004). Interestingly, there were more ppe-
pos neurons with cytoplasmic Arc mRNA expression in the
METH-pre-treated, CC group than in the saline-pre-treated,
CC group (Fig. 4; t = !2.4, p = 0.01), and also slightly
more ppe-pos neurons with cytoplasmic Arc mRNA in
METH-pre-treated, 30 min relative to METH-pre-treated,
CC rats (Fig. 4b; t = 1.9, p = 0.04). However, there was no
difference between the saline- and METH-pre-treated 30-min
groups in the numbers of ppe-pos neurons with cytoplasmic
Arc mRNA expression (Figs 4 and 5a; t = 0.18, p = 0.43).
(a) (b)
Fig. 3 Nuclear Arc mRNA expression in striatal efferent neurons.
Data are mean (± SEM; saline n = 6–8; METH n = 10–18 per time
point) numbers of labeled neurons per 0.5 mm2 determined from
double ﬂuorescent in situ hybridization staining for preproenkeaphalin
and Arc (activity-regulated cytoskeleton-associated) mRNAs in the
dorsomedial striata of rats treated approximately 3 weeks prior to
killing with (a) saline (4 9 1 mL/kg) or (b) a neurotoxic regimen of
(±)-methamphetamine (METH; 4 9 10 mg/kg, s.c. at 2-h intervals).
Rats were either killed immediately upon removal from the home cage
(‘caged control’; CC), allowed to explore a novel environment for
5 min and then killed (5 min), or allowed to explore the novel
environment for 5 min before being returned to the home cage for
25 min before being killed (30 min). There is a signiﬁcant main effect
of METH-pre-treatment relative to saline-pre-treatment (p < 0.02).
*Signiﬁcant main effect of time (5-min point signiﬁcantly different
from both the CC and 30-min groups).
(a) (b) (c)
(d) (e) (f)
Fig. 2 Representative photomicrographs of Arc mRNA expression in
rat dorsomedial striatum. Representative in situ hybridization histo-
chemical images from rats pre-treated with saline [4 9 1 mL/kg; (a–c)
or a neurotoxic regimen of (±)-methamphetamine (METH; 4 9 10 mg/
kg, s.c. at 2-h intervals] and then either killed immediately upon
removal from the home cage (‘caged control’; a, d), allowed to explore
a novel environment for 5 min and then killed (5 min; b, e), or allowed
to explore the novel environment for 5 min before being returned to
the home cage for 25 min before being killed (30 min; c, f). Green is
Sytox nuclear counter-stain, blue is preproenkephalin mRNA and red
is Arc (activity-regulated cytoskeleton-associated) mRNA expression.
Scale bar = 10 lm.
© 2012 The Authors
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Upon observing impaired cytoplasmic Arc expression in
ppe-neg neurons in the METH-pre-treated, 30-min group, we
assessed whether this impairment was uniformly distributed
across METH-pre-treated rats or whether this difference
correlated to the DA depletion in each animal. Using only
cell counts from the METH-pre-treated, 30-min group, we
correlated the numbers of striatal efferent neurons with Arc
mRNA in the cytoplasm with the percent DA depletion as
assessed by DAT autoradiography (Fig. 5b and c). The
numbers of ppe-pos neurons with cytoplasmic Arc mRNA
were not signiﬁcantly correlated with DA loss (Fig. 5b;
R2 = 0.015, p = 0.7). Conversely, the numbers of ppe-neg
neurons with cytoplasmic Arc mRNA expression was
signiﬁcantly inversely correlated to the DA depletion
(Fig. 5c; R2 = 0.518, p = 0.019), indicating that greater
DA loss is associated with fewer ppe-neg neurons with
cytoplasmic Arc mRNA expression. In the METH-pre-
treated, 5-min group, there was no signiﬁcant correlation
between cells with nuclear Arc and DA depletion (ppe-pos
R2 = 0.005, p > 0.5; ppe-neg R2 = 0.05, p > 0.05).
Discussion
Herein, we report novel ﬁndings that basal Arc transcription
in striatal efferent neurons is enhanced, but Arc mRNA
transcriptional activation and cytoplasmic localization in
response to behavioral activation is severely impaired, in rats
with METH-induced neurotoxicity. Speciﬁcally, behavioral
activation associated with spatial exploration of a novel
environment – the classic paradigm used to examine Arc
mRNA induction and trafﬁcking (Guzowski et al. 1999;
Chawla et al. 2005; Vazdarjanova et al. 2006; Daberkow
et al. 2007) – resulted in no concomitant increase in cells
with nuclear Arc expression above the elevated CC levels in
METH-pre-treated groups. There was also no signiﬁcant
overall increase in total number of neurons with cytoplasmic
Arc mRNA in the METH-pre-treated, 30-min group, partic-
ularly with respect to ppe-neg neurons, similar to the
suppressed cytoplasmic expression previously reported fol-
lowing a striatally mediated response-reversal task (Daber-
kow et al. 2008). Interestingly, the degree of DA depletion
was signiﬁcantly negatively correlated with the numbers of
ppe-neg cells with cytoplasmic Arc, suggesting that the loss
of this expression may arise as a consequence of disrupted
DA signaling in striatum. Taken together, these data reveal a
profound dysregulation of Arc transcriptional activation and
subcellular trafﬁcking. As Arc mRNA, and the resulting Arc
protein, is critical to normal neuroplasticity processes
(Chowdhury et al. 2006), such disruption may contribute
to disrupted Arc-mediated memory processes of the basal
ganglia subsequent to METH pre-treatment (Daberkow et al.
2008; Pastuzyn et al. 2012).
We presently demonstrate an intriguing increase in basal
(CC) Arc mRNA transcription following METH-induced
neurotoxicity relative to saline-pre-treated controls. Persistent
changes in basal gene expression are not uncommon after
repeated exposure to psychostimulants (c.f. (Unal et al.
2009), including reports from our lab showing long-term
decreases in preprotachykinin mRNA expression after
METH-induced neurotoxicity (Chapman et al. 2001; John-
son-Davis et al. 2002). However, to our knowledge, there are
no prior reports of long-term changes in basal immediate-early
(a) (b)
Fig. 4 Cytoplasmic Arc mRNA expression in striatal efferent neurons.
Data are mean (± SEM; saline n = 6–8; METH n = 10–18 per time
point) numbers of labeled neurons per 0.5 mm2 determined from
double ﬂuorescent in situ hybridization staining for preproenkeaphalin
and Arc (activity-regulated cytoskeleton-associated) mRNAs in the
dorsomedial striata of rats treated approximately three weeks prior to
killing with (a) saline (4 9 1 mL/kg) or (b) a neurotoxic regimen of (±)-
methamphetamine (METH; 4 9 10 mg/kg, s.c. at 2-h intervals). Rats
were either killed immediately upon removal from the home cage
(‘caged control’; CC), allowed to explore a novel environment for
5 min and then killed (5 min), or allowed to explore the novel
environment for 5 min before being returned to the home cage for
25 min before being killed (30 min). *Signiﬁcantly different from all
other saline-pre-treated groups, p " 0.05. #Signiﬁcantly greater than
number of ppe-pos neurons in same group. ^Signiﬁcantly greater than
the number of ppe-pos neurons with Arc mRNA in the cytoplasm in
the saline-pre-treated, CC group. §Signiﬁcantly greater than the
number of ppe-pos with Arc mRNA expression in the cytoplasm in
the METH-pre-treated, CC group. ¶Signiﬁcantly less than the
number of ppe-neg neurons with Arc mRNA in the cytoplasm in
the saline-pre-treated, 30-min group.
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gene expression in striatal neurons as a consequence of
METH-induced neurotoxicity. Given that prior work
suggested a relatively preferential impact of METH-induced
neurotoxicity on striatonigral neuron function (Chapman
et al. 2001; Johnson-Davis et al. 2002; Daberkow et al.
2008), the equivalent increases in basal Arc transcription
observed in ppe-pos and ppe-neg neurons were surprising
and suggest global alterations in striatal efferent neuron
function following METH-induced neurotoxicity. This up-
regulation may reﬂect alterations in signals regulating Arc
transcription, including brain-derived neurotrophic factor or
glutamate. Although both of these molecules are elevated 24
–72 h after exposure of animals to a neurotoxic regimen of
METH (Thomas et al. 2004; Mark et al. 2007), whether they
remain elevated in striatum weeks later remains unknown.
Clearly, further studies are needed to examine the mecha-
nisms underlying long-term dysregulation of basal Arc
transcription and also the extent to which the expression of
other plasticity-related genes is similarly altered.
The present studies also reveal a profound impairment of
acute, novelty-induced transcription of Arc in rats with
METH-induced neurotoxicity. The basis for this observation
remains presently unknown, but changes in phasic DA
release seem a likely contributing factor. Partial monoamine
loss is associated with impaired phasic-like, but not tonic-
like, DA release (Bergstrom and Garris 2003; Howard et al.
2011). Modeling data suggest that D1-DA receptors should
be particularly sensitive to changes in phasic DA amplitude
(Dreyer et al. 2010). Consistent with this model, phasic-like
stimulation of DA transmission increases gene expression in
and electrophysiological activity of striatonigral, but not
striatopallidal, neurons (Chergui et al. 1997; Gonon 1997;
Onn et al. 2000). Finally, we presently report that in METH-
pre-treated rats, the impairment in numbers of ppe-neg
neurons with cytoplasmic Arc mRNA correlates with the
extent of DA loss, which is further known to correlate with
the degree of impairment of phasic-like DA neurotransmis-
sion (Bergstrom and Garris 2003; Howard et al. 2011). Thus,




Fig. 5 Cytoplasmic Arc mRNA expression in striatal efferent neurons
of rats killed 30 min after exposure to a novel environment and
relation to degree of methamphetamine-induced dopamine depletion.
Partial monoamine depletion signiﬁcantly only affects the numbers of
ppe-neg neurons with cytoplasmic Arc mRNA expression. (a) Mean
(± SEM; saline n = 8; METH n = 11) numbers of labeled neurons per
0.5 mm2 determined from double ﬂuorescent in situ hybridization
staining for preproenkeaphalin and Arc (activity-regulated cytoskele-
ton-associated) mRNAs in the dorsomedial striata of rats treated
approximately 3 weeks prior to killing with saline (4 9 1 mL/kg) or a
neurotoxic regimen of (±)-methamphetamine (METH; 4 9 10 mg/kg,
s.c. at 2-h intervals). These data are the same ‘30-min’ data presented
in Fig. 4, but are re-graphed to highlight the differences between the
striatal efferent neuron subtypes at this time point. *Signiﬁcantly
different from number of ppe-neg neurons in saline-pre-treated rats.
#Signiﬁcantly different from number of ppe-pos neurons in saline-pre-
treated rats. (b) Correlation between the numbers of ppe-pos neurons
with Arc mRNA in the cytoplasm and the percent DA loss, as
assessed by [125I]RTI-55 autoradiography for dopamine transporter
binding, induced by the neurotoxic regimen of METH (4 9 10 mg/kg,
s.c. at 2-h intervals) three weeks prior to killing. (c) Correlation
between the numbers of ppe-neg neurons with Arc mRNA in the
cytoplasm and the percent dopamine (DA) loss, as assessed by [125I]
RTI-55 autoradiography for dopamine transporter binding, induced by
the neurotoxic regimen of METH (4 9 10 mg/kg, s.c. at 2-h intervals)
3 weeks prior to killing. *Signiﬁcant correlation, p = 0.019.
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contribute to the observed deﬁcits in Arc expression
subsequent to METH-induced neurotoxicity.
Decreased phasic DA neurotransmission and consequent
decreases in D1-DA receptor activation may also impair Arc
transcription by altering upstream signaling cascades. Acti-
vation of D1-DA receptors enhances NMDA receptor-
mediated currents in striatonigral neurons (Cepeda et al.
1993; Andre et al. 2010; Jocoy et al. 2011) and increases
activation of extracellular signal-regulated kinase (ERK1/2)
(Valjent et al. 2005; Pascoli et al. 2011). Arc transcription is
regulated by NMDA receptor and ERK1/2 activation (Korb
and Finkbeiner 2011). Thus, decreased D1-DA receptor
activation because of attenuated phasic DA transmission
likely results in decreased NMDA receptor and ERK1/2
activation and, thus, decreased activity-dependent Arc
induction in ppe-neg neurons.
Although the above-delineated effects can explain the
basis for the impairment of acute, novelty-induced Arc
transcription in ppe-neg neurons, the basis for the impaired
transcriptional activation in ppe-pos neurons is less apparent.
One possibility is that it also arises as a consequence of
impaired phasic DA signaling and decreased D1-DA receptor
activation in striatum. Disruption of striatal D1-DA receptor
activation decreases cortical excitability (Steiner and Kitai
2000; Yano et al. 2006; Gross and Marshall 2009). Addi-
tionally, cortical immediate-early gene induction by DA
receptor agonists is blunted in rats with METH-induced
neurotoxicity (Belcher et al. 2009). Furthermore, novelty-
induced c-fos mRNA expression in striatopallidal neurons is
dependent on corticostriatal transmission (Ferguson and
Robinson 2004), sensitive to decreases in D1-DA receptor
activation (Ferguson et al. 2003), and sensitive to blockade
of NMDA receptors or ERK1/2 signaling (Ferguson et al.
2003; Ferguson and Robinson 2004). These data thus suggest
a model, wherein loss of D1-DA receptor activation in
striatum because of disrupted phasic signaling secondary to
METH-induced monoamine toxicity may lead to decreased
cortical excitability and, consequently, decreased gene
expression in ppe-pos neurons.
An alternative explanation for the overall loss of novelty-
induced Arc transcription is that chronic elevations in basal
Arc mRNA expression suppress further transcriptional
activation. Massed exposures to a spatial environment in a
single day impair Arc transcription (Guzowski et al. 2006)
and a-amino-3-hydroxy-5-methylisoxazole-4-propionate
(AMPA) receptor activation can inhibit Arc transcription
(Rao et al. 2006). Although there are DNA regulatory
elements that repress Arc transcription (Pintchovski et al.
2009), what binds to those regulatory sites and the
situations under which they are engaged are currently
undeﬁned. Therefore, the extent to which transcriptional
repression of the Arc gene versus impaired activation of
post-synaptic receptors (NMDA, D1) or intracellular sig-
naling cascades contributes to the loss of evoked Arc
expression in rats with METH-induced neurotoxicity
remains to be determined.
The present results conﬁrm prior observations (Daberkow
et al. 2007, 2008) that normal, saline-pre-treated animals
have more ppe-neg neurons than ppe-pos neurons with Arc
mRNA in the cytoplasm. At present, the basis for this
phenotypic difference in normal animals remains unknown,
but it may be related to differences in Arc trafﬁcking or
cytoplasmic mRNA stability, given that Arc mRNA is a
substrate for translation-dependent decay (Giorgi et al.
2007). The lack of transcriptional activation of Arc in rats
with METH-induced neurotoxicity makes it somewhat
difﬁcult to discern whether DA contributes to this phenotypic
difference; however, the present results suggest that the
trafﬁcking/stability of Arc mRNA in ppe-neg neurons in
normal animals is dependent on DA signaling. First, despite
the lack of novelty-induced transcriptional activation,
METH-pre-treated, CC rats have more ppe-pos neurons with
cytoplasmic Arc than do saline-pre-treated, CC rats, sug-
gesting that METH-pre-treated rats still trafﬁc basally
transcribed Arc mRNA into the cytoplasm in ppe-pos
neurons. Conversely, despite having high basal numbers of
ppe-neg neurons with transcriptional activation of Arc,
METH-pre-treated, 30-min rats do not have greater numbers
of ppe-neg neurons with cytoplasmic Arc expression com-
pared with saline-pre-treated, 30-min rats. Thus, the elevated
basal transcription of Arc mRNA in ppe-neg neurons of
METH-pre-treated rats does not translate into greater num-
bers of neurons with cytoplasmic Arc, suggesting some
disruption of Arc trafﬁcking/stability in ppe-neg neurons.
Second, whereas there is a slight, but signiﬁcant, increase in
the numbers of ppe-pos neurons with cytoplasmic Arc
mRNA in the METH-pre-treated, 30-min group relative to
the numbers in the METH-pre-treated, CC group, there is no
such increase in the numbers of ppe-neg neurons. Taken
together, these observations suggest that METH-induced
neurotoxicity is associated with impaired acute transcrip-
tional activation of Arc in both subtypes of striatal efferent
neurons, as well as impaired trafﬁcking/stability speciﬁcally
in ppe-neg neurons.
We presently report that a neurotoxic regimen of METH
has signiﬁcant, long-term impact on the regulation of
transcriptional activation and subcellular expression of Arc
mRNA. This METH-induced effect on Arc mRNA tran-
scription and expression may thus impair Arc protein
translation, with Arc protein synthesized within 60 min of
neuronal stimulation (Lyford et al. 1995; Vazdarjanova
et al. 2006; Baez et al. 2011). Importantly, this disrupted
activity-dependent striatal Arc expression, and hypothesized
impact on protein synthesis, may underlie previously reported
changes in basal ganglia-mediated learning and memory
processes in METH-pre-treated rats, including response-
reversal (Daberkow et al. 2008; Pastuzyn et al. 2012),
sequential motor (Chapman et al. 2001), and stimulus-
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response versus action-outcome (Son et al. 2011) learning.
Our present results therefore suggest Arc mRNA or the
factors regulating it as potential novel therapeutic targets in
the treatment of METH-induced cognitive impairments
(Volkow et al. 2001; Kalechstein et al. 2003; Johanson
et al. 2006), as Arc is a critical mediator underlying normal
neuroplasticity processes (Chowdhury et al. 2006; Rial
Verde et al. 2006). Future work will thus need to examine
whether therapeutically restoring partial DA loss will resolve
the molecular and cellular changes that occur, as well as
improve cognitive functionality compromised with METH
addiction and abuse.
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CHAPTER 5 
DISCUSSION AND PERSPECTIVES 
Summary of mRNA Regulation within Striatal Efferent Neurons 
The basal ganglia critically mediate normal motor behaviors and action selection. The 
striatum is the key input nucleus of the basal ganglia, and within the striatum, two discrete 
populations of spiny efferent neurons exist that mediate normal control of motor behavior 
and action selection [1-3]. Thus, unraveling normal neuroplasticity processes within the 
striatum, as well as how neurodegeneration disrupts such signaling, is critical to advancing 
our understanding of basal ganglia function. Importantly, the immediate-early gene Arc 
provides a useful neuronal tool to examine such neuroplasticity within the striatum due to its 
key role in mediating normal LTP, LTD, and homeostatic plasticity processes [4]. Such 
understanding of Arc mRNA regulation, as well as general processes mediating mRNA 
regulation, in striatal efferent neurons will allow further identification of novel therapeutic 
targets for the treatment of basal ganglia-mediated neurological and neurodegenerative 
disorders.  
We have previously demonstrated that following behavioral activation by exploration 
of a novel environment, Arc mRNA expression is robustly induced in phenotypically 
identified striatal efferent neurons of normal animals [5]. While equivalent numbers of 
striatonigral and striatopallidal neurons showed transcriptional activation of the Arc gene in 
response to this behavioral activation, 30 minutes after novel environment exposure, there 
were more striatonigral neurons with Arc mRNA in the cytoplasm than striatopallidal 
neurons [5]. Differences in posttranscriptional mRNA processing within the nucleus, in 
cytoplasmic mRNA trafficking, or in translational regulation in striatal efferent neuron 
subpopulations conceivably could contribute to this phenotypic difference in the numbers of 
cells with cytoplasmic Arc mRNA. Importantly, in vitro studies demonstrate that Arc mRNA 
is regulated at the posttranscriptional level by the RNA-binding protein, eukaryotic initiation 
factor 4A3 (eIF4A3), and the exon-junction complex (EJC)[6,7]. Following the first round of 
protein translation, the EJC can target Arc mRNA for degradation through the process of 
translation dependent decay (TDD) [6,8,9,7]. Thus, neuron specific differences in eIF4A3 
could have potentially contributed to more striatonigral than striatopallidal neurons having 
cytoplasmic Arc mRNA expression in normal animals.  
Additionally, rats that had a partial monoamine depletion induced by a neurotoxic 
regimen of methamphetamine (METH) demonstrated significant blunting of the numbers of 
cells with cytoplasmic Arc mRNA expression relative to saline-pretreated rats following 
performance on a striatally mediated T-maze task [10]. These observations additionally 
suggested that METH-induced monoamine depletion substantially disrupted Arc mRNA 
signaling in response to striatally mediated learning, but whether such effects were due to 
alterations in Arc mRNA transcriptional activation or cytoplasmic mRNA localization was, at 
the time, unknown.  
Altogether, these previous observations that striatal efferent neurons differentially 
regulate Arc mRNA cytoplasmic localization and that METH-induced neurotoxicity 
disrupted normal transcriptional activation and subcellular localization of Arc required in-
depth investigation to further understand the mechanisms regulating such mRNA expression 
and cytoplasmic localization within striatal efferent neurons. Thus, the studies presented in 
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  this dissertation began to determine the factors contributing to the differences in 
cytoplasmic Arc mRNA localization within striatal efferent neurons. Furthermore, these 
studies examined how such mRNA regulation could be disrupted in the context of partial 
monoamine loss induced by METH. Herein, we presently report evidence that striatal 
efferent neurons differentially regulate immediate-early genes (IEGs) essential to synaptic 
plasticity processes and that partial monoamine loss induced by METH disrupts such normal 
mRNA regulation. 
First, we characterized the mRNA and protein expression of EJC factors in the 
dorsal striatum and hippocampus following both novel environment exploration and 
striatally mediated learning on a T-maze task (Chapter 2)[11]. Through those studies, we 
demonstrated that the expression of both eIF4A3 mRNA and protein increased within the 
dorsal striatum in response to behavioral activation by exploration of a novel environment. 
However, expression of another EJC core component, Magoh, did not show such activity-
dependent mRNA expression, further uniquely implicating eIF4A3 in neuroplasticity 
processes. Additionally, following striatally mediated learning on a T-maze task, which is 
known to require the dorsomedial (DM) striatum [5,12,13], only expression of eIF4A3 
mRNA in the DM striatum significantly correlated to behavioral performance, in a manner 
very similar to Arc mRNA [10]. Importantly, it has previously been suggested that only the 
expression of Arc mRNA within the brain region required for a particular task correlates to 
behavioral performance on that task [14]. Thus, our observations point to a potential role for 
eIF4A3 in Arc-dependent learning and memory processes. Altogether, these studies 
provided the first characterization of the expression of this critical component of the EJC in 
the adult mammalian brain and demonstrated a potential role for eIF4A3 in Arc-dependent 
neuroplasticity processes in the dorsal striatum. 
125
We then went on to examine the expression of other synaptic plasticity-associated 
mRNAs that share discrete transcriptional and dendritic trafficking characteristics with Arc 
mRNA (Chapter 3). Specifically, we selected the transcription factor, zif268/egr-1, which is 
an IEG activated by exposure to a novel environment with a time course similar to that of 
Arc mRNA [14].  However, unlike Arc mRNA, zif268 mRNA is not trafficked to activated 
synapses for localized protein translation [15,16]. Additionally, we investigated the 
expression of the constitutively expressed, dendritically trafficked mRNA, Map2 [17,18]. 
Most importantly for these studies, neither zif268 nor Map2 mRNAs are subject to 
cytoplasmic mRNA regulation through EJC-dependent TDD [6], thereby making both 
mRNAs extremely useful tools to examine the cytoplasmic localization of mRNAs in striatal 
efferent neurons. Intriguingly, we found that there also were phenotypic differences in the 
numbers of striatonigral vs. striatopallidal neurons with cytoplasmic expression of zif268 
mRNA following exploration of a novel environment. Furthermore, closer examination of 
the subcellular expression of zif268 mRNA 30 minutes after novel environment exploration 
revealed that more striatopallidal than striatonigral neurons had nuclear retention of zif268 
mRNA, suggesting that mRNA trafficking out of the nucleus in striatopallidal neurons may 
be different than that in striatonigral neurons. Such differences in nucleocytoplasmic 
trafficking could account for the greater number of striatonigral neurons with IEG mRNAs 
in the cytoplasm. Clearly, further studies are necessary to assess how general these 
differences are and whether the phenotypic differences in nuclear and cytoplasmic mRNA 
distribution in striatal efferent neurons are linked. 
In the context of METH-induced DA depletion, cytoplasmic localization of zif268 
was significantly disrupted, despite the fact that transcriptional activation was essentially 
unchanged relative to saline-pretreated rats. Such examination of the activity-induced 
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  subcellular localization of zif268 demonstrates that striatal efferent neuron subpopulations 
may, in fact, undergo differential mRNA regulation in response to neuronal activation and 
that DA may play a role in mediating nuclear mRNA export. Finally, when we examined the 
expression of constitutively expressed Map2 mRNA, there were no significant differences 
between striatal efferent neuron subpopulations in subcellular mRNA localization and 
numbers of cells with cytoplasmic Map2 mRNA. Such observations suggest that acute 
regulation of nuclear posttranscriptional processing or mRNA export for IEGs may underlie 
these cytoplasmic localization differences. Altogether, these studies demonstrate that 
differences in the distribution of Arc mRNA to the peri-nuclear cytoplasm in striatal efferent 
neuron subpopulations does not appear to be regulated by eIF4A3 and the EJC [6], but 
rather may arise as consequence of striatal efferent neuron-specific differences in nuclear 
posttranscriptional mRNA processing and/or mRNA export. 
Finally, we examined the induction and cytoplasmic localization of Arc mRNA 
within striatal efferent neurons subsequent to partial monoamine depletion induced by 
METH so as to determine whether the previously reported METH-induced disruption of 
cytoplasmic Arc expression after performance on a striatally mediated T-maze [10] was due 
to impaired transcriptional activation or cytoplasmic localization of Arc mRNA (Chapter 4). 
In these studies, we found that long-term monoamine depletion induced by METH results 
in significant elevations in basal Arc mRNA levels within striatal efferent neurons, but also 
complete abrogation of transcriptional activation of Arc mRNA in response to novel 
environment exploration, in contrast to that seen in normal animals [19]. Additionally, 
activity-dependent localization of Arc mRNA to the cytoplasm was dysregulated, with 
striatonigral neurons showing considerable disruption of cytoplasmic Arc localization. 
Furthermore, we also demonstrated that the extent of DA depletion correlated with this 
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  disruption of cytoplasmic Arc mRNA expression, in line with previous reports that partial 
DA depletion more significantly impairs striatonigral neuron function [20-22]. Given that the 
degree of DA depletion also correlates with the degree of disruption in phasic DA signaling 
[23] and that phasic DA signaling may selectively alter D1 DA receptor-mediated signaling 
[24-28], these findings suggest that DA activation of the D1 receptor may critically 
contribute to posttranscriptional mRNA processing in striatonigral efferent neurons. 
Importantly, given its critical role in synaptic plasticity underlying consolidation of learning 
and memory, disruption of Arc mRNA transcriptional activation and cytoplasmic 
localization may likely contribute to behavioral and cognitive deficits in humans with a 
history of METH abuse [29-32]. 
 
Role of mRNA Regulation in Diseases of the Basal Ganglia 
Many basal ganglia-mediated pathologies are caused by aberrant synaptic plasticity 
due to disruptions in normal neuronal posttranscriptional processing, cytoplasmic mRNA 
stability, and dendritically localized protein translation. For example, mutations in the UPF3b 
protein in humans leads to disruption of nonsense-mediated mRNA decay (NMD) and 
cytoplasmic mRNA regulation and results in childhood-onset schizophrenia and autism 
spectrum disorders (ASDs [33]), as well as mental retardation with or without ASDs [34,35]. 
Interestingly, UPF3b, and more generally NMD, can be regulated by the micro-RNA, miR-
128 [36], whose levels have also been shown to be deregulated in transgenic mouse models 
of basal ganglia pathologies, including Huntington’s disease [37] and Parkinson’s disease [38]. 
Altered translational regulation at activated synapses can also disrupt normal synaptic 
plasticity. For example, enhanced levels of protein synthesis due to a single-nucleotide 
polymorphism in the promoter of the cap-binding eIF4E gene in humans leads to ASDs [39-
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  41], and eIF4E-transgenic mice also exhibit autistic-like behaviors, including excessive 
repetitive and perseverative behaviors, and synaptic pathophysiology within striatum [42]. 
Finally, disorganized mRNA localization of plasticity-associated mRNAs can underlie 
pathologies of the basal ganglia. The RNA-binding protein Fragile X Mental Retardation 
Protein (FMRP) interacts with the brain-predominating nuclear export factor, NXF2 [43], 
and is essential to mRNA (including Arc) localization to activated synapses [44,45]. 
Dysfunction of FMRP is implicated in the ASD, Fragile X syndrome (FXS; [46-49]). Given 
that there is disruption of GABAergic neurotransmission and cortical excitability in FXS 
[50,51], dysfunction in FMRP-mediated protein trafficking may also disrupt striatal neuron 
function at both the pre- and postsynaptic levels through the deregulation of local protein 
synthesis essential to normal synapse formation and synaptic plasticity. Therefore, 
dysfunction of mRNA stability, localization, and dendritic protein synthesis can have 
profound effects on normal neuronal function. Thus, improving our understanding of 
normal mRNA regulatory processes in striatal projection neurons will allow for more 
comprehensive treatment strategies to ameliorate aberrant neuroplasticity processes in 
disorders of the basal ganglia. 
The loss of dopamine neurons in the substantia nigra pars compacta coupled with 
decreased dopamine input to striatum leads to hallmark symptoms of Parkinson’s disease 
(PD) [52]. Replacement of endogenous dopamine with L-DOPA is the most beneficial 
therapy currently available to PD patients [53]. However, the subsequent development of L-
DOPA-induced dyskinesia is one of the most problematic side effects in the treatment of 
PD [54]. These debilitating dyskinesias likely result from aberrant synaptic plasticity at 
corticostriatal synapses [55,56]. In light of our present studies on Arc mRNA regulation 
within the partially dopamine-denervated striatum, it is interesting Arc protein is significantly 
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upregulated and correlates with the severity of L-DOPA-induced dyskinesia in a rat model of 
L-DOPA-induced dyskinesias [57]. Furthermore, chronic L-DOPA treatment in 6-OHDA-
lesioned rats preferentially induces Arc mRNA expression within striatonigral neurons, 
which are also the neuron population more severely affected by partial monoamine loss 
induced by METH [19,22,20,10]. Thus, our present observations for disrupted Arc mRNA 
cytoplasmic localization following partial monoamine depletion (Chapter 4 [19]), as well as 
the fact that Arc mRNA and protein are upregulated in response to chronic L-DOPA, 
further support a model whereby cytoskeletal remodeling and aberrant synaptic plasticity 
within striatonigral neurons may lead to the development of dyskinesias during the course of 
PD treatment [58]. Arc mRNA and the factors and cellular processes regulating it are, 
therefore, potentially critical therapeutic targets in the amelioration of adverse effects 
associated with the pharmacological management of PD.   
Lastly, the present studies highlight potential differences in striatal efferent neurons 
in the regulation of nuclear mRNA export of activity-regulated genes. Striatal efferent 
neurons express different dopamine receptors [59], with downstream cellular signaling 
mediated by the cellular response to dopamine [60,61]. Importantly, we now demonstrate 
that in normal animals, there are striatal efferent neuron-specific differences in cytoplasmic 
mRNA localization of the IEGs Arc (Chapter 4) and zif268 (Chapter 3) mRNA. 
Furthermore, animals with METH-induced dopamine depletion have blunted activity-
dependent cytoplasmic localization of Arc (Chapter 4) and zif268 (Chapter 3) mRNA relative 
to normal animals. These results point to a key role for dopamine in contributing to such 
divergent numbers of striatal efferent neurons with cytoplasmic mRNA localization and 
highlight the possibility for cell-specific regulation of nuclear mRNA export. It is possible 
that striatal efferent neuron subpopulations do employ different regulatory mechanism for 
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  nuclear mRNA processing, as several reports have recently suggested cell-specific regulation 
of factors essential to mRNA processing. First, specific nuclear TREX components, which 
are essential to normal nuclear mRNA processing and export [62,63], play component-
specific roles in mouse embryonic development (THOC1 [63-66]), adipocyte differentiation 
(THOC5 [67]), or cancer development (THOC5 [68,69]). Second, both the proteins 
ALY/REF and the TREX component, THOC1, show tumor-specific expression 
differences, as well as variations in regional expression [69]. Lastly, TREX components are 
differentially regulated in the mouse testis and specifically regulate the expression of a subset 
of genes in this region [70]. Such observations are intriguing in light of our present 
observations, because the expression of Arc mRNA regulatory factors, BDNF [71] and 
NMD components [72,36], are also highly expressed in the testes, second only to expression 
within the mammalian brain, suggesting by analogy that there may also be neuron-specific 
roles for these factors in the regulation mRNAs, such as Arc. Thus, these recent studies 
suggest the possibility for tissue- and gene-specific regulatory roles for nuclear processing 
factors essential to nuclear mRNA export [63]. How these export factors are themselves 
expressed and regulated within striatal efferent neuron subpopulations remains to be 
determined. Further understanding the neuron-specific regulation of IEG nuclear export 
within striatal efferent neurons would offer essential understanding of normal basal ganglia-
dependent functions, as well as identify novel therapeutic targets in the treatment of basal 
ganglia-mediated pathologies.  
 
Future Directions 
Herein, we demonstrate that striatal efferent neuron subpopulations appear to 
differentially regulate nuclear posttranscriptional mRNA processing or nuclear export of the 
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activity-regulated mRNAs Arc and zif268, but not constitutively expressed Map2, in response 
to novel environment exploration. Unlike Arc, zif268 is not a candidate for cytoplasmic 
translation-dependent mRNA decay mediated by eIF4A3 and the EJC [6]. Thus, EJC-
dependent mRNA decay likely does not contribute to the observed differences in 
cytoplasmic Arc mRNA expression within striatopallidal vs. striatonigral neurons [5,19]. 
Despite the fact that eIF4A3 shares a similar expression profile and activation kinetics with 
Arc mRNA in response to behavioral activation and striatally-mediated learning [11], our 
observations that zif268 also shows differential cytoplasmic distribution within striatal 
efferent neurons suggests two potential alternative mechanisms contributing to the 
phenotypic differences in cytoplasmic mRNA expression. Thus, future studies must carefully 
examine these two potential mechanisms so as to definitively determine how cytoplasmic 
expression differences arise within striatal efferent neuron subpopulations. 
The first potential mechanism contributing to the observed differences in numbers 
of cells with Arc and zif268 in the cytoplasm could be a spatially restricted mechanism 
regulating mRNA cytoplasmic localization, such as nuclear posttranscriptional mRNA 
processing or nuclear export differences. Distribution of mRNA-protein (mRNP) complexes 
from the nucleus to the cytoplasm requires complex intracellular signaling and could thus be 
a critical processing point whereby neuronal mRNA transport is actively regulated [73,74]. 
Yet how nuclear export proceeds in neurons in general, and striatal efferent neurons in 
particular, requires further scrutiny. Future investigations into the regulatory processes 
mediating differences in nucleocytoplasmic mRNA localization within striatal efferent 
neurons are thus necessary. As described in Chapter 3, protein kinase A (PKA) has been 
shown to contribute to the nucleocytoplasmic export of proteins in vitro [75,76], but whether 
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  this kinase also plays a potential role in the regulation of mRNA export in striatal efferent 
neurons remains to be determined.  
Future studies must thus specifically examine how pharmacological manipulation of 
PKA in vivo alters the neuron-specific cytoplasmic localization expression of mRNAs, such 
as Arc and zif268. For example, preceding novel environment exploration with systemic 
administration of a D1-type DA receptor antagonist, such as SCH23390, would selectively 
inhibit activation of AC activity and thus production of PKA. Such D1-type DA receptor 
selective manipulations could thus potentially result in diminished numbers of striatonigral 
neurons with Arc or zif268 in the neuronal cytoplasm 30 minutes after novel environment 
exploration. Conversely, preceding novel environment exploration with systemic 
administration of A2A-receptor antagonists, such as istradefylline or preladenant, would 
selectively activate PKA only within striatopallidal neurons [77,78]. This alternative 
pharmacological treatment could then potentially augment the numbers of striatopallidal 
neurons with cytoplasmic IEG expression 30 minutes after novel environment exploration. 
These neuron-specific pharmacological manipulations would thus suggest that the key 
differences in nuclear mRNA export within striatal efferent neuron subpopulations likely 
arise due to differential activation of PKA mediated by neuron-specific DA receptors. 
The second alternative is that striatal efferent neurons have neuron-specific 
differences in cytoplasmic mRNA degradation that do not depend on the EJC, thus 
potentially contributing to the observed phenotypic differences in numbers of cells with 
cytoplasmic Arc and zif268 mRNA. While Arc mRNA is a candidate for NMD initiated by 
continued presence of EJCs within the 3’UTR following the first round of protein 
translation [6,79], the IEG zif268 is not a candidate for such mRNA regulation [6]. 
Additionally, while the core EJC component eIF4A3 showed an expression profile within 
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  the adult rodent brain very much like Arc mRNA (Chapter 2 [11]), the fact remains that 
mRNA degradation can proceed through multiple mechanisms, which are only beginning to 
be fully understood [72,80,81]. Thus, while zif268 may not be subject to Arc-like, EJC-
dependent NMD, it is possible that alternative mechanisms of mRNA decay mediated by 
EJC-independent pathways (i.e., UPF2/RNPS1-mediated NMD [81] or Staufen1-mediated 
mRNA decay (SMD [80])) could also potentially contribute to the observed phenotypic 
differences in numbers of striatal efferent neurons with cytoplasmic mRNA. At this point, it 
is unknown whether Arc or zif268 are candidates for these alternative branches of mRNA 
decay, although Arc does associate with Staufen1 [44] and could thus also be regulated by 
this pathway. Interestingly, both the EJC-dependent and independent branches of NMD 
(i.e., UPF2/RNPS1-activated), as well as SMD, all initiate mRNA degradation through a 
convergent mechanism: phosphorylation of UPF1 [72,82,80,83,81]. Preliminary examination 
of UPF1 phosphorylation within dorsomedial striatum following spatial exploration of a 
novel environment revealed a significant time-dependent increase in total field area with 
phosphorylated-UPF1 signal (Barker-Haliski and Keefe, unpublished). Thus, while UPF1 
phosphorylation may show activity-dependent increases in the adult mammalian striatum, 
the significantly delayed profile of phospho-UPF1 does not support the more rapidly 
observed differences in numbers of cells with cytoplasmic Arc and zif268. Additionally, there 
are more striatopallidal neurons with zif268 in the nucleus 30 minutes after novel 
environment exploration (Chapter 3), thereby making differences in cytoplasmic mRNA 
degradation a less-likely factor contributing to neuron-specific differences in numbers of 
cells with IEGs in the cytoplasm. Thus, future studies must more closely examine discrete 
markers of mRNA degradation pathways within striatal efferent neurons so as definitively 
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  determine whether nuclear mRNA export or cytoplasmic mRNA decay underlie neuron-
specific differences in cytoplasmic mRNA. 
While our preliminary analysis examined regional changes in striatal UPF1 
phosphorylation, it is possible that mRNA decay may still be differentially activated within 
striatal efferent neuron subpopulations, but that this difference cannot be readily identified 
by such global analysis of phosphorylated-UPF1. Such neuron-specific differential activation 
could thus also contribute to phenotypic differences in numbers of cells with mRNA in the 
cytoplasm. Future studies must thus examine the phenotype-specific phosphorylation state 
of UPF1 in response to neuronal stimulation paradigms, so as to clearly define whether 
mRNA decay is being differentially activated within striatal efferent neuron subpopulations. 
Furthermore, targeted pharmacological manipulation of mRNA decay components within 
striatal efferent neuron subpopulations could specifically tease apart the specific components 
contributing to such differences in cytoplasmic mRNA availability. For example, the general 
translation inhibitor cycloheximide (CHX) also specifically blocks NMD [84,85] by 
selectively disrupting the transient association of UPF1 with the EJC [82,86,87]. Although 
CHX still allows UPF1 phosphorylation, it stabilizes the association of UPF1 with the 
UPF3b-EJC-mRNA complex [88], thereby disrupting recruitment of the decay factors 
Dcp1a, Xrn1, and Rrp4 [82,86] and thus mRNA degradation. Conversely, the natural 
product Pateamine A (specifically, its active metabolite, desmethyl,desamino-Pateamine A 
(DMDA-PatA)) blocks EJC-dependent NMD by selectively trapping eIF4A3 in an unstable 
conformation, thereby disrupting the interaction of eIF4A3 with UPF1 and selectively 
inhibiting UPF1 phosphorylation necessary to initiate mRNA degradation [88,89]. Thus, 
these two inhibitors of NMD exert their effects by targeting different aspects of NMD 
activation, thereby providing useful tools to selectively examine one pathway of mRNA 
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decay within activated neurons. Furthermore, cytoplasmic expression of zif268 mRNA 
within both neuronal phenotypes would likely be immune to such pharmacological 
manipulations in vivo, whereas Arc mRNA, which is subject to EJC-dependent NMD [6], 
should be disrupted by both CHX and DMDA-PatA treatment. However, if such in vivo 
studies on Arc and zif268 show no change in numbers of cells with either IEG in the 
cytoplasm, it would further indicate that NMD does not contribute to the phenotypic 
expression differences within striatal efferent neuron subpopulations. Such studies using 
targeted pharmacological approaches could thus further define whether NMD is, in fact, 
playing a role in the phenotype-specific differences in numbers of cells with Arc or zif268 in 
the cytoplasm. 
Furthermore, using co-cultured primary striatal and cortical neurons from transgenic 
mice that selectively express reporter proteins for D1- or D2-type DA receptors [90], would 
allow for in vitro examination of NMD activation in isolated striatal neuron subtypes. 
Application of pharmacological compounds that target NMD, such as CHX or DMDA-
PatA, prior to stimulation of D1- or D2-containing neurons could selectively define in vitro 
whether EJC-dependent NMD might differentially regulate IEG mRNA cytoplasmic 
expression. Should these studies show no neuron-specific changes in numbers of cells with 
cytoplasmic IEGs, it would further indicates that either an alternative branch of mRNA 
decay (i.e., SMD) or phenotypic differences in nuclear export are mediating such cytoplasmic 
expression differences. Thus, using isolated striatal neuron subtypes would more clearly 
define whether mRNA degradation is mediating changes in numbers of cells with 
cytoplasmic IEG expression, and if so, clarify the specific mRNA decay process involved. 
Altogether, such in-depth investigations into the neuron-specific subcellular 
regulation of mRNAs examining either nuclear mRNA export processes or mRNA decay 
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  pathways will more fully define the basis for neuron-specific differences in the numbers of 
striatal neurons with cytoplasmic IEG expression. Examination of these processes under 
both normal conditions and in the context of neurological and neurodegenerative disorders 
would offer a yet unexplored level of differential cellular regulation underlying 
neuroplasticity processes within striatal efferent neuron subpopulations. Such studies would 
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